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Abstract 
Abstract 
The transmembrane sialomucin, CD34, is a marker of primitive 
haemopoietic stem and progenitor cells. Studies have implicated a role 
for CD34 in both heterotypic and homotypic cell adhesion and signalling 
pathways, including cell cycle regulation and control of haemopoietic 
progenitor cell self-renewal, potentially by influencing the balance 
between asymmetrical and symmetrical cell division. Asymmetrical cell 
division depends on cell polarisation, which may be conferred by location 
and/or interaction with neighbouring cells. The haematological synapse 
is proposed to be an adhesive structure formed between homotypically 
aggregated CD34-positive cells, which is analogous to the immunological 
synapse formed between a T cell and antigen-presenting cell. We aimed 
to investigate the mechanisms by which this specialised junction is 
formed and how it may be involved in the control of haemopoietic 
stem/progenitor cell division kinetics. 
KG1 and primary AC133-positive cells were found to be polarised 
prior to aggregation. As during immunological formation, additional 
adhesion molecules are recruited to the contact point between 
homotypically aggregated cells and are involved at different stages of 
adhesion, while others are actively excluded. The aggregation was found 
to be dependent on divalent cations and can be influenced by cytokines. 
Surface molecules became redistributed by mechanisms that included 
transport by lipid rafts and the interacting cells were able to communicate 
via gap junctions, the disruption of which abolished the effect of 
aggregation on self-renewal. Interaction between AC133-positive cells 
influenced the plane of cell division in a way that suggests unequal 
sharing of polarised surface markers including Notch-1 between daughter 
cell progeny. Therefore, interaction between haemopoietic stem and 
progenitor cells results in the formation of a 'haematological synapse', 
comparable to the immunological synapse, which functions in the contact-
mediated inhibition of haemopoietic progenitor cell self-renewal through 
modulation of the cell cycle and the plane of cell division. 
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Chapter 1. Introduction 
CHAPTER 1. INTRODUCTION 
1.1 Haemopoiesis 
Haemopoiesis is the process by which all cells circulating in the 
blood are formed and, in adult humans, takes place mainly in the bone 
marrow of the pelvis and sternum.1  A small population of haemopoietic 
stem cells (HSC), capable of both self-renewal and progenitor cell 
production, gives rise to eight major lineages as shown in Figure 1.1.2  
Figure 1.1 The hierarchy of haemopoietic cell development. LT-CIC- long-
term culture-initiating cell; CAFC- cobblestone area-forming cell; CFU-GEMM-
mixed lineage colony-forming cell; BFU-E- burst-forming unit erythroid; CFU-E-
colony-forming unit erythroid; CFU-MK- megakaryocyte colony-forming cell; 
CFU-Mast- mast cell colony-forming cell; CFU-Eos- eosinophil colony-forming 
cell; CFU-GM- granulocyte-macrophage colony-forming cell; CFU-G-
granulocyte colony-forming cell; CFU-M- macrophage colony-forming cell. 
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Within the marrow microenvironment, haemopoietic stem and 
progenitor cells are closely associated with the stromal cells of the 
marrow which produce a variety of haemopoietic growth factors and 
cytokines capable of regulating stem cell self-renewal, proliferation and 
death.' More than 30 haemopoietic cytokines and growth factors have 
been identified, which increase or decrease progenitor cell proliferation 
and differentiation. Cytokines such as granulocyte-macrophage colony-
stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-
CSF) and interleukin-3 (IL-3) activate a number of downstream signalling 
pathways including the phosphatidylinositol (PI)-3-kinase, Janus kinase 
(Jak)/ signal transducers and activators of transcription (STAT) and/or the 
mitogen-activated protein (MAP) kinase pathways thereby affecting cell 
cycle progression, cell survival and differentiation as well as cytoskeletal 
reorganisation. In particular, G-CSF and IL-3 in combination have been 
shown to significantly increase progenitor cell self-renewal, probably 
through the activation of more than one downstream signalling pathway.3 
These cytokines and growth factors may be soluble, stick to extracellular 
matrix components or may be expressed on the surfaces of stromal cells 
themselves. Therefore, adhesive interactions between progenitor cells 
and components of the marrow microenvironment are important in the 
regulation of both growth and differentiation.4  
1.2 Symmetrical and asymmetrical cell division 
The balance between self-renewal and differentiation must be 
tightly controlled in order to sustain haemopoiesis throughout life, without 
depletion of the stem cell pool.5 As well as control through extrinsic 
factors, such as cytokines, provided by the stem cell niche, self-renewal 
has also been proposed to be controlled through intrinsic mechanisms 
such as asymmetrical cell divisions It is thought that haemopoietic stem 
cell numbers are maintained through the balance between asymmetrical 
and symmetrical cell division.' 
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For a dividing stem cell, there are three basic possible outcomes 
as shown in Figure 1.2. Asymmetrical cell division leads to the production 
of one stem cell and one daughter cell capable of differentiation, thereby 
maintaining stem cell numbers. While asymmetrical division is associated 
with homeostasis, symmetrical division allows for expansion of stem cell 
numbers, necessary at times of physiological stress such as 
haemorrhage, through the production of two stem cells over two 
differentiated cells!' 8 Through symmetrical division, the size of the stem 
cell pool can be controlled through factors controlling self-renewal versus 
differentiation.9 
(a) 
	
(b) 	 (c) 
Figure 1.2. The possible outcomes of stem and progenitor cell division. 
The cell can either divide asymmetrically (a) producing one stem cell (white) and 
one daughter cell (blue), or symmetrically producing two stem cells (b) or two 
daughter cells capable of differentiation.8 
1.2.1 The regulation of asymmetrical cell division 
Studies in Drosophila have provided clues for the mechanisms 
controlling asymmetrical cell division within the haemopoietic system. 
Asymmetrical cell division can be conferred either by positioning the two 
daughter cells within different microenvironments, therefore exposing 
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each cell to different environmental signals, or by the uneven partitioning 
of cell fate determinants in the parent cell leading to their unequal 
inheritance by the daughter cells, established by the plane of cell 
division."' 11 
In the Drosophila germline, studies have indicated the importance 
of the niche in controlling stem cell division. A niche is defined as a set of 
cells or extracellular substrates that houses one or more stem cells and is 
capable of controlling their self-renewal and differentiation in vivo.12 Not 
only does this niche provide signals which control self-renewal and 
differentiation and anchor cells close to these signals, it has also be 
shown that adhesion between a niche cell and stem cell can result in 
asymmetrical cell division through stem cell polarization and orientation of 
the mitotic spindle."' 13 
Germline stem cells (GSC) in the Drosophila testes will usually 
divide asymmetrically, producing one stem cell and one gonioblast. A 
collection of somatic cells, known as the hub, provides the stem cell niche 
at the testis apical tip. These hub cells express Upd, the ligand that 
activates the Drosophila JAK/STAT pathways, which has been shown to 
be involved in GSC self-renewal.11 ' 14 It has been demonstrated that, in 
dividing stem cells, the mitotic spindle is orientated perpendicular to the 
hub-GSC contact point in all cases (Figure 1.3).13 In non-dividing cells in 
early interphase, where only one centrosome can be observed, it was 
found to be adjacent to the hub. Following centrosome duplication, the 
second centrosome can be seen to migrate to the opposite pole of the 
cell.11 Importantly, mis-orientated mitotic spindles resulted in the 
production of two stem cells through symmetrical division.13 The E-
cadherin homolog Shotgun (Shg) and the p-catenin homolog Armadillo 
(Arm) are found to localise at the GSC-hub cell interface indicating the 
involvement of adherens junctions as an anchor for these cells 
(discussed later).11 Additionally, Drosophila Apc2, a homolog of the 
adenomatous polyposis coli (APC) tumour suppressor also localises to 
this contact point.13 As APC proteins have been demonstrated to interact 
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with microtubules and p-caten in , this provides a likely mechanism for the 
link between the cell membrane and centrosome.11' 15 
The unequal segregation of cell fate determinants in the control of 
the symmetry of cell division has also been demonstrated in Drosophila. 
In neurogenesis, a neuroblast divides asymmetrically along the apical-
basal axis to produce one neuroblast and one smaller precursor cell, the 
ganglion mother cell (GMC). In turn, the neurons and glial cells of the 
central nervous system are produced through asymmetrical cell division 
of the GMC.16 
Neuroblast Sensory Organ 
Precursor (SOP) 
0 
Male germline 
stem cell 
Figure 1.3 Asymmetrical cell division in the male GSC is achieved through 
orientation of the mitotic spindle through adherens junction components. 
The cell in contact with the hub remains a GSC whereas the gonioblast has no 
contact with the hub cell. During mitosis in the neuroblast, cell fate determinants 
such as Baz/Par6/aPKC(red) and Pins and Gai (green) move to a crescent on 
the apical side of the cells whereas Numb and Prospero and associated proteins 
(blue) are found at the opposite pole. In SOPs Pins and Gai (green) are found at 
the anterior crescent together with additional determinants of cell fate such as 
Numb and Pon (blue).16 
Similarly, sensory organ precursor cells (SOPs) in the 
peripheral nervous system undergo a number of asymmetric divisions 
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leading to the production of 5 different daughter cell types. In both SOPs 
and GMCs, Numb becomes localised to a crescent (Figure 1.3) during 
mitosis, together with other cell fate determinants such as Prospero and 
Prospero mRNA and the adaptor proteins Partner of Numb (pon), 
Miranda and Staufen, and then is present in only one of the daughter 
cells at anaphase.17 In the neuroblast, a complex of proteins, known to be 
involved in establishing cell polarity, containing Bazooka/Par-3, Par-6 and 
aPKC, plus Gai and partner of Insecuteable (Pins) which is recruited to 
the complex by the adapter protein Insecuteable, is localised to the apical 
side of the cell, nearest the neural epithelium, where it regulates the 
orientation of the mitotic spindle as well as directing Numb and the other 
associated proteins to the basal side of the ce11.16' 18 In SOPs, in response 
to signals from the Wnt receptor Frizzled, the cell fate determinants Dig, 
Pins and Gai are polarised to the anterior crescent where they direct the 
movement of the Bazooka/Par-3, Par-6 and the aPKC complex to the 
opposite crescent.17' 19  Division along the apical basal axis in neuroblasts 
and along the anterior posterior axis in SOPs leads to asymmetrical cell 
division and the formation of two daughter cells with unequal amounts of 
these determinants.16 
In the developing mouse cerebral cortex, the size of the neocortex 
is determined by movement of the mitotic spindle, resulting in either 
asymmetrical or symmetrical divisions. Spindle rotation was observed 
prior to cell division, the exact position of which was proposed to be 
controlled by extrinsic or intrinsic signalling pathways.2° In mammalian 
neuroepithelial cells, the cleavage orientation during mitosis has been 
demonstrated to lead to the differential inheritance of adherens junctional 
proteins, thereby influencing how the daughter cells can respond to 
external stimuli.21  Studies in the developing mammalian cerebral cortex 
have revealed that Notch-1 is distributed unequally in mitotic cells. 
Following asymmetrical cell division, Notch-1 was found to be inherited 
exclusively by the daughter neuronal cell.22 The Notch family of 
transmembrane glycoproteins are known to play critical roles in cell fate 
34 
Chapter 1. Introduction 
determination and the maintenance of differentiation.23 Significantly, all 
four Notch receptors can be found on haemopoietic progenitor cells and 
their ligands, including Jagged-1,-2 and Delta-1 are expressed on bone 
marrow stroma but also, in the case of Jagged-1, on haemopoietic cells 
such as macrophages and megakaryocytes.24 Following ligand binding, 
the intracellular domain of Notch translocates to the nucleus where it acts 
as a transcriptional activator.23 In particular, Notch-1 has been shown to 
be expressed on haemopoietic progenitor cells, where it appears to be 
involved in cell fate decisions and the inhibition of differentiation.25 
Knockout of Notch-1, but not Notch-2, has been demonstrated to impair 
embryonic haemopoietic cell development.26 Both in vitro and in vivo, 
Notch-1 activation has been shown to inhibit haemopoietic stem cell 
differentiation, particularly along the myeloid lineage and, using 
secondary transplantation studies, increase self-renewal.23 Notch-1 is 
proposed to exert these effects through cell cycle control proteins, 
enhancing the degradation of the cyclin-dependent kinase inhibitors, 
p27kiP1  and p21ciP1.27 In haemopoietic progenitors, members of the cyclin-
dependent kinase inhibitor family have been demonstrated to decrease 
self-renewal, providing further evidence for a link between Notch-1 
signalling and haemopoiesis.28 However, in contrast to these results, 
Notch-1 signalling has also been shown to decrease progenitor cell self-
renewal and promote differentiation along a number of lineages.29 It has 
been suggested that the effect of binding to the ligand, Delta-1, may be 
dependent on ligand density.36 Therefore, the precise role of Notch 
signalling during haemopoietic stem and progenitor self-renewal and 
differentiation remains to be determined. 
1.3 Intercellular communication 
Direct interactions, between cells or between a cell and the extracellular 
matrix, are vital to the function of multi-cellular organisms. As well as 
allowing cells to aggregate into tissues and organs, these two basic types 
of interaction provide a means by which information can be relayed from 
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one cell to another or between a cell and the extracellular environment.31  
Cell proliferation, cytoskeletal organisation and cell polarity are among a 
number of aspects of cell structure and function that can be controlled by 
cell adhesion events.32 
1.3.1 Cell adhesion molecules 
Specific cell-to-cell adhesion is mediated by integral membrane 
proteins known as cell adhesion molecules (CAMS), a group that includes 
integrins, cadherins, selectins and members of the IgG superfamily. 
Through their extracellular domains, CAMS mediate homotypic adhesion 
between cells of the same type as well as heterotypic interactions 
between cells of different types. These interactions may be transient or 
more long lasting such as those between cells involved in maintaining the 
structure of solid organs.31  CAMS may bind the same type of CAM on 
another cell (homophilic). For example, binding between nerve cell 
adhesion molecules (N-CAMS) forms an association between cells during 
development. However, CAMS can also directly bind to a different type of 
CAM on an adjacent cell (heterophilic), for example, intercellular 
adhesion molecules (ICAMS) expressed on endothelial cells bind 
integrins on the surface of leukocytes during migration to sites of 
inflammation.33 The cytoplasmic domains of CAMS are often associated 
with a number of intracellular adapter proteins, which link the CAM to the 
cytoskeleton or to downstream signalling pathways leading to effects on 
gene expression and protein activity.31  
1.3.2 Intercellular junctions 
Although CAMS may be widely distributed across the cell surface, 
they are often found densely clustered together forming specialised cell 
junctions, a mechanism which ensures that a number of relatively weak 
interactions act in concert and lead to stronger adhesion.31  Intercellular 
junctions can be roughly divided into three main groups, anchoring, 
occluding and communicating junctions.34 
36 
Chapter 1. Introduction 
Anchoring junctions attach cells and their cytoskeletons to 
neighbouring cells or the extracellular matrix.34 Adherens junctions are 
one example of an anchoring junction and are known to play a role in cell 
to cell communication as well as cell adhesion and tissue organisation.35 
Adherens junctions connect actin filaments in adjacent cells and are 
commonly described between epithelial cells where they form a 
continuous adhesion belt. In adherens junctions, specialised cadherin 
proteins together with desmogleins and desmocollins, are linked to 
intermediate filaments and provide strength and rigidity to the epithelial 
layer by transmitting shear forces from one region to the whole cell 
layer.31  
Occluding junctions seal cells together in a sheet and prevent the 
passage of small molecules from one side to the other. The role of 
epithelial cell layers as barriers between fluid compartments and sites of 
selective transport is mediated by the presence of tight junctions which 
form part of this group. These consist of bands of plasma membrane 
proteins of the IgG superfamily which completely encircle a cell and form 
the closest known cell-to-cell contacts. In epithelial sheets, these 
junctions prevent the movement of ions and other molecules between 
cells and also help to maintain cell polarity by preventing the movement 
of lipids and membrane proteins between the apical and basolateral 
domains of the plasma membrane.33 
Communicating junctions mediate the passage of signals from one 
cell to another, a group which includes chemical synapses and gap 
junctions.34 
1.3.3 Gap junctions 
Gap junctions consist of two symmetrical cylinders, made up of six 
oligomerised transmembrane proteins called connexins, which attach 
head to head to form a direct channel between the cytoplasm of adjacent 
cells.36 The resulting hydrophilic pore allows ions and molecules of 
around 1 kDa or less, including second messengers such as cyclic-AMP 
and Ca2+, to pass freely through the channels while proteins and nucleic 
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acids cannot.38'33 Therefore, gap junctions function to couple the 
metabolic and electrical activities of adjacent cells. Many cell types have 
been demonstrated to communicate via gap junctions including cardiac 
and smooth muscle, epithelial cells and, more recently, progenitor cells 
and stromal cells of the bone marrow.37 
1.4 Adhesion and haemopoiesis 
1.4.1 The bone marrow microenvironment 
The bone marrow microenvironment is composed of stromal cells, 
including fibroblasts, reticular cells, endothelial cells and adipocytes, and 
extracellular matrix components such as fibronectin, laminin and 
proteoglycans.38 
1.4.1.1 Stromal cells 
Contact between haemopoietic cells and components of the of the 
marrow microenvironment, such as stromal cells and extracellular matrix 
proteins, are essential for the maintenance of normal haemopoiesis.39 
Cytokines such as GM-CSF and G-CSF are not uniformly distributed but 
are found on distinct areas of the cell surface of specific populations of 
stromal cells or bound to extracellular matrix proteins.40 This varying 
distribution probably provides different environments within the marrow 
that promote the growth of different progenitors.38 In particular, the 
addition of stromal cells to long-term progenitor cell cultures has been 
shown to significantly delay the production of CFU-GM compared to 
those cultured without stromal cells, indicating that adhesion of progenitor 
cells to the stroma may reduce quiescent cell activation.'" 
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1.4.1.2 The extracellular matrix 
The extracellular matrix is made up of components such as 
fibronectin, laminin and proteoglycans.38 It is now widely accepted that 
contact between cells and the extracellular matrix can affect cellular 
processes such as growth, differentiation and apoptosis.42  
1.4.1.2.1 Proteoglycans 
Proteoglycans are composed of a core protein surrounded by 
multiple sulphated side chains known as glycosaminoglycans (GAG).43 
Within the bone marrow microenvironment, these proteoglycans are 
present either on the surface of stromal cells or within the extracellular 
matrix. The precise function of proteoglycans in haemopoietic tissue 
remains unclear. However, as they are commonly found on cell 
membranes and are proposed to be important in cellular recognition, a 
possible role in the control of haemopoiesis is likely." It has been 
suggested that glycosaminoglycans can regulate cell growth indirectly 
through interaction with cytokines and their receptors or by affecting 
adhesion between progenitor cells and the extracellular matrix.43 In long-
term bone marrow cultures, treatment with xylosides, agents which 
stimulate GAG synthesis, leads to a 30-40-fold increase in chondroitin 
sulphate concentration in the culture medium associated with a dose-
dependent stimulation of haemopoiesis." Heparan sulphate on the 
surface of stromal cells binds both G-CSF and IL-3 and is therefore able 
to present these growth factors to haemopoietic cells.38 Additionally, 
heparan sulphate produced by cells of the M2-104B cell line added to 
bone marrow cultures leads to the maintenance of long-term culture-
initiating cells (LTC-IC).43 The GAG, hyaluronate (HA) also forms a major 
part of the extracellular matrix. CD44, expressed on CD34-positive 
progenitor cells, binds HA directly, and is therefore strongly implicated in 
mediating stromal/progenitor cell interactions.45 It has been concluded 
that GAGs may have three key roles in the regulation of haemopoiesis, 
by co-localising progenitors in specific areas of the marrow, by presenting 
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cytokines and, in the case of heparan sulphate, by having direct effects 
on growth by binding transcription factors or blocking cell cycle 
progression .43  
1.4.2 The role of adhesion molecules in haemopoiesis 
Haemopoietic progenitors express more than 20 different adhesion 
receptors including integrins, cadherins, selectins, CD44 molecules, 
members of the IgG superfamily and sialomucins.46 As well as functioning 
to retain progenitor cells within the marrow, these adhesion receptors 
may themselves act to produce growth or survival signals or regulate 
cytokine or growth factor-dependent signals, thus playing a key role in the 
regulation of haemopoiesis.4 Expression of these adhesion molecules 
may also enable stem and progenitor cells to localise to specific parts of 
the marrow where they are exposed to different growth factors or 
cytokines, thus playing a role in determination of cell fate.38 
1.4.2.1 Integrins 
The 22 members of the integrin family are heterodimers composed 
of 1 of 14 a chains and 1 of 8 13 chains.47 Integrins often exist on resting 
cells in a low affinity state, unable to bind well to their ligands. lntegrin 
activation may be through 'inside-out' signalling where cytokines or other 
surface receptors lead to the production of second messengers, including 
PI3-kinase, which are responsible for inducing intracellular signals 
commonly resulting in integrin regulation through interaction with the actin 
binding protein talin.48-5° Activation of integrins may either result from an 
increase in the affinity for ligand binding due to conformational changes in 
the extracellular domain of the receptor or an increase in avidity of the 
interaction due to receptor clustering.51  As well as 'inside-out' signalling, 
integrins can also be activated externally by divalent cations.52 All integrin 
receptor/ligand binding is dependent on divalent cations such as Mg2+ 
and Ca2+, although they may have multiple effects depending on the cell 
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type and context and can be involved in both enhancing and reducing 
ligand binding."' 53' 54 
The 131 (CD29), p2 (CD18) and 133 (CD61)-containing members 
have been identified on haemopoietic progenitor cells, the most widely 
studied being a4131 (VLA-4 or CD49d/CD29) and a5f31 (VLA-5 or 
CD49e/CD29), which are present on more than 50% of marrow-derived 
CD34-positive cells.47 These 131 integrins are involved in 'homing' and 
retention of progenitor cells within the bone marrow.55 Signals from other 
receptors can regulate the binding of VLA-4 and VLA-5 to their ligands, 
vascular cell adhesion molecule-1 (VCAM-1) and fibronectin.56 Cytokines 
have also been shown to both activate and increase the expression of 
integrin adhesion molecules on haemopoietic progenitor cells and 
therefore influence both cell-to-matrix and cell-to-cell interactions.57' 58 
Additionally, the cytoplasmic tails of integrins interact with a number of 
cytoskeletal proteins and form focal adhesion complexes. Through these 
interactions, the extracellular matrix becomes linked to the actin 
cytoskeleton potentially leading to changes in cell shape.59 In migrating 
astrocytes, integrin activation has been demonstrated to recruit mPar6 
and PKC to the leading edge of the cell and is therefore essential for 
establishing cell polarity.60 Importantly, signal transduction molecules 
such as PI3-kinase have been shown to be recruited to these focal 
adhesion complexes resulting in the activation of downstream signalling 
pathways involved in proliferation and differentiation." In chronic myeloid 
leukaemia (CML), the abnormal circulation and proliferation of progenitor 
cells has been linked to defects in 31 integrin-mediated adhesion.62 
Upregulation of the cyclin-dependent kinase inhibitor, p27, decreased 
expression of cyclin E and reduced cyclin E-cdk 2 activity have been 
reported following 131-receptor engagement on CD34-positive cells 
showing that (31 integrins are linked to control of the cell cycle.63 
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1.4.2.2 Cadherins 
E- (Epithelial), P- (Placental) and N- (Neural) cadherin mediate 
calcium-dependent homophilic cellular interactions. Their cytoplasmic 
domains are linked to the cytoskeleton through a group of proteins known 
as catenins and thereby influence cell migration." Cadherins have been 
shown to be essential during embryonic development, N-cadherin knock-
out mouse embryos die around day 10.65 However, the expression and 
function of cadherins within the haemopoietic system is less clear. E-
cadherin has been found on progenitors of the erythroid lineage only.66 
However, N-cadherin has been reported to be expressed both on a sub-
population of early progenitor cells as well as on marrow stromal cells. 
Blocking antibodies to N-cadherin lead to a dose-dependent reduction in 
cytokine-induced colony formation indicating an involvement in progenitor 
cell development. These antibodies also reduced homotypic aggregation 
between cells of the KG1a cell-line suggesting a role for N-cadherin in 
adhesion between progenitor cells.67 
Members of the cadherin family cluster at the point of cell-to-cell 
contact forming specialised structures known as adherens junctions." 
Through their intracellular tails, the cadherins are connected to the actin 
cytoskeleton via a or 13 catenin.35 These adherens junctions have been 
reported to be essential in controlling the axis of cell division, 
demonstrated by the finding that, in Drosophila, disruption of adherens 
junction-associated components leads to asymmetric epithelial divisions 
during embryogenesis instead of the usual symmetric divisions." From 
studies on the Drosophila ovary, it has been hypothesized that the 
cadherins themselves may provide spatial clues to stem cells and are 
therefore involved in their regulation. In their niche, germ stem cells are in 
contact with neighbouring differentiated cells and the basement 
membrane. The asymmetric division of one of these stem cells results in 
self-renewal, producing one stem cell and one daughter cell. In 
Drosophila germ stem cells, it is the physical dissociation of the daughter 
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cell from the specialised environment that deprives it of self-renewing 
signals leading to differentiation." In agreement with this, when DE 
cadherins are reduced or absent, the germ stem cells no longer interact 
with cap cells of the ovary and have been shown to differentiate 
prematurely." Therefore, cadherins may play a role in influencing self- 
renewal and differentiation in multipotent 	68 The adherens 
junctions components N-cadherin and p-catenin have also been shown to 
be asymmetrically localised on HSC attached to osteoblasts, an 
interaction which has been proposed to be partly responsible for 
maintenance of the niche size.71  
1.4.2.2.1 Wnt signalling 
As well as linking cadherins to the actin cytoskeleton, p-catenin is 
also a transcription co-factor in the Wnt signalling pathway. The Wnt 
pathway is involved in a number of cellular processes including the 
regulation of proliferation and differentiation." Activation of this pathway, 
through Wnt binding to its receptors, members of the frizzled family, 
inhibits glycogen synthase -313 (GSK-313), a serine/threonine kinase, 
which, together with casein kinase I (CKI) and complexed with APC and 
axin, is responsible for the ubiquitination and degradation of 13-catenin 
through its phosphorylation."' 72 It is the resulting accumulation of 
cytoplasmic f3-catenin with the transcription factor T cell factor/lymphoid 
enhancer factor (TCF/LEF) that leads to target gene expression." It has 
been proposed that the two functions of 13-catenin are not mutually 
exclusive and that factors which affect Wnt signalling may also mediate 
cadherin/catenin binding." In particular, the 13-catenin/TCF complex has 
been shown to bind to the E-cadherin promoter in murine keratinocytes 
causing down-regulation indicating that the variety of pathways which 
intersect with the Wnt pathway may influence each other." 
In murine haemopoietic progenitors, inhibition of the Wnt pathway 
reduces haemopoietic stem cell growth in vitro and decreases in vivo 
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reconstitution. Therefore it was concluded that Wnt proteins promote 
growth and inhibit differentiation within the haemopoietic system.74 
Parts of the Wnt pathway are also directed towards cytoskeletal 
signalling pathways and the control of cell polarity. Studies in Drosophila 
have shown that the Wnt pathway is involved in planar polarity signalling, 
a pathway which has also been implicated in the control of epithelial cell 
polarity in vertebrates." The interaction between Frizzled and cadherin-
like cell adhesion molecules such as Fat and Dachsous, plus the 
membrane associated signalling molecule Four Jointed, activate Frizzled 
and are responsible for cell asymmetry through an unknown 
mechanism." 
Another component of the Wnt signalling pathway, APC, has been 
shown to localise to the end of microtubules and have been suggested to 
play a key role in microtubule-dependent cell migration.15 Additionally, 
APC has been shown to form a complex with the polarity complex, 
mPar3/mPar6/aPKC, which are present at the tip of developing 
hippocampal neurons in culture and is responsible for neuronal polarity. 
APC deletion leads to defects in neural polarity, as does inhibition of 
GSK-3p, indicating that both these components of the Wnt pathway may 
contribute to cell polarization." 
1.4.2.3 Selectins 
The selectin family of glycoproteins consists of three structurally 
related members, E- (Endothelial), P- (Platelet) and L- (Leukocyte) 
selectin, all of which are involved in the calcium dependent adhesion of 
leukocytes to vascular endothelial cells and platelets."' 79 Haemopoietic 
progenitor cells express L-selectin and ligands for both P- and E-selectin. 
The role of L-selectin on CD34-positive stem and progenitor cells is 
unknown, although a role in progenitor cell homing was indicated by the 
finding that the platelet recovery following PBSC transplantation 
correlated with the level of L-selectin expression.°  Ligands for 
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haemopoietic cell L-selectin have also been suggested to include CD34, 
present on blood vessel endothelial cells, including those of the bone 
marrow stroma.81  Both P- and E-selectin have been reported to be 
expressed on endothelial cells of the bone marrow." A role in progenitor 
cell homing was suggested by the finding that blocking antibodies to both 
P- and E-selectin reduce progenitor cell rolling on bone marrow venules 
and sinusoids.82 The ligand for P-selectin on CD34-positive cells is the 
sialomucin P-selectin glycoprotein ligand-1 (PSGL-1), and is discussed 
late r.83 
1.4.2.4 CD44 
The CD44 family is a diverse group of transmembrane 
glycoproteins, due to alternative splicing and varying glycosylation.45  
Haemopoietic stem and progenitor cells most commonly express 
standard CD44, the smallest isoform which lacks the entire variable 
region." The extracellular domain of CD44 interacts with hyaluronic acid 
in the bone marrow extracellular matrix." 
CD44 is proposed to have roles in regulating both cell-cell and cell-
matrix adhesion. CD44 is found to be localised to areas of actin 
polymerisation and is linked to the cytoskeleton through members of the 
ezrin-radixin-moesin (ERM) family of cytoskeletal-linker proteins. ERM 
proteins also act as scaffolds for the association of signalling molecules 
such as protein kinase C (PKC).85 Therefore CD44 is thought to be 
involved in signalling cascades though the actin cytoskeleton.86 CD44 
itself has no intrinsic kinase activity. However, its intracellular tail forms 
complexes with signalling molecules such as the Rho-GTPases and 
members of the family of tyrosine kinases, some of which have been 
shown to be phosphorylated after antibody stimulation of CD44. CD44 
can also act as a co-receptor for growth factors and cytokines and the 
ErbB family of receptor tyrosine kinases where CD44 is essential for 
kinase activity and is therefore involved in the regulation of cell survival, 
proliferation and differentiation.85 
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Antibody engagement of the standard isoform of CD44 leads to 
reduced homing of CD34-positive cells to the bone marrow and spleen in 
the rat. These progenitor cells also display reduced settlement on 
cultured stromal elements. Engagement of a variant isoform has been 
shown to reduce stroma formation in long-term bone marrow cultures and 
inhibit T cell maturation." In agreement with these findings, CD44 and 
HA are essential for the homing of human CD34-positive cells to the 
spleen and bone marrow of mice. Additionally, stromal cell-derived factor-
1 (SDF-1) was shown to enhance progenitor cell adhesion to HA. In 
response to a HA gradient, these progenitor cells developed a polarized 
morphology accompanied by cellular migration along this gradient. 
Therefore, CD44 is proposed to be important in SDF-1 dependent 
migration of stem/progenitor cells to the bone marrow." 
1.4.2.5 The IgG superfamily 
The IgG family of cell adhesion molecules has more than 100 
members with diverse structures and functions.88 One member of this 
family implicated in haemopoietic progenitor cell adhesion is 
platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31). 
PECAM-1 is expressed on platelets, granulocytes, monocytes, 
endothelial cells, and some T cells as well as on CD34-positive cells, 
where it supports homophilic cell adhesion as well as heterophilic cell 
adhesion to heparan and chondroitin sulphates. Engagement of PECAM-
1 on bone marrow CD34-positive cells using specific antibodies increases 
VLA-4 mediated aggregation to VCAM-1 indicating the role of PECAM-1 
in integrin activation signalling pathways as well as direct cell-cell 
adhesion." 
1.4.3 Gap junctions and haemopoiesis 
As well as communication through cell surface ligands and their 
specific receptors, it has also been proposed that gap junctional 
communication may play a role in haemopoiesis." Connexin 43 (Cx43) 
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has been found to be constitutively expressed by fat cells and stromal 
cells within the bone marrow. Additionally, in cell lines, stromal cells are 
coupled extensively by Cx43 gap junctions.91  Gap junctional interactions 
have been demonstrated between stromal and blood cells, as well as 
among stromal cells themselves, by the transfer of the gap junction 
probe, Lucifer Yellow.37 Durig et a/. demonstrated that primary CD34-
positive cells become electrically coupled to stromal cell lines through 
Cx43 gap junctions within one hour of attachment.92 Additionally, when 
haemopoiesis is increased, expression of Cx43 in mouse marrow has 
been shown to increase by at least one order of magnitude. Similarly 
when gap junctional communication between stromal cells and 
haemopoietic cells was reduced to 2% of normal levels, blood formation 
stopped, indicating the importance of gap junctional communication in the 
maintenance of haemopoiesis.93 A role for gap junctional communication 
in progenitor cell self-renewal is indicated by the preliminary finding that 
in T cells and haemopoietic progenitor cells, homotypic and heterotypic 
aggregation induced by anti-sialomucin antibodies is accompanied by the 
transfer of calcein, a dye which passes through gap junctions. As this 
aggregation significantly reduced progenitor cell self-renewal it is possible 
that gap junctions may play a key role in this process." 
1.5 The Immunological Synapse 
While the concept of the neuronal synapse has existed for more 
than a hundred years, its counterpart within the immune system has been 
identified more recently.95 The immunological synapse is a specialised 
junction at the contact interface between a T cell and antigen-presenting 
cell which is formed through a multi-step process involving receptor 
ligation and cytoskeletal polarization.96 Through this interaction, antigen 
receptors on the T cell surface recognise antigenic peptides bound to 
major histocompatibility molecules (MHC) on the antigen-presenting 
cell." The characteristic distribution of cell surface molecules at the 
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synapse provides a stable contact point for the sustained signalling 
required for T cell activation.96 
1.5.1 T cell polarization 
Circulating, unstimulated T cells are rounded with a uniform 
distribution of receptors across their cell surfaces.98 However, in response 
to a chemokine gradient or following ligation of antigen receptors, T cells 
become polarised meaning that they become morphologically and 
functionally asymmetrical with a leading edge, or lamellapodium, rich in 
adhesion molecules and chemokine receptors, together with a trailing 
edge, or uropod, at the rear.98' 99 These adhesion molecules have 
increased avidity compared to those on the resting T cell to enhance T 
cell-antigen-presenting cell interaction, potentially induced by exposure to 
chemokines.10°  
Following initial antigen recognition, a T cell becomes polarized 
with respect to the antigen-presenting cell, an effect which is dependent 
on an intact cytoskeleton and is accompanied by a sharp increase in 
intracellular calcium levels within the T cell.96 The microtubule organising 
centre, or centrosome, is usually located at the trailing end of a migrating 
cell, however early signalling events lead to its relocation between the 
target cell and the nucleus.101 This is accompanied by an increase in 
actin polymerisation and accumulation of F-actin at the contact 
interface.102  
Both cytoskeletal polarization and receptor redistribution following 
early antigen recognition events are proposed to be regulated by the 
Rho-GTPases including RhoA, Cdc43Hs and Rac1 , which are activated 
by the GTP/GDP exchange factor Vav1.99 Following early TCR triggering, 
the activation of Vav1 is elicited by tyrosine phosphorylation and/or 
products of the PI3-kinase pathway.103 The Rho-GTPases are proposed 
to be coupled to the cytoskeleton by effector proteins which themselves 
regulate actin-binding proteins.99 
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Many of the proteins involved in cell polarity in Drosophila such as 
Par3 and Dig contain protein-binding domains known as PDZ domains 
(See section 1.2.1).1" These proteins form complexes which regulate cell 
polarity by the recruitment of cell surface and signalling molecules, 
interactions with the cytoskeleton and by directing the redistribution and 
activity of other PDZ-domain containing proteins. Recently PDZ domain-
containing proteins have been identified in T cells and have been found to 
differentially localize during T cell polarization. Knock-out of one of these 
proteins, Scribble, was shown to inhibit the redistribution of cell surface 
receptors indicating that, as in Drosophila, PDZ-domain containing 
proteins may be responsible for defining particular sub-domains during T 
cell polarization.105 
1.5.2 Immunological synapse formation 
Cell surface molecules at the contact interface arrange into distinct 
regions or clusters known as the immunological synapse, which is 
proposed to be necessary for the T cell to integrate stimulus from antigen 
recognition together with co-stimulus from the antigen-presenting cell. 
Initially the adhesive contact is between a central cluster of adhesion 
molecules such as the (32 integrin lymphocyte function-associated 
antigen-1 (LFA-1) on the T cell surface and ICAM-1 on the antigen-
presenting cell.106 This close adhesion functions to bring the clustered T 
cell receptor (TCR) and MHC molecules, initially located in an outer ring 
surrounding the central zone, into close enough proximity for stable 
interaction."' LFA-1-mediated signalling itself has been implicated in 
remodelling the actin cytoskeleton through Rac-1 activation through Vav 
and Pl3kinase and therefore may contribute to immunological synapse 
formation by more than one mechanism.108,109 
Within minutes of MHC-peptide engagement, signalling events 
cause the TCR-MHC complex to move into the centre of the contact 
interface. This area is termed the central supramolecular activation 
cluster (c-SMAC) and also contains co-stimulatory molecules such as 
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CD28 and CD80, together with associated signal transduction molecules 
such as PKC-0.99 LFA-1, bound to its ligand ICAM-1, moves to a ring 
surrounding this central zone. This area is termed the adhesion ring or 
peripheral supramolecular activation cluster (p-SMAC) and contains a 
number of other molecules including the actin binding protein talin.1°7 
Together, these separate domains form the stable 'bulls-eye' structure of 
the immunological synapse as shown in Figure 1.4.107,110 Due to its large 
size and negative charge, like CD44 and CD45, CD43 is actively 
excluded from the immunological synapse which is proposed to aid 
integrin-mediated adhesion by removing steric hindrance.1" In order for 
cytoskeletal changes to affect changes in membrane molecule 
distribution, these molecules themselves must be linked to the 
cytoskeleton. Candidate cytoskeletal-linker proteins include members of 
the ERM family and talin.112 
1.5.3 TCR signalling 
The T cell receptor is composed of a heterodimer of one a and one 
p chain which is responsible for antigen recognition, associated with one 
homodimer of chains and CD3 which consists of one y, one 8 and two c 
chains which possess Immunoreceptor Tyrosine-based Activation Motifs 
(ITAMS) enabling signal transduction.113 
Upon engagement of the TCR, members of the family of protein 
tyrosine kinases (PTK) initiate downstream signalling pathways by 
phosphorylating ITAMs on the 	and CD3 subunits of the TCR.114 
Members of the Syk-family kinases, ZAP-70 and Syk, are then recruited 
to the phosphorylated receptor and activated. A number of signalling 
pathways are then activated by the resulting PTK activity including 
activation of phospholipase C which in turn leads to an increase in 
intracellular calcium levels and activation of protein kinase C (PKC) 
through the production of inositol 1,4,5 triphosphate (1P3) and 
diacylglycerol (DAG) respectively. Also the ERK/MAP kinase cascade 
becomes stimulated through the activation of the small GTP-binding 
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protein Ras. Together, these signalling pathways result in T cell activation 
by inducing the transcription of cell cycle entry genes including growth 
factors such as IL-2.115 Ultimately, as a result of TCR-MHC/peptide 
engagement, T cells proliferate and differentiate into effector cells 
capable of orchestrating the adaptive immune response.107,116 
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Figure 1.4 The mature immunological synapse. a. shows the T cell and 
antigen-presenting cell in profile. The stimulatory MHC-peptide complex is 
shown in red, co-stimulatory molecules are shown in blue while inhibitory 
molecules are yellow. Molecules that do not participate in signalling are shown 
in grey. The arrow indicates converging signalling pathways that result in T cell 
activation. b. shows the face on view with the characteristic `bull's eye' pattern of 
receptor segregation. The c-SMAC is shown in brown, the p-SMAC is green, 
while molecules that are specifically excluded from the synapse are shown in 
the grey zone."' 
1.6 Lipid rafts 
The fluid mosaic model of the cell membrane, in which lipids are 
randomly distributed within the bilayer, has recently been revised due to 
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the discovery of patches of certain lipids forming distinct membrane 
domains known as 'rafts'.117 
1.6.1 Lipid raft structure 
The outer leaflet of biological membranes is composed of 
sphingolipids, glycosphingolipids and phosholipids, for example, 
phosphatidylcholine. In contrast, the inner leaflet mainly contains 
phospholipids such as phosphatidylserine. Lipid rafts are composed of 
glycosphingolipids and cholesterol, the attractive forces between which 
are proposed to be responsible for the existence of these domains within 
the otherwise unsaturated phospholipid environment.117118 The rafts are 
proposed to make up 40% of immune cell membranes although this 
figure may vary substantially between different cell types.119 In resting 
cells, rafts are proposed to be sub-microscopic structures of less than 
50nm in diameter and may be dynamic, continually forming and 
dispersing.119,117 However, cross-linking of proteins within these rafts 
leads to their coalescence forming larger platforms, potentially more than 
500nm in diameter, depending on the cell type.118 Lipid rafts can be 
distinguished from other areas of the cell membrane by their insolubility in 
non-ionic detergents such as Triton-X or Brij at low temperatures and 
their light low-density buoyancy in sucrose gradients.117'12° Particular 
proteins are also detergent insoluble and therefore reside within lipid 
rafts, some of which are commonly used as raft markers.117 These 
include those associated with the outer leaflets of rafts such as 
glycosylaphosphatidylinositol (GPI)-linked proteins, for example, Thy-1.121 
Alternatively, cytoplasmic dually acylated proteins such as the -family 
tyrosine kinase, Lyn are associated with the inner leaflet of these 
rafts.122,117 
1.6.2 Lipid raft function 
By concentrating certain cell surface receptors and signalling 
molecules, lipid rafts are proposed to act as important platforms for cell 
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adhesion, signal transduction and membrane trafficking.123 Specifically, 
these rafts are proposed to act to organise the TCR, co-stimulators, 
signal transduction molecules and the actin cytoskeleton at the 
immunological synapse.121  
1.6.2.1 Lipid rafts and T cell function 
A number of proteins involved in early T cell signalling events are 
found to be constitutively associated with lipid rafts, including the protein 
tyrosine kinases Lck and Fyn and the adaptor protein LAT.122 By cross-
linking and staining rafts using FITC-labelled cholera toxin-B, 
engagement of the T cell receptor has been shown to lead to the 
transport and clustering of lipid rafts at the immunological synapse. This 
raft polarization was proposed to involve an intracellular signalling 
pathway including Vavl , Rac and reorganisation of the actin 
cytoskeleton.124 In resting cells, the TCR is excluded from lipid rafts. 
However, rafts clustered at the immunological synapse are found to 
contain increased concentrations of the hyperphosphorylated T cell 
receptor together with associated signal-transduction molecules such as 
ZAP-70, Vav, PLC, PKC8 and PI3-kinase.117, 121, 125 Treatment of T cells 
with methyl-13-cyclodextrin (MBCD), an agent which extracts cellular 
cholesterol and therefore disrupts lipid rafts, had been shown to inactivate 
the TCR signalling cascade, indicating the importance of lipid rafts in TCR 
signal transduction.126 However, it has been suggested that, while lipid 
rafts are necessary for early events in T cell signal transduction, TCR 
signalling pathways induced by anti-CD3 antibodies are raft independent. 
As these earlier pathways involve co-stimulatory molecules such as 
CD28, it is hypothesized that rafts may be involved in CD28-associated 
signal transduction and T cell 'priming', enabling them to respond to lower 
levels of antigen."' Also, lipid rafts on antigen-presenting cells have been 
found to contain class II MHC molecules and are proposed to act as 
platforms to deliver raft associated class II-peptide complexes to the 
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immunological synapse, demonstrating an additional method by which 
lipid rafts facilitate T cell activation.127 
Additionally, treatment of T cell lines and primary T cells with 
MBCD has been shown to significantly reduce LFA-1 mediated 
adhesion.128 However, LFA-1 could only be found in lipid rafts in T cell 
lines isolated with 0.05% Triton X while LFA-1 in primary T cells was only 
found within rafts isolated using an alternative detergent, Brij 35. It has 
been suggested that extraction of lipid rafts with Triton X-100 may cause 
components to be lost from rafts, especially those with only a weak 
association.129 However, when levels of cholesterol and the ganglioside 
GM1, a lipid raft marker, were compared in T cell lines and primary T 
cells, GM1 levels were found be significantly higher in primary T cells 
while cholesterol levels were significantly lower. Additionally, LFA-1 
colocalises with cholesterol but not GM1 in primary T cells indicating that 
LFA-1 exists in cholesterol rich, GM1 poor rafts while in T cell lines, LFA-
1 is present in lipid rafts enriched in both. Together, these results suggest 
that lipid rafts are heterogeneous and specific molecules may localise 
within subsets of rafts.128 In agreement with this suggestion, the leading 
edge of and uropod of T cells have distinct clusters of rafts with different 
compositions. Those at the leading edge are enriched in the raft marker, 
ganglioside-3 (GM-3) together with chemokine receptors. However, those 
rafts at the uropod contain GM1 and cell adhesion molecules such as 
CD44. It was therefore concluded that distinct raft subtypes may be 
responsible for the redistribution of certain molecules to distinct areas of 
the cell membrane.13° 
1.6.2.2 Lipid rafts and other cell types 
B cells 
It has also been proposed that lipid rafts play a key role in B cell 
signalling, both in its initiation and its control."' Like the TCR, the B cell 
receptor (BCR) is also excluded from lipid rafts in resting cells. However, 
following BCR cross-linking it becomes recruited into rafts without the 
initiation of BCR signalling.131 These rafts have been shown to coalesce 
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into larger patches following BCR stimulation.132 Additionally, proteins 
involved in BCR signalling such as Lyn and IgGa become phosphorylated 
within the rafts, followed by phosphorylation of the BCR itself.133 Rafts are 
also proposed to enhance B cell signalling by recruiting the co-receptor 
complex CD19-CD21 as B cell stimulation proceeds."' 
Mast cells 
In both mast cells and basophils, initial signalling events following 
antigen stimulation involve phosphorylation of the IgE receptor by Lyn. In 
RBL-2H3 mast cells, cross-linking of this receptor has been shown to 
lead to its localisation within lipid rafts. Also, MBCD treatment significantly 
reduces phosphorylation of the IgE receptor, together with structural 
interactions between the receptor and Lyn.134 
Endothelial cells 
During leukocyte adhesion to endothelial cells, adhesion 
molecules on the endothelial cells cluster at the point of contact through a 
signalling mechanism involving members of the Src family of tyrosine 
kinases. In human umbilical vein endothelial cells (HUVEC), adhesion of 
cells of the monocytic cell line THP-1 leads to recruitment of both E-
selectin and ICAM-1 into lipid rafts. This was proposed to be a 
mechanism whereby these adhesion molecules can associate with 
members of the family.135 
Haemopoietic stem/progenitor cells 
Lipid rafts have been proposed to play a role in the polarization of 
human CD34-positive stem and progenitor cells. Using 
immunofluorescence, the cholesterol binding stem/progenitor cell marker 
CD133 has been shown to be located at the uropod of polarised CD34-
positive cells together with several adhesion molecules such as CD43, 
CD44, ICAM-1 and ICAM-3. As CD133 has been shown to be localised 
within lipid rafts, it was concluded that lipid rafts are clustered at the 
uropod of these cells.136 Through the utilisation of specific inhibitors, this 
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polarization was shown to depend on PI3-kinase activity. Other molecules 
such as CD34 and CD45 were shown to remain spread over the entire 
cell surface whereas the raft marker, GM1 was localised to the leading 
edge of these cells, suggesting that a subset of rafts also localises at this 
point.137 
1.7 The Haematological Synapse 
1.7.1 The Haematological synapse 
An adhesive structure formed at the contact point between 
homotypically aggregated CD34-positive cells is proposed to constitute 
the haematological equivalent of the immunological synapse. Madjic et al. 
were the first group to show that cells of the CD34-positive cell line, 
KG1a, will aggregate when incubated with the class II anti-CD34 
antibody, QBEND10.138 This aggregation was found to be accompanied 
by actin polymerisation and is dependent on ATP, divalent cations and an 
intact cytoskeleton. Blocking antibodies to LFA-1 and ICAM-1 have been 
shown to significantly inhibit QBEND10 induced aggregation. Therefore, 
this aggregation is proposed to be caused, in part, by the simultaneous 
activation of the p2 integrin adhesion pathway.138 
More recently, KG1a cells incubated with either anti-CD34 or anti-
CD43 have been shown to form multi-cellular aggregates. This is 
accompanied by the formation of a cap of CD34 or CD43 respectively, 
which colocalises with F-actin. Stimulation with either anti-CD34 or anti-
CD43 induces the tyrosine phosphorylation of novel proteins through the 
non-receptor tyrosine kinases Syk and Lyn indicating the signalling 
potential of this aggregation .139  
CD34-positive cells isolated from normal bone marrow have been 
shown to aggregate when incubated with QBEND10, with CD34 localised 
at the intercellular contact points. CD34-positive cell-to-cell adhesion was 
also confirmed to be a normal physiological process in vivo and in vitro. 
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CD34-positive cells in developing myeloid colonies (CFU-GM) and 
haematons, (multi-cellular aggregates) isolated from freshly aspirated 
bone marrow were bound together with CD34 localised at the common 
contact point between the cells. The aggregation of KG1a and CD34-
positive cells was found to be inhibited by genistein, a protein tyrosine 
kinase inhibitor and enhanced by staurosporine, a PKC inhibitor, 
indicating the involvement of cellular signalling pathways. In agreement 
with this, upon aggregation, CD34 on KG1a cells was found to have 
increased phosphorylation of tyrosine on its intracellular tail accompanied 
by the translocation of PKC from the membrane to the cytoplasm. 
Importantly, QBENDIO-induced aggregation was also found to 
significantly reduce progenitor cell self-renewal.1" Engagement of CD34 
with antibodies to alternative epitopes had no effect on progenitor cell 
proliferation indicating that the effect seen is due to aggregation and 
specific epitope recognition, not merely antibody binding (M.Gordon, 
personal communication). In addition to this, aggregation of KG1a cells 
was found to down-regulate proteins of the retinoblastoma (Rb) pathway 
including p107, p130, pRb and E2F and up-regulate the cyclin-dependent 
kinase inhibitors (CKIs), p16Ink4a and p 27Kipl (Bullock et al., submitted 
2006), all of which play key roles in the regulation of the cell cycle shown 
in Figure 1.5.28' 141  
Regulation of the G1 checkpoint, referred to as the checkpoint of 
cell growth, involves three groups of proteins, the cyclins, the cyclin-
dependent kinases (CDKs) and the cyclin dependent kinase inhibitors. 
E2F is a transcription factor essential for progression through the cell 
cycle. Hypophosphorylated members of the Rb family of proteins, 
including p107, p130 and pRb, bind E2F and keep it in an inactive state. 
E2F is released when Rb proteins are phosphorylated by the cyclin D-
CDK4 complex. In turn, the cyclin-dependent kinase inhibitors, including 
p16 and p27, are negative regulators of this complex, thereby preventing 
Rb phosphorylation and E2F release.142 
The observed down-regulation of Rb proteins together with up-
regulation of the CKIs suggests that aggregation induced by anti-CD34 
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has an effect on the regulation of the cell cycle. It was therefore 
concluded that the aggregation of CD34-positive cells may function to 
prevent inappropriate proliferation in vivo and, therefore, expression of 
CD34 may be an important control mechanism in the maintenance of 
normal haemopoiesis.14°  
Figure 1.5 Control of the G1 to S phase checkpoint of the cell cycle. 
Proteins of the retinoblastoma (Rb) family sequester the transcription factor E2F. 
The phosphorylation of Rb proteins by the cyclin D-CDK4 complex leads to E2F 
release which allows cells to pass the restriction (R) point. The cyclin D-CDK4 
complex is, in turn, negatively regulated by the cyclin-dependent kinase 
inhibitors p16 and p27. 
1.7.2 The Sialomucins 
The sialomucins are a family of mucin-like transmembrane 
glycoproteins which are involved in a wide range of cell-cell and cell-
extracellular matrix interactions within the haemopoietic system. Although 
members of this family bear little homology at the cDNA level, all are 
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highly glycosylated polypeptides with multiple sialylated, mainly 0-linked 
carbohydrate side chains.78 Their rod-like structure ensures that many 
members of this family protrude well beyond the cell membrane, allowing 
optimal exposure of the terminal sugars to carbohydrate receptors.143 
This extended structure and their overall negative charge suggests a role 
as a repulsive barrier around a cell. However, their affinity for a 
sialomucin receptor on a neighbouring cell overcomes this repulsion.78 
A number of sialomucin family members are expressed on 
primitive haemopoietic cells, including CD34, CD43, CD45, CD164 and 
PSGL-1.4  
1.7.2.1 CD34 
CD34, a 110-120 kDa sialomucin, is a marker of primitive 
haemopoietic stem and progenitor cells, as well as being expressed on 
small vessel endothelial cells and embryonic fibroblasts.144 CD34 
expressed on high endothelial venules functions as a ligand for L-selectin 
and is proposed to play a role in leukocyte adhesion and 'homing' during 
inflammation.81' 145 However, the CD34 glycoforms expressed on stem 
and progenitor cells, due to alternative post-translational modifications, do 
not function as ligands for L-selectin. Blocking antibodies to L-selectin 
also have no effect on QBENDIO-induced aggregation between CD34-
positive cells.14° The function and natural ligand of CD34 within the 
haemopoietic environment remain unknown.78 
An alternative splicing mechanism gives rise to two species of 
CD34 mRNA. The full-length protein in formed from exons 1-8 while the 
100kDa truncated form is the result of the insertion of exon X between 
exons 7 and 8 introducing a stop codon into this region, leading to 16 of 
the usual 73 amino acids in the cytoplasmic domain (see Figure 1.6).148" 
147 The significance of this truncated form has yet to be determined 
although studies have suggested that it's expression may change during 
haemopoietic cell differentiation.145 
The binding epitopes of anti-CD34 antibodies are differentially 
sensitive to enzymatic cleavage. Based on this, monoclonal antibodies to 
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CD34 are divided into three classes. Class I antibodies are sensitive to 
neuraminidase (NA), chymopapain (CP) and Pasteurella hemolytica-
derived glycoprotease (GP) and include MY10 and ICH3. QBEND10 
belongs to class II, members of which are insensitive to NA while class Ill 
members such as TUK3 are insensitive to all three.145 Aggregation 
between CD34-positive cells is only achieved through engagement of the 
epitopes of CD34 sensitive to GP and CP, meaning not antibodies 
belonging to class 111.138 
mCD34FL mCD34CT mCD43 
Figure 1.6 The predicted structure of murine full-length (FL) and truncated 
(CT) CD34 together with CD43. The blue boxes represent mucin-rich domains, 
the green boxes, cysteine-rich domains while potential N-linked carbohydrates 
are shown by black circles and horizontal bars represent potential 0-linked 
carbohydrates. Potential protein kinase C (PKC), tyrosine kinase (TK) and 
casein kinase II (CK2) phosphorylation sites are shown on the intracellular tails 
together with the potential PDZ-binding domain, DTEL.146  
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The gene for CD34 is located on chromosome 1q where a number 
of cell adhesion molecules, such as leukocyte adhesion molecule-1 
(LAM-1), are also located.148 Studies have suggested roles for CD34 in 
both progenitor/stem cell adhesion and signal transduction.145 Homing of 
CD34 positive cells to the bone marrow following intravenous bone 
marrow transplantation has been proposed to involve CD34 in a 
mechanism similar to leukocyte-endothelial cell interactions. Interaction 
between CD34 and an L-selectin like molecule may mediate initial 
interactions between stem/progenitor cells and bone marrow capillary 
endothelial cells, followed by stronger binding by an additional integrin, 
leading to movement of these cells through the endothelial layer to reach 
the stromal matrix.150 In agreement with this theory, human CD34 
expressed on murine thymocytes will selectively adhere to human but not 
murine stroma. It has been suggested that this effect may be mediated by 
activation of other CAMs on the thymocytes." An anti-adhesive role for 
CD34 has been demonstrated in murine mast cells where increased 
expression of both CD34 and the related sialomucin, CD43, decreased 
mast cell aggregation and mast cell repopulation of the peritoneal cavity. 
Additionally, CD34 knock-out decreased the ability of progenitor cells to 
repopulate the bone marrow.146 It was hypothesized that homotypic 
aggregation induced by anti-CD34 antibodies may be due to unmasking 
of other cell adhesion molecules on CD34-positive cells. However, there 
are important differences between the murine and human systems, 
particularly as mature human mast cells are CD34-negative. It was 
therefore concluded that CD34 may be both pro-adhesive and anti-
adhesive depending on the context.151  
As well as a potential role in cell adhesion, CD34 had also been 
implicated in cytoplasmic signal transduction pathways, particularly in the 
inhibition of cell maturation." 
Full length CD34 has two potential protein kinase C (PKC) 
phosphorylation sites plus an additional tyrosine kinase phosphorylation 
site on its intracellular tail indicating a potential role in signal transduction, 
while the truncated form lacks these regions.144 Forced expression of full 
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length, but not truncated, CD34 on murine Al myeloid leukaemia cells 
impedes their terminal differentiation to macrophages induced by 
interleukin-6.152 In CD34 knockout mice, erythroid and myeloid 
differentiation have been found to be significantly delayed. The number 
and colony-forming activity of these progenitors was also reduced. 
However, the animals develop normally which has lead to the suggestion 
that other molecules with functions overlapping CD34 may be able to 
compensate for its loss.78 
1.7.2.2 CD43 
Due to structural similarities in their heavily glycosylated 
extracellular domains, CD34 and CD43 are proposed to have partially 
overlapping functions in haemopoietic cell adhesion and signal 
transduction.145139 
CD43 is expressed on a variety of haemopoietic cells and almost 
all mature leukocytes and, although its precise function is unclear, CD43 
is proposed to have functions in both cell adhesion and activation 
signalling.139,153,145 
CD43 is excluded from the immunological synapse through 
interaction of its cytoplasmic tail with members of the ERM family of 
cytoskeletal linker proteins.154 This exclusion is proposed to aid adhesion 
through removing steric hindrance, a theory which is supported by the 
finding that CD43-deficient cells are hyper-adhesive in response to 
antigen stimulation. However, failure of CD43 to move from the T cell-
antigen-presenting cell contact interface has been found to have no effect 
on immunological synapse formation or antigen-induced proliferation, 
suggesting that CD43 has a regulatory role in integrin-mediated T cell 
adhesion that is independent from receptor redistribution.1" CD43 may 
also possess pro-adhesive functions as it has been shown to bind directly 
to ICAM-1 and E-selectin.155' 156 Engagement of CD43 using specific 
antibodies results in increased binding of Jurkat leukaemic T cells to 80 
and 38 kDa fibronectin fragments as well as to VCAM-1 and ICAM-1. 
Blocking antibodies to VLA-5 blocked this binding to fibronectin while 
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antibodies to LFA-1 inhibit binding to ICAM-1. These data suggest that 
CD43 may mediate the adhesion of f31 and 132 integrins.'43  
Additionally, CD43 actively participates in signal transduction and 
activation in T lymphocytes, monocytes and natural killer cells.139 The 
intracellular tail of CD43 is a substrate for phosphorylation by PKC, 
indicating a potential role in transmembrane signalling.145 One particular 
anti-CD43 antibody, L10, directly stimulates T cell activation through a 
pathway involving diacylglycerol (DAG) and inositol-phosphate generation 
as well as PKC and calcium mobilisation.143 The cytoplasmic tail of CD43 
also interacts with 13-catenin leading to the activation of c-myc and cyclin 
D1 genes, providing further evidence that CD43 is able to mediate 
cytoplasmic signalling pathways and may be involved in the control of 
progenitor cell proliferation.157 
1.7.2.3 CD45 
The transmembrane protein tyrosine phosphatase, CD45, is 
exclusively expressed on cells of the haemopoietic system including on 
all nucleated haemopoietic cells. Due to alternate splicing and 
glycosylation, several different isoforms of CD45 exist, the expression of 
which has been proposed to vary during erythroid, myeloid and lymphoid 
differentiation.158,159 
The exact role of CD45 remains unclear, although it has been 
shown to be essential for antigen-receptor signalling as well as for normal 
T and B cell development.158 It is widely accepted that CD45 de-
phosphorylates and therefore regulates members of the Src-family of 
tyrosine kinases including those involved in integrin-mediated 
macrophage adhesion.18° This regulation, however, may be positive or 
negative depending on the cell type involved. The varying expression of 
CD45 on progenitor cells has led to the suggestion of a function in 
controlling cytokine signalling and, therefore, in the activation, 
differentiation and proliferation of haemopoietic progenitor cells.158 
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Monoclonal anti-CD45 antibodies have been shown to reduce 
erythropoietin-induced erythropoiesis in cord blood CD34-positive cells.169 
Additionally, the varying levels of CD45 during progenitor cell 
development could lead to alternate adhesive interactions between cells 
and the microenvironment which represents an additional mechanism by 
which CD45 may contribute to haemopoiesis.159 
1.7.2.4 CD164 
CD164 is expressed on CD34 positive haemopoietic progenitors 
and, to a smaller extent, on committed erythroid and myeloid progenitor 
cells.161 CD164 has been demonstrated to be involved in adhesion of 
CD34-positive cells to the bone marrow stroma. Engagement of CD164 
on haemopoietic progenitor cells has been shown to reduce recruitment 
of quiescent cells into the cell cycle indicating that CD164 may function to 
suppress progenitor cell proliferation within the marrow 
microenvironment.162 Additionally, CD164 has been shown to strongly 
colocalise with CD34 on cord blood and bone marrow CD34-positive 
cells, leading to the suggestion of a functional link between these two 
sialomucins.163 
1.7.2.5 PSGL-1 
PSGL-1 expressed on leukocytes, is involved in adhesion to 
vascular endothelial cells in response to chemoattractant signals 
produced during inflammation.lm On CD34-positive progenitors, PSGL-1 
has been shown to be the sole ligand for P-selectin which may be soluble 
or expressed on the surface of marrow endothelial cells." In progenitor 
cell cultures, adhesion to P-selectin has been shown to inhibit cytokine-
stimulated CD34-positive cell proliferation indicating that PSGL-1 may 
function as a negative regulator of haemopoiesis.83 
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1.8 Aims of the investigation 
This investigation aims to confirm the existence of a 
`haematological synapse' between homotypically aggregated CD34-
positive cells, which is analogous to the immunological synapse formed 
between a T cell and antigen-presenting cell. We hypothesize that 
aggregation between CD34-positive cells may involve additional adhesion 
molecules which may be transported to the contact site via lipid rafts. As 
in Drosophila, we anticipate that surface markers may become unequally 
segregated on haemopoietic stem/progenitor cells and the effect of 
aggregation on progenitor cell self-renewal may be due to the induction of 
asymmetrical cell division. 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Cells 
2.1.1 Cell lines 
Cells of the KG1a cell line were maintained in RPMI 1640 medium 
(GIBCO Brl, Paisley, UK), supplemented with 10% foetal calf serum 
(FCS) (Biowest, Nuaille, France) and 1% penicillin/streptomycin 
(GIBCO BrI) and incubated at 37°C in humidified 5% CO2. 
2.1.2 Primary cells 
Donations for transplantation provided normal human marrow cells 
(NBM) while peripheral blood stem cells (PBPC) were obtained following 
granulocyte colony-stimulating factor (G-CSF) mobilisation. 
All samples were obtained with informed consent and Research 
Ethics Committee approval. 
2.1.2.1 CD34/AC133 isolation 
NBM or PBPC samples were diluted in Hanks' Buffered Salt 
Solution (HBSS) (Gibco), layered over Lymphoprep (Axis-Shield, Oslo, 
Norway) and centrifuged for 30 minutes at 1800 rpm. Mononuclear cells 
were harvested from the interface and washed twice in HBSS by 
centrifuging for 5 minutes at 1800 rpm. Cells were then counted using a 
haemocytometer after dilution in 5% glacial acetic acid (Sigma, Poole,UK) 
to lyse any red blood cells present. 
AC133 and CD34-positive cells were isolated using MiniMacs 
technology according to the manufacturers instructions (Miltenyi Biotech, 
Camberley, UK). Briefly, cells were resuspended in 300p1 Macs buffer 
(PBS (Gibco), 0.5% bovine serum albumin (PAA laboratories, Pasching, 
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Austria) and 2mM EDTA(Sigma)) per 108 cells together with 100p1 FcR 
blocking reagent and 100p1 of either AC133 Microbeads or monoclonal 
hapten-conjugated CD34 antibody (QBENDIO). Cells to be labelled with 
CD133 microbeads were then incubated for 30 minutes at 4°C while 
those to be labelled with QBENDIO were incubated for 15 minutes, 
washed and incubated for a further 15 minutes with 100p1 Anti-Hapten 
Microbeads at 4°C. The cells were then washed and resuspended in 2m1 
Macs buffer per 108 cells. The cells were then passed through a pre-
wetted MS MiniMacs column mounted on a magnet. Following this, the 
column was rinsed 4 times in Macs buffer, removed from the magnet and 
the cells eluted with 2m1 buffer. 
2.2 Aggregation 
2.2.1 Optimal aggregation conditions 
Cells were suspended at a concentration of 1x106/ml in a15 
medium composed of alpha medium (GIBCO) supplemented with 15% 
foetal calf serum. Aliquots of 100p1 were transferred to the wells of 96-
well microtitre plates. Cells were then exposed to QBENDIO, anti-CD43 
(Sigma), or isotype control antibody (Santa Cruz, California, US) by 
adding 2p1 of the relevant antibody to the well and incubating for the 
relevant amount of time at 37°C with 5% CO2. Stock concentrations of 
antibodies were 200n/m1 giving a standard final concentration of 4µg/ml. 
Additional control wells contained no antibody. Aliquots of 30p1 were then 
air-dried onto Teflon-coated multi-well slides (BDH, Lutterworth, UK), 
fixed in ethanol, stained with Giemsa (Sigma) and random fields scored 
for aggregation. At least 500 cells were scored per well to give the 
percentage of cells in aggregates. The score for cells with the IgG control 
antibody was subtracted from this value to give the specific aggregation 
index. 
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2.2.2. Effect of cytokines on aggregation 
KG1a or primary AC133-positive cells were resuspended in a15 
and aggregated as normal but in the presence of 25ng/ml IL-3 (First Link, 
Brierly Hill, UK), 10Ong/m1 G-CSF (Chugai, Tokyo, Japan) or a 
combination of the two. These concentrations were shown to be optimal 
in a standard CFU-GM assay for progenitor cell self-renewal.2 After the 
relevant amount of time at 37°C, cells were harvested and scored for 
aggregation. 
2.2.2.1 Effect of cytokines on the surface expression of CD34 
KG1a cells were counted and 3m1 aliquots placed into T25 flasks 
(Corning Incorporated, New York, USA) at a concentration of 1x106/ml. 
One flask was left untreated while the remaining 3 were treated with 
25ng/m1 IL-3, 10Ong/m1 G-CSF or a combination of the two. After 24 
hours at 37°C, cells were washed once in PBS and incubated with 
phycoerythrin (PE) conjugated anti-CD34 (Beckton-Dickinson, New 
Jersey, USA) for 30 minutes at 37°C. After two washes in PBS, cells were 
resuspended in 800p1 1% paraformaldehyde and transferred to 
fluorescence activated cell sorter (FACS) tubes (Beckton-Dickinson). 
Samples were then analysed using a FACScan flow cytometer (Beckton-
Dickinson) with the capture gates set using the untreated cells. The 
fluorescence histograms were obtained for each treatment with 10000 
events recorded per sample. 
2.2.3 Effect of EDTA on aggregation 
KG1a or primary AC133-positive cells were resuspended in a15 
alone or in a15 containing 5 or 10mM EDTA (Sigma), similar 
concentrations to those which have previously been described to affect 
QBEND10-induced aggregation.136' 1" After the relevant amount of time 
at 37°C, cells were harvested and scored for aggregation. 
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2.2.4 Effect of PI3-kinase inhibitors on aggregation 
KG1a or primary AC133-positive cells were resuspended in a15 
alone or a15 containing either 50nm Wortmannin or 1041 LY294002 
(both Sigma), standard concentrations used for inhibition of the PI3-
kinase pathway.165 After pre-treatment for 30 minutes at 37°C, cells were 
aliquoted into 96 well plates and aggregated as normal. 
2.2.5 Effect of Lithium Chloride on aggregation 
KG1a or primary AC133-positive cells were resuspended in a15 
alone or a15 containing 4mM lithium chloride (LiCI) (Sigma) and left for 
16 hours at 37°C, which has been shown to lead to significant 
cytoplasmic accumulation of 13-catenin in epidermal keratinocytes.166 
Cells were then aggregated as normal and after the relevant amount of 
time, cells harvested and scored for aggregation. 
2.3 Immunofluorescence 
2.3.1 Antibodies 
QBENDIO was a kind gift from L.Healy. (Institute of Caner 
Research, London, UK). Anti-CD43, fluorescein isothiocyanate (FITC)-
conjugated anti-ICAM, tetramethylrhodamine isothiocyanate (TRITC)-
conjugated phalloidin, goat anti-rabbit-TRITC and goat anti-mouse-FITC 
were from Sigma. Anti-LFA-1, PECAM-1, PSGL-1, CD44, N-cadherin, a4 
integrin, a5 integrin, connexin-43 and FITC-conjugated anti-CD43 were 
obtained from Santa Cruz. Also from Santa Cruz were fluorochrome-
conjugated secondary antibodies including goat anti-rabbit-FITC, rabbit 
anti-goat FITC, bovine anti-mouse-rhodamine, and goat anti-rabbit 
rhodamine. FITC-conjugated CD164 was from BD Biosciences (Oxford, 
UK), while pericentrin and anti-Notch-1 were supplied by AbCam 
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(Cambridge, UK). Mouse, rabbit and goat IgG control antibodies were 
supplied by Dako (Glostrup, Denmark). 
2.3.2 Immunofluorescence 
Following aggregation, cells were gently resuspended and an 
aliquot of 30p1 spread onto multiwell slides. Cells were then air dried and 
fixed in 3% paraformaldehyde (Sigma) for 15 minutes or acetone (BDH) 
for 1 minute. Slides were rehydrated for 10 minutes in PBS and then 
blocked for 1 hour with 3% bovine serum albumin (PAA laboratories, 
Somerset, UK). Cells were then covered in 100µg/m1 primary antibody 
(CD34, CD43, LFA-1, ICAM-1, CD44, PSGL-1, PECAM-1, 131-integrins, 
CD164, pericentrin, Notch-1 or IgG control) for 1 hour at room 
temperature in a dark humidified chamber. After four, 5 minute washes in 
PBS, cells were incubated with 0.5% or 1% fluorochrome—conjugated 
secondary antibody. To control for non-specific antibody trapping, some 
aggregated cells were incubated with a non-matching secondary 
antibody. Slides were then washed four times in PBS. For dual staining 
experiments, the above steps were repeated for the second antibody. To 
dual stain F-actin, cells were fixed in 4% paraformaldehyde then 
permeabilised with 0.5% Triton-X (Sigma) for 15 minutes at room 
temperature followed by incubation with tetramethyirhodamine 
isothiocyanate (TRITC)-conjugated phalloidin (Sigma) for 30 minutes at 
37°C. All slides were then mounted in Vectashield containing DAPI (Vecta 
Laboratories, Burlingame, CA). 
2.3.3 Microscopy 
Cells were scored for aggregation using a Zeiss Axioscop light 
microscope under the x10 objective lens. Cells stained for the presence 
of CD34, CD43, LFA-1, ICAM-1, CD44, PSGL-1, PECAM-1, P1-integrins, 
CD164, pericentrin and Notch-1 were examined using a Zeiss Axiovert 
100 fluorescent microscope with SmartCapture imaging software under 
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the x40 or x100 oil emersion objective lens. Cells dual stained for CD34 
and F-actin were examined under the x100 oil emersion lens on a Zeiss 
Meta 512 confocal microscope, using the Argon laser to view FITC 
(allowing excitation at 458, 477, 488 and 514 nm) and the HeNe 543 
laser to view TRITC (for excitation at 543m). 
2.4 Immunoprecipitation 
2.4.1 Immunoprecipitation 
Immunoprecipitation was performed using the ExactaCruz 
immunoprecipitation system (Santa Cruz). Fifty microlitres of mouse 
matrix, 50µ1 of anti-CD34 (MY10, BD biosciences) or mouse IgG control 
antibody and 5000 PBS were added together and incubated at 4°C for 2 
hours. Meanwhile, KG1a cells were washed in PBS and counted. Aliquots 
of 2x107 cells were placed in microcentrifuge tubes and lysed by 
incubation with 400111 lysis buffer for 15 minutes on ice. Following 
microcentrifugation, the supernatant was removed, an 80µI total lysate 
sample taken, and the lysate pre-cleared by adding 50p1 mouse matrix for 
30 minutes. After spinning, the supernatant was added to the washed 
antibody/matrix complex and incubated at 4°C overnight. After 4 washes 
in RIPA buffer, 160µ1 sample buffer (0.1M Tris HCL, 3%SDS, 1% 
glycerol, 2.5% R-mercaptoethanol, 0.005% bromophenol blue (all Sigma)) 
was added to the matrix and the samples boiled for 4 minutes and stored 
at —80°C. 
2.4.2 Western Blotting 
Samples were electrophoresed on polyacrylamide gels, prepared 
as in Table 2.1. Samples and Kaleidoscopic Prestained Markers (Biorad, 
Hercules, Ca) were run at 100v and transferred to 0.45pM PVDF 
membrane (Millipore corporation, MA, USA) using a semi-dry transfer cell 
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(Biorad) for 50 minutes. The membranes were then blocked for 1 hour at 
room temperature in 5% milk (Marvel, Dublin, Eire) made up with TBS 
containing 0.05% Tween (BDH). Primary antibody (Santa Cruz) was 
applied to the membranes at 1/500 milk/TBS-Tween and left at 4°C 
overnight. After four 5 minute washes in TBS-Tween, the relevant 
secondary HRP conjugate was diluted 1/1000 in Milk/TBS-Tween and 
applied to the membrane for 1 hour at room temperature with shaking. 
The membranes were then washed and visualised using an ECL 
chemiluminescent visualisation kit (Amersham, Buckinghamshire, UK). 
6.5% 
Resolving gel 
10% 
Resolving gel 
Stacking gel 
37.5:1 
Acrylamide/Bis 
(30%) 
2.2m1 3.3ml 8301x1 
Water 6.1m1 5m1 3.4ml 
Tris (0.5M) pH 8.8 2.5m1 2.5m1 630111 
(pH 6.8) 
SDS 10% 100p1 100p1 50p1 
Ammonium 
persulfate 
100p1 100111 50p1 
Total volume 11m1 11m1 4.96m1 
Table 2.1 Composition of polyacrylamide gels. Acrylamide was from 
Biorad, all other reagents were obtained from Sigma. 
72 
Chapter 2. Materials and Methods 
2.5 siRNA 
2.5.1 Knock-down 
Cells were seeded at a concentration of 2x105/ml in 400µ.1 x-vivo 
15 serum free media (BioWhittaker, Maryland, USA) in 12 well plates. For 
each well to be transfected, 7111 OPTIMEM (Invitrogen, Paisley, UK) was 
mixed with 3µI Oligofectamine (Invitrogen) and left at room temperature 
for 10 minutes. In a separate tube stock LFA-1 or HCAM (CD44) siRNA 
(Santa Cruz) was diluted by adding 3111 of 10µM slow thawed stock 
solution to 87111 OPTIMEM for each well to be transfected. The diluted 
oligofectamine and siRNA were then combined and mixed gently. After 
20 minutes at room temperature, 100111 of the above solution was added 
to each well and the plate incubated overnight at 37°c with 5% CO2. The 
following day, a further 100111 of the diluted oligofectamine/siRNA was 
added to each well to transfect cells with a second hit of siRNA. After 4 
hours, 60121 FCS was added to each well and the plate incubated at 37°c 
with 5% CO2. At the relevant time point, cells were air dried onto multi-well 
slides and fixed using 100% ethanol. After air drying, slides were stained 
and examined using fluorescence microscopy. Knock-down was then 
confirmed using Western Blotting and the percentage knock-down 
calculated using Image J densitometry software (National Institute of 
Health, USA). 
2.5.2 Effect of knock-down on aggregation 
Following siRNA treatment, at the optimum time point for LFA-1 
knockdown, cells were removed, washed in PBS and resuspended in 
a15. Cells were then aggregated as normal and at the relevant time 
points, cells aliquoted onto multi-well slides, fixed, stained with Giemsa 
and scored for aggregation. 
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2.6 Gap junctions 
2.6.1 Staining 
KG1a or primary AC133-positive cells were split into two groups, 
one of which was incubated with 500nm calcein (Sigma) for 30 minutes at 
37°C. The other group were incubated with 4x106 M PKH26 dye (Sigma) 
for 3 minutes at room temperature. After washing, cells were 
resuspended at 1x106/m1 in (x15 and the following plate prepared for both 
primary and KG1a cells (Figure 2.1). 
Calcein 	PKH26 	50:50 mix 
0 • 0 
O 
O 
Unaggregated 
Aggregated — CD34 
Aggregated — CD43 
Figure 2.1 96-well plate set up to test transfer of calcein through gap 
junctions. 
After incubation at 37°C for 18 hours, aliquots from each 50/50 mix well 
were taken and scored for aggregation. The remaining cells were 
analysed by fluorescent microscopy. 
2.6.2 Immunofluorescence 
Aliquots of 30µ1 were taken from each well, mixed with Vectashield 
containing DAPI (Vecta Laboratories) and mounted on microscope slides. 
Red, green and yellow cells were then scored and the percentage red 
cells acquiring calcein during aggregation and therefore appearing yellow 
calculated. 
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2.6.3 Inhibition of gap junctional communication 
Plates of KG1a and primary AC133-positive cells were prepared 
as above with half the cells stained with calcein and the other half with 
PKH26. An additional set of plates were prepared with 150µM 
carbenoxolone (Sigma), a specific gap junction inhibitor, added to each 
well.167 After 18 hours, aliquots were removed and scored for aggregation 
and the remaining cells examined by fluorescent microscopy. 
2.6.3.1 Primary and secondary CFU-GM replating assay 
AC133-positive cells were suspended at 5x103/m1 in 
methylcellulose (Stem Cell Technologies, Vancouver, Canada) 
supplemented with 10% GM-Mix (20ng/m1 stem cell factor, 1 rig/m1 GM-
CSF, 5ng/ml IL-3 and 10Ong/m1 G-CSF, all from First Link, Brierly Hill, 
UK). The methylcellulose was placed into 35mm petri dishes in 1m1 
aliquots and incubated at 37°C for 1 week. On day 7 the number of 
colonies containing 50 or more cells was scored. Then, 90 colonies 
containing 50 cells or more were picked individually and dispersed into 
100µI methylcellulose supplemented with GM-mix in separate wells of a 
96-well microtitre plate. After a further 7 days at 37°C, the number of 
secondary colonies consisting of 50 or more cells was scored in each 
well. The data were analysed using a program written for Microsoft Excel 
(Microsoft, Redmond, USA) by Dr NM Blackett, with values entered being 
the number of secondary colonies produced by each individual primary 
colony. The number of secondary colonies indicates the self-renewal 
occurring during colony development. The results are displayed as a 
cumulative distribution representing the number of primary colonies 
containing n secondary colony forming cells. The area under the curve 
(AUC) is calculated and provides the progenitor cell proliferation index.3' 8 
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2.7 Lipid rafts 
2.7.1 Cholesterol depletion 
Cells were incubated with 10mM methyl-I3-cyclodextrin (MBCD) 
(Sigma) in RPMI for 15 minutes or RPMI alone, washed 3 times in PBS 
and aggregated as above.128 Aliquots of 30p1 were then air-dried onto 
Teflon-coated multi-well slides, fixed in ethanol, stained with 
Romanowsky dyes and scored for aggregation. At least 500 cells were 
scored per well to give the percentage of cells in aggregates. The score 
for cells with the IgG control antibody was subtracted from this value to 
give the specific aggregation index. 
2.7.2 Cholesterol reconstitution 
Cells were resuspended in HBSS containing 60µg/ml water soluble 
cholesterol (Sigma) and 0.2 % BSA for 30 minutes at 37°C.128 Cells were 
then washed in PBS, resuspended in oc15 and aggregated as above. 
After 3 hours, cells were air dried onto multi-well slides, fixed, stained and 
scored for aggregation. 
2.7.3 Trypan Blue exclusion assay 
KG1a cells were treated with either 10mM MBCD or RPMI alone, 
washed and resuspended in RPMI. At each time point an aliquot of 20p1 
cell suspension was added to an equal amount of 4% trypan blue 
(Northumbria Biologicals, UK) . Trypan blue positive cells were counted 
as dead while trypan blue negative cells were counted as viable and the 
percentage cell death calculated. 
76 
Chapter 2. Materials and Methods 
2.7.4 lmmunofluorescence 
Coverslips were coated with poly-L-lysine solution (Sigma) for 10 
minutes and allowed to dry completely. Aliquots of 200µ1 of aggregated or 
unaggregated KG1a cells were then placed onto the dried coverslips and 
allowed to adhere for 45 minutes at room temperature. Following one 
wash with PBS, lipid rafts were cross-linked by adding 100µI of 10µg/m1 
FITC labelled cholera toxin B (Sigma) to each coverslip and incubating on 
ice for 30 minutes in the dark followed by an additional 10 minute 
incubation at room temperature. The coverslips were then washed 3 
times in PBS and the cells fixed by covering with 4% paraformldehyde for 
20 minutes. The coverslips were washed one further time and mounted 
onto microscope slides with one drop of Vectashield containing DAPI 
(Vecta laboratories). 
2.7.5 Lipid raft isolation 
Lipid rafts were isolated from aggregated and unaggregated cells 
by sucrose density gradient ultracentrifugation.168 Cells were washed 
once, resuspended in 0.4ml ice cold MBS-BL+ (50mM MES, 150mM 
NaCI, 1mM phenylmethyl suphonylfluoride, 1mM sodium vanadate, 
1ug/m1 protease inhibitor cocktail, 1% Triton X-100, all from Sigma) and 
kept on ice for 30 minutes. Cells were the lysed after the addition of 0.4ml 
80% sucrose and dispensed into a 5m1 ultracentrifuge tube. This cell 
lysate was then gently overlayed with 2.7ml 30% sucrose followed by 
1.5m1 5% sucrose. The tubes were placed into an SW55Ti rotor and 
centrifuged at 40000rpm for 24 hours at 4°C. Ten fractions of 0.5m1 were 
then removed from the top of the gradient and frozen. Lipid rafts float to 
the interface between the 3% and 5% layers and can be found in 
fractions 3 and 4.168' 169 The pellet was resuspended in 0.5ml 1x sample 
buffer diluted to lx with an equal volume of PBS, boiled for 3 minutes and 
frozen. 
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2.8 Statistics 
Results were analysed using GraphPad Instat software, version 
3.05 (GraphPad software Inc, San Diego, CA) unless otherwise indicated. 
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CHAPTER 3. AGGREGATION IN KG1A AND PRIMARY AC133-
POSITIVE CELLS 
3.1 Introduction 
Majdic et al. were the first group to describe homotypic adhesion 
between cells of the CD34-positive cell line, KG1a. This aggregation was 
induced by engagement of the class II epitope of CD34 by the 
monoclonal anti-CD34 antibody, QBENDIO, and was found to be 
dependent on cellular energy, an intact cytoskeleton and divalent cations, 
as indicated by treatment with the chelating agent, EDTA. Blocking 
antibodies to LFA-1 and ICAM-1 inhibited QBEND10-induced aggregation 
after 60 minutes indicating that this adhesion is also dependent on 62 
integrins.139 
More recently, exposure of KG1a cells to either QBEND10 or anti-
CD43 was shown to induce cell polarization with the formation of a cap of 
CD34 or CD43 respectively which co-localises with F-actin.139 
Within this laboratory, it has been demonstrated that QBENDIO-
induced aggregation also occurs between primary CD34-positive cells 
isolated from normal human bone marrow and peripheral blood 
progenitor cell (PBPC) harvests. CD34 was found to be localised at the 
intercellular binding sites between cells induced to aggregate with 
QBENDIO and also between CD34-positive cells within developing 
myeloid colonies in vitro and in multicellular aggregates from normal bone 
marrow, without exposure to QBENDIO. It was therefore concluded that 
CD34-mediated homotypic aggregation occurs physiologically in vitro and 
in vivo.1" 
CD34 is a marker of haemopoietic stem and progenitor cells as 
well as being expressed on small vessel endothelial cells and embryonic 
fibroblasts.144 CD43 has a more widespread distribution, being expressed 
on haemopoietic cells and almost all mature leukocytes.139 Due to 
structural similarities in their heavily glycosylated extracellular domains, 
the transmembrane sialomucins, CD34 and CD43 are proposed to have 
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partially overlapping functions.139' 145 The function and natural ligand of 
CD34 within the haemopoietic environment are unknown, although roles 
for CD34 in both cell adhesion and signal transduction have been 
suggested.78, 140, 170 
Full length CD34 has two protein kinase C (PKC) phosphorylation 
sites on its intracellular tail plus an additional tyrosine kinase 
phosphorylation site, indicating a potential role in cell signalling.144 
Exposure of KG1a cells to QBENDIO or anti-CD43 has been shown to 
induce capping of CD34 or CD43 respectively, which is co-localised with 
F-actin. This capping was accompanied by the tyrosine phosphorylation 
of a set of proteins including Lyn and Syk at the site of the long-lived cap. 
It was concluded that ligation of both CD34 and CD43 can activate similar 
signalling pathways involving tyrosine phosphorylation.139 
More recently, KG1a and primary CD34-positive cell aggregation, 
induced by QBENDIO, has been shown to be inhibited by the tyrosine 
kinase inhibitor, genistein, and increased by staurosporine, a PKC 
inhibitor. Additionally, aggregation was found to lead to the tyrosine 
phosphorylation of CD34 itself and translocation of PKC from the 
membrane to the cytoplasm, indicating the signalling potential of CD34-
mediated aggregation.1" KG1a aggregation has also been shown lead to 
alterations in the protein levels of members of the retinoblastoma 
pathway and the cyclin-dependent kinase inhibitors (Bullock et al., 
submitted 2006), which play key roles in regulation of the cell cycle.28, 141 
Importantly, QBEND10-induced aggregation in primary CD34-positive 
cells has been shown to significantly decrease progenitor cell self-
renewal, indicating that CD34-mediated aggregation may result in 
contact—mediated inhibition of progenitor cell proliferation.140 Pre-
treatment with Class I (3C5) and class Ill (HPCA-2) anti-CD34 antibodies 
has no effect on progenitor cell proliferation, indicating that it is 
aggregation and not merely engagement of CD34 that leads to the effect 
on self-renewal (M.Gordon, personal communication). 
Within the marrow microenvironment, haemopoietic stem and 
progenitor cells are closely associated with stromal cells which produce 
growth factors and cytokines regulating cell proliferation, differentiation 
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and death through a number of downstream signalling pathways including 
the PI3-kinase, JAK/STAT and MAP kinase pathways.1  In particular, G-
CSF and IL-3 in combination have been shown to significantly increase 
progenitor cell self-renewal, an effect which has been proposed to be 
mediated through the PI3-kinase pathway.3 It is conceivable that factors, 
which affect progenitor cell proliferation and differentiation, may also 
affect CD34-positive cell aggregation. IL-3 has been shown to activate 
LEA-1, a member of the [32 integrin family of cell adhesion molecules on 
macrophages and 131 integrins on haemopoietic progenitor cells, 
providing a link between integrin-mediated cell adhesion and cytokine 
signalling within the haemopoietic system.57' 171 A subgroup of cytokines 
known as chemokines have also been implicated in the activation of 
integrins on leukocytes." Additionally, combinations of cytokines, 
including GCS-F have been shown to increase the expression of several 
members of the integrin family, as well as CD44.58 Significantly, the 
expression of CD34 has shown to be decreased by cytokines including 
IL-1, TNF-a and IFN-y both in vitro and in vivo.172' 173 Cytokines may 
therefore be capable of influencing cell-to-cell adhesion. 
The PI3-kinase pathway has also been implicated in the control of 
lymphocyte polarization and chemotaxis. Inhibition of the PI3-kinase 
pathway inhibited the redistribution of the adhesion molecule, ICAM-3, 
and the cytoskeletal linker protein, moesin, in response to stromal cell 
derived factor-1a (SDF-1a) as well as lymphocyte chemotaxis.174 
Additionally, TCR triggering has been suggested to result in the 
redistribution of cell surface markers and cytoskeletal polarization through 
activation of the Rho family of small GTP-binding proteins. The Rho-
GTPases can be activated by the GTP/GDP exchange factor Vav1 which, 
in turn, is activated by tyrosine phosphorylation or by binding products of 
the PI3-kinase pathway."' 175 The PI3-kinase pathway has also been 
suggested to be involved in the polarization of CD34-positive cells during 
migration, after exposure to a combination of early acting cytokines 
including foetal liver tyrosine kinase 3 ligand (FLT3L), stem cell factor 
(SCF), thrombopoietin (TPO) and SDF-1a.137 The role of the PI3-kinase 
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pathway in the polarization of CD34-positive cells in response to 
QBENDIO has yet to be investigated. 
Within the haemopoietic system, one signalling pathway implicated 
in the control of haemopoietic stem and progenitor cell proliferation as 
well as cell orientation, cell polarity and adhesion in other systems, is the 
Wnt pathway."' 176 Activation of Wnt signalling controls differentiation and 
proliferation through inhibition of GSK-3p, bound to adenomatous 
polyposis coli (APC) protein, leading to the accumulation of p-catenin in 
the cytoplasm which can then bind the TCF/LEF family of transcription 
factors. In Drosophila, planar polarity is regulated, in part, by the Wnt 
receptor Frizzled through an unknown mechanism." Additionally APC is 
implicated in polarized cell migration by its localisation to the tips of 
membrane projections in migrating epithelial cells.15 APC has also been 
linked to an integrin-based adhesion signalling complex that orientates a 
cell prior to polarised migration."' 177 
Significantly, p-catenin also binds the cytoplasmic domains of a 
group of cell surface adhesion molecules known as cadherins and 
provides a link between cadherins and the actin cytoskeleton through a-
catenin.64 In Drosophila, the cadherins play key roles in the control of 
stem cell self-renewal and differentiation." N-cadherin and p-catenin 
have been shown to localise to the junction between haemopoietic stem 
cells and osteoblasts, an interaction which has been proposed to be 
crucial in regulation of the haemopoietic cell numbers through control of 
niche size." N-cadherin has also been implicated in adhesion between 
KG1a cells and blocking antibodies lead to a dose-dependent reduction in 
cytokine-induced primary cell colony formation.67 It has been suggested 
that the numerous pathways which intersect with the Wnt pathway may 
be capable of regulating one another." However, the full involvement of 
the cadherins and 13-catenin in CD34-mediated aggregation has yet to be 
established. 
This investigation aims to study the process of aggregation in 
KG1a and primary CD34-positive cells, the effect of cytokines known to 
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influence progenitor cell self-renewal on this process and possible 
signalling pathways involved in cell adhesion and polarization. 
3.2 Results 
3.2.1. Optimal aggregation conditions 
3.2.1.1. Optimal antibody concentration 
To determine the dose of antibody required for optimal 
aggregation, KG1a cells were suspended in a15 alone or a15 containing 
various concentrations of the anti-CD34 antibody, QBENDIO, anti-CD43 
or isotype control antibody. After 3 hours, cells were air-dried onto slides, 
fixed, stained and scored for aggregation. Optimum aggregation was 
achieved with 4µg/ml of either QBEND10 or anti-CD43 (Figure 3.1). 
3.2.1.2. Optimal aggregation time 
To determine the time course of aggregation, KG1a cells were 
resuspended at 1x106/m1 in a15 alone or a15 containing 4µg/m1 
QBENDIO, anti-CD43 or IgG control antibody. At the relevant time point, 
cells were air dried onto slides, fixed, stained and scored for aggregation. 
With both QBENDIO and anti-CD43, aggregation peaks at 3 hours and 
declines towards the final time point, 5 days (Figure 3.2). At 3 hours, 
unaggregated and aggregated cells were air-dried onto multi-well slides, 
fixed with ethanol for 5 minutes and coverslips mounted with one drop of 
vectashield containing DAPI. After 3 hours exposure to QBEND10, KG1a 
cells can be seen to form multicellular aggregates (Figure 3.3). 
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Figure 3.1 Optimal antibody dose to induce aggregation of KG1a cells 
KG1a cells were resuspended at 1x106/m1 in a15. Aliquots of 100µI were placed 
in 96-well plates in triplicate and incubated at 37°c either alone or with 4µg/ml 
QBENDIO, anti-CD43 or IgG control antibody. At the relevant time point, cells 
were gently resuspended and air-dried onto multi-well slides. After fixing in 
ethanol for 5 minutes, cells were stained with Giemsa and scored for 
aggregation. The average percentage aggregation with IgG control antibody was 
subtracted from the average percentage values obtained for cells incubated with 
anti-CD34 or anti-CD43 to give the specific aggregation index. At least 500 cells 
were scored per well. Values are expressed as specific aggregation index (%) ± 
standard deviation, n=3. 
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Figure 3.2 The time course of antibody-induced aggregation of KGla cells. 
KG1a cells were resuspended at 1x106/ml in a15. Aliquots of 100µI were placed 
in 96-well plates in triplicate and incubated at 37°C either alone or with 4µg/m1 
QBENDIO, anti-CD43 or IgG control antibody. At the relevant time point, cells 
were gently resuspended and air-dried onto multi-well slides. After fixing in 
ethanol for 5 minutes, cells were stained with Giemsa and scored for 
aggregation. The average percentage aggregation with IgG control antibody was 
subtracted from the average percentage values obtained for cells incubated with 
anti-CD34 or anti-CD43 to give the specific aggregation index. At least 500 cells 
were scored per well. Values are expressed as specific aggregation index (%) ± 
standard deviation, n=3. 
3.2.2 Aggregation in primary AC133-positive cells 
3.2.2.1 Time course of primary cell aggregation 
To determine if aggregation in primary cells follows a similar time 
course to that in KG1a cells, AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology and resuspended in a15 
containing 4µg/mIQBEND10 or IgG control antibody. AC133 (CD133) is 
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Unaggregated 
	
Aggregated 
Figure 3.3 Aggregation of KGla cells. After 3 hours, samples of unaggregated 
and aggregated KG1a cells exposed to QBENDIO were air-dried onto multi-well 
slides, fixed in ethanol for 5 minutes and coverslips mounted using one drop of 
vectashield containing DAPI. Slides were visualised under the fluorescent 
microscope using the x10 objective lens. 
an alternative haemopoietic stem and progenitor cell marker, which has 
been shown to be selectively expressed on CD34bright cells. Antibodies to 
AC133 are commonly used as alternative to CD34 selection.178 This was 
necessary as CD34-positive cell selection contain anti-CD34 antibodies, 
typically QBENDIO, therefore exposing cells to an aggregation-inducing 
antibody during selection. At the relevant time point, cells were air dried 
onto slides, fixed, stained and scored for aggregation. In comparison to 
KG1a cells, primary AC133-positive cell aggregation was slower, peaking 
at 24 hours and was completely absent at 5 days (Figure 3.4). Therefore, 
further studies into events at the point of optimal aggregation will look at 
KG1a cells after 3 hours and primary cells after exposure to QBENDIO 
for 24 hours. 
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Figure 3.4 The time course of QBENDIO-induced aggregation of primary 
AC133-positive cells. Cells were isolated on AC133 using MiniMacs 
technology and resuspended at 1x106/ml in a15. Aliquots of 1001.11 were placed 
in 96-well plates and incubated at 37°C either alone or with 4µg/mIQBEND10 or 
IgG control antibody. At the relevant time point, cells were gently resuspended 
and air-dried onto multi-well slides. After fixing in ethanol for 5 minutes, cells 
were stained with Giemsa and scored for aggregation. The percentage 
aggregation with IgG control antibody was subtracted from the percentage 
values obtained for cells incubated with anti-CD34 to give the specific 
aggregation index. At least 500 cells were scored per well. Values are 
expressed as specific aggregation index (%) ± standard error, n=5 
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3.2.3 Effect of cytokines on aggregation 
3.2.3.1 G-CSF and IL-3 reduce QBENDIO-induced aggregation of 
KG1a cells. 
As aggregation has been shown to reduce progenitor cell self-
renewal, it is conceivable that factors which have been shown to alter 
self-renewal in haemopoietic cells, may affect the level of aggregation 
itself. G-CSF and IL-3 in combination have been shown to synergistically 
increase self-renewal.3 To investigate the effect of these cytokines on 
aggregation, KG1a cells were resuspended in a15 alone or in a15 
containing 10Ong/m1 G-CSF, 25ng/ml IL-3 or a combination of the two. 
Aliquots of 100u1 were placed in 96-well plates with or without 4µg/m1 
QBENDIO or IgG control. After 1 and 3 hours, cells were air dried onto 
slides, fixed, stained and scored for aggregation. G-CSF significantly 
reduced QBENDIO-induced aggregation at 1 and 3 hours whereas the 
reduction with IL-3 was significant at 2 hours (Figure 3.5). 
3.2.3.2 G-CSF and IL-3 reduce QBENDIO-induced aggregation of 
primary AC133-positive cells. 
To investigate the effect of these cytokines on aggregation in 
primary cells, AC133-positive cells were resuspended in a15 alone or in 
a15 containing 10Ong/m1 G-CSF, 25ng/ml IL-3 or a combination of the 
two. Aliquots of 100µI were placed in 96-well plates with 44/m1 
QBENDIO or IgG control. At the relevant time point, cells were air dried 
onto slides, fixed, stained and scored for aggregation. Aggregation was 
significantly reduced at 6 hours with IL-3 and with G-CSF, IL-3 and the 
combination at 24 hours (Figure 3.6). 
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Figure 3.5 The effect of cytokines on QBENDIO-induced aggregation of 
KG1a cells. KG1a cells were resuspended at 1x106/ml in a15 alone or a15 
containing 10Ong/m1 G-CSF, 25ng/mI IL-3 or a combination of the two. Aliquots 
of 100p.I were placed in triplicate into 96-well plates and incubated at 37°C either 
with 4µg/mIQBEND10 or IgG control antibody After 1, 2 and 3 hours, cells were 
gently resuspended and air-dried onto multi-well slides. After fixing in ethanol for 
5 minutes, cells were stained with Giemsa and scored for aggregation. The 
average percentage aggregation with IgG control antibody was subtracted from 
the average percentage value obtained for cells incubated with anti-CD34 to 
give the specific aggregation index. At least 500 cells were scored per well. 
Values are expressed as specific aggregation index (%) ± standard error, n=5. 
Results were analysed using the paired t-test. * p=<0.05. 
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Figure 3.6 The effect of cytokines on QBENDIO-induced aggregation of 
primary AC133-positive cells. Cells were isolated on AC133 using MiniMacs 
technology and resuspended at 1x106/m1 in a15 alone or a15 containing 
10Ong/m1 G-CSF, 25ng/ml IL-3 or a combination of the two. Aliquots of 1000 
were placed in 96-well plates and incubated at 37°C with 4µg/ml QBEND10 or 
IgG control antibody. At the relevant time point, cells were gently resuspended 
and air-dried onto multi-well slides. After fixing in ethanol for 5 minutes, cells 
were stained with Giemsa and scored for aggregation. The percentage 
aggregation with IgG control antibody was subtracted from the percentage 
values obtained for cells incubated with anti-CD34 to give the specific 
aggregation index. At least 500 cells were scored per well. Values are 
expressed as specific aggregation index (%) ± standard error, n=5. Results were 
analysed using the paired t-test. * p<0.05, **p<0.01 
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3.2.3.3 Combinations of cytokines reduce aggregation after a 24 
hour exposure 
As haemopoietic stem and progenitor cells may be exposed to 
cytokines for long periods within the marrow microenvironment and these 
cytokines may take time to exert their effects, KG1a cells were exposed 
to cytokines for 24 hours before being aggregated as normal to determine 
if a longer exposure would results in a greater effect on aggregation. After 
exposure to cytokines for 24 hours, the combination of G-CSF and IL-3 
significantly decreased aggregation induced by QBENDIO at 3 and 24 
hours (Figure 3.7). 
3.2.3.4 Cytokines have no effect on the expression of CD34 on KGla 
cells 
As cytokines have been suggested to potentially reduce the 
expression of CD34 both in vivo and in vitro, cells treated with G-CSF, IL-
3 and a combination of the two for 24 hours and CD34 stained using anti-
CD34-PE.172' 173 The fluorescence intensity was examined using the 
FACS scan flow cytometer. The capture gates were set using untreated 
cells and the fluorescence profile for cytokine treated cells overlaid to 
highlight any differences. No differences were observed between 
untreated and cytokines treated cells indicating that cytokines do not 
reduce QBENDIO-induced aggregation though reduction in the surface 
expression of CD34 (Figure 3.8) 
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Figure 3.7 The effect of a 24 hour exposure to cytokines on QBENDIO-
induced aggregation. KG1a cells were resuspended at 1x106/m1 in a15 alone 
or a15 containing 10Ong/m1 G-CSF, 25ng/ml IL-3 or a combination of the two 
and incubated at 37°C. After 24 hours, aliquots of 1000 were placed in triplicate 
into 96-well plates and incubated at 37°C with 411g/m1 QBENDIO or IgG control 
antibody After 1, 3 and 24 hours, cells were gently resuspended and air-dried 
onto multi-well slides. After fixing in ethanol for 5 minutes, cells were stained 
with Giemsa and scored for aggregation. The average percentage aggregation 
with IgG control antibody was subtracted from the average percentage value 
obtained for cells incubated with anti-CD34 to give the specific aggregation 
index. At least 500 cells were scored per well. Values are expressed as specific 
aggregation index (%) ± standard error, n=5. Results were analysed using the 
paired t-test. * p=<0.05, **p=<0.01 
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Figure 3.8 The effect of cytokines on the expression of CD34 on KGla 
cells. Capture gates were set using untreated cells (a) and the fluorescence 
profiles overlaid in green for KG1a cells treated with (b) G-CSF, (c) IL-3 or (d) a 
combination of the two. KG1a cells were pre-treated with 100 ng/ml G-CSF or 
25ng/ml IL-3 or a combination of the two for 24 hours at 37°C, cells were stained 
with PE-conjugated anti-CD34 for 30 minutes, washed and resuspended in 1% 
paraformaldehyde. 	Cells were then analysed using the FACscan flow 
cytometer. 
3.2.4 Effect of EDTA on aggregation 
3.2.4.1 5mM EDTA is the optimum dose to reduce QBENDIO induced 
aggregation of KG1a cells 
Previous studies had found that EDTA inhibits QBEND10 induced 
aggregation at the optimal aggregation time point suggesting that 
aggregation is dependent on the availability of divalent cations. To 
determine if this effect is seen throughout the time course of aggregation 
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Chapter 3. Aggregation in KG1a and primary AC133-positive cells 
and establish the optimum dose of EDTA, KG1a cells were resuspended 
in a15 alone or a15 containing 5 or 10mM EDTA. Cells were then 
aliquoted into 96-well plates either alone or with 4lIg/m1QBEND10 or IgG 
control antibody. At the relevant time point, cells were air dried onto 
slides, fixed, stained and scored for aggregation. The trypan blue assay 
for cell viability confirmed that neither dose was toxic to cells (Figure 3.9). 
Aggregation was reduced with 5mM EDTA at both 1 and 3 hours. 
-10 
Time (hours) 
Figure 3.9 The effect of EDTA on QBENDIO-induced aggregation of KG1a 
cells. KG1a cells were resuspended at 1x106/ml in a15 alone or a15 containing 
5mM or 10mM EDTA. Aliquots of 100111 were placed into 96-well plates in 
triplicate and incubated alone or with 414/m1 QBEND10 or IgG control antibody 
After 1 and 3 hours, cells were gently resuspended and air-dried onto multi-well 
slides. After fixing in ethanol for 5 minutes, cells were stained with Giemsa and 
scored for aggregation. The average percentage aggregation with IgG control 
antibody was subtracted from the average percentage value obtained for cells 
incubated with anti-CD34 to give the specific aggregation index. At least 500 
cells were scored per well. Values are expressed as specific aggregation index 
(%), n=1. 
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3.2.4.2 EDTA treatment significantly reduces QBEND10-induced 
aggregation of KG1a cells. 
To confirm the effect of 5mM EDTA on QBENDIO-induced 
aggregation, KG1a cells were resuspended in a15 alone or a15 
containing 5mM EDTA. Aliquots of 100µI were placed in 96-well plates 
with or without 4tig/m1QBEND10 or IgG control. After 3 hours, cells were 
air dried onto slides, fixed, stained and scored for aggregation. 
Aggregation was significantly reduced with 5mM EDTA both at 1 and 3 
hours (Figure 3.10). 
Figure 3.10 The effect of EDTA on QBEND10-induced aggregation of KG1a 
cells. KG1a cells were resuspended at 1x106/m1 in a15 alone or a15 containing 
5mM EDTA. Aliquots of 100111 were placed into 96-well plates in triplicate and 
incubated with 41.tg/m1 QBEND10 or IgG control antibody After 1 and 3 hours, 
cells were gently resuspended and air-dried onto multi-well slides. After fixing in 
ethanol for 5 minutes, cells were stained with Giemsa and scored for 
aggregation. The average percentage aggregation with IgG control antibody was 
subtracted from the average percentage value obtained for cells incubated with 
anti-CD34 to give the specific aggregation index. At least 500 cells were scored 
per well. Values are expressed as specific aggregation index (%) ± standard 
error, n=5. Results were analysed using the paired t-test. * p<0.05, ** p<0.01 
Sp
ec
ifi
c  
ag
gr
eg
at
io
n  
in
de
x  
(%
)  ±
  S
E 
95 
Chapter 3. Aggregation in KG1a and primary AC133-positive cells 
3.2.4.3 EDTA treatment has no effect on aggregation induced with 
anti-CD43 in KG1a cells 
To establish if aggregation induced by anti-CD43 was also 
reduced with 5mM EDTA, KG1a cells were resuspended in a15 alone or 
a15 containing 5mM EDTA. Aliquots of 100µ1 were placed in 96-well 
plates with 41,1g/m1 QBEND10 or IgG control. At the relevant time point, 
cells were air dried onto slides, fixed, stained and scored for aggregation. 
EDTA had no effect on aggregation induced by anti-CD43 at either 1 or 3 
hours (Figure 3.11). 
3.2.4.4 EDTA significantly reduces QBEND10-induced aggregation 
of primary AC133-positive cells 
To establish if EDTA also reduces aggregation in primary cells, 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15 alone or a15 containing 
5mM EDTA. Aliquots were then placed in 96-well plates with 412g/m1 
QBEND10 or IgG control. At the relevant time point, cells were air dried 
onto slides, fixed, stained and scored for aggregation. Aggregation 
induced by QBENDIO was significantly reduced both at 6 and 18 hours 
with 5mM EDTA (Figure 3.12). 
3.2.4.5 EDTA reduces aggregation induced by anti-CD43 in primary 
AC133-positive cells 
To investigate whether aggregation induced by anti-CD43 in 
primary cells is sensitive to EDTA, AC133-positive cells were 
resuspended in a15 alone or a15 containing 5mM EDTA. Aliquots were 
then placed in 96-well plates with or without 4µ9/m1 QBENDIO. At the 
relevant time point, cells were air dried onto slides, fixed, stained and 
scored for aggregation. Aggregation was significantly reduced at 6 and 24 
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hours (Figure 3.13), therefore differing from the aggregation profile seen 
in KG1a cells. 
1 
—*— Untreated 
—c-- 5mM EDTA 
2 
	
3 
Time (hours) 
Figure 3.11 The effect of EDTA on anti-CD43-induced aggregation of KG1a 
cells. KG1a cells were resuspended at 1x106/m1 in a15 alone or a15 containing 
5mM EDTA. Aliquots of 100111 were placed into 96-well plates in triplicate and 
incubated with 41.19/m1 anti-CD43 or IgG control antibody After 3 hours, cells 
were gently resuspended and air-dried onto multi-well slides. After fixing in 
ethanol for 5 minutes, cells were stained with Giemsa and scored for 
aggregation. The average percentage aggregation with IgG control antibody was 
subtracted from the average percentage value obtained for cells incubated with 
anti-CD34 to give the specific aggregation index. At least 500 cells were scored 
per well. Values are expressed as specific aggregation index (%) ± standard 
error, n=5. Results were analysed using the paired t-test. p=NS. 
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Time (hours) 
Figure 3.12 The effect of EDTA treatment on QBEND10-induced 
aggregation of primary AC133-positive cells. Primary AC133-positive cells 
were isolated from PBPC samples using MiniMacs technology. Cells were the 
resuspended at 1x106/m1 in a15 alone or a15 containing 5mM EDTA. Aliquots of 
100111 were placed in 96-well plates and incubated at 37°C with 411g/m1 
QBENDIO or IgG control antibody. At the relevant time point, cells were gently 
resuspended and air-dried onto multi-well slides. After fixing in ethanol for 5 
minutes, cells were stained with Giemsa and scored for aggregation. The 
percentage aggregation with IgG control antibody was subtracted from the 
percentage values obtained for cells incubated with anti-CD34 to give the 
specific aggregation index. At least 500 cells were scored per well. Values are 
expressed as specific aggregation index (%) ± standard error, n=5. Results were 
analysed using the paired t-test. * p<0.05, **p<0.01. 
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Time (hours) 
Figure 3.13 The effect of EDTA treatment on anti-CD43-induced 
aggregation of primary AC133-positive cells. Primary AC133-positive cells 
were isolated from PBPC samples using MiniMacs technology. Cells were the 
resuspended at 1x106/ml in a15 alone or a15 containing 5mM EDTA. Aliquots of 
100µI were placed in 96-well plates and incubated at 37°C with 4µg/ml 
QBEND10 or IgG control antibody. At the relevant time point, cells were gently 
resuspended and air-dried onto multi-well slides. After fixing in ethanol for 5 
minutes, cells were stained with Giemsa and scored for aggregation. The 
percentage aggregation with IgG control antibody was subtracted from the 
percentage values obtained for cells incubated with anti-CD43 to give the 
specific aggregation index. At least 500 cells were scored per well. Values are 
expressed as specific aggregation index (%) ± standard error, n=5. Results were 
analysed using the paired t-test. * p<0.05, ** p<0.01. 
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3.2.5 Effect on PI3-kinase inhibitors on aggregation 
3.2.5.1 The effect of PI3-kinase inhibitors on KG1a aggregation 
Cytokines have been demonstrated to exert their effects on 
haemopoietic cell differentiation and proliferation through numerous 
signalling pathways including the Jak/Stat, MAP kinase and PI3-kinase 
pathways.3 Significantly the PI3-kinase pathway has also been implicated 
in lymphocyte polarization and adhesion as well as polarization of CD34-
positive cells in response to cytokines.137' 174 
To establish the role of the PI3-kinase pathway in QBEND10-
induced aggregation, KG1a cells were resuspended in a15 alone or a15 
containing either 1nm wortmannin or 1 OpM LY294002. Cells were 
incubated for 1 hour at 37°C and aliquoted into 96-well plates with 4µg/m1 
QBENDIO or IgG control. At the relevant time point, cells were air dried 
onto slides, fixed, stained and scored for aggregation. Although 
LY294002 appears to reduce the length of aggregation, no significant 
differences were observed between the levels of aggregation in control 
cells and those pre-treated with inhibitors although aggregation was 
reduced with LY294002 after 5 days (Figure 3.14). 
3.2.5.2 PI3-kinase inhibitors have no significant effect on QBENDIO-
induced aggregation in primary AC133 positive cells. 
To establish if primary cell aggregation was affected by inhibitors 
of the PI3-kinase pathway, primary AC133-positive cells were 
resuspended in a15 alone or a15 containing either 1nm wortmannin or 
101AM LY294002. Cells were incubated for 1 hour at 37°C and aliquoted 
into 96-well plates with 4µ9/m1 QBEND10. At the relevant time point, cells 
were air dried onto slides, fixed, stained and scored for aggregation. No 
significant differences were observed between the specific aggregation 
index of control cells and those pre-treated with inhibitors (Figure 3.15), 
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indicating that alternative signalling pathways may involved in QBEND10-
induced polarization and aggregation. 
Time (hours) 
Figure 3.14 The effect of PI3-kinase inhibitors on QBENDIO-induced 
aggregation of KG1a cells. Cells were resuspended at 1x106/m1 in a15 alone 
or a15 containing 1nm wortmannin or 1011M LY294002. After 1 hour at 37°C, 
cells were aliquoted into 96-well plates in triplicate with 4µ,g QBENDIO or IgG 
control antibody. At the relevant time point, cells were gently resuspended and 
air dried onto slides. Cells were then fixed in ethanol for 5 minutes, stained with 
Giemsa and scored for aggregation. The average percentage aggregation with 
IgG control antibody was subtracted from the average percentage value 
obtained for cells incubated with anti-CD34 to give the specific aggregation 
index. At least 500 cells were scored per well. Values are expressed as specific 
aggregation index (%) ± standard error, n=5. Results were analysed using the 
paired t-test, p=NS. 
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Figure 3.15 The effect of PI3-kinase inhibitors on QBENDIO-induced 
aggregation of primary AC133-positive cells. AC133-positive cells were 
isolated from PBPC samples using MiniMacs technology. Cells were then 
resuspended at 1x106/ml in a15 alone or a15 containing 1nm wortmannin or 
10µM LY294002. After 1 hour at 37°C, cells were aliquoted into 96-well plates 
with 4µg QBENDIO or IgG control antibody. At the relevant time point, cells 
were gently resuspended and air dried onto slides. Cells were then fixed in 
ethanol for 5 minutes, stained with Giemsa and scored for aggregation. The 
percentage aggregation with IgG control antibody was subtracted from the 
percentage value obtained for cells incubated with anti-CD34 to give the specific 
aggregation index. At least 500 cells were scored per well. Values are 
expressed as specific aggregation index (%) ± standard error, n=5. Results were 
analysed using the paired t-test, p= NS. 
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3.2.6 Effect of activation of the Wnt pathway on aggregation 
3.2.6.1 Lithium Chloride has no effect on aggregation induced by 
QBENDIO in KG1a cells 
The Wnt pathway and cadherins have been implicated in the 
control of haemopoietic stem and progenitor cell proliferation and 
differentiation as well as cell polarity and adhesion."' 176 Therefore, in 
order to investigate the role of the Wnt pathway in QBENDIO-induced 
aggregation, cells were treated with lithium chloride (LiCI), a reagent 
which inhibits GSK-3p activity leading to accumulation of 13-catenin and 
Wnt pathway activation.179 Therefore, KG1a cells were resuspended in 
a15 alone or a15 containing LiCI. After 18 hours at 37°C, cells were 
aliquoted into 96- well plates with 411g/m1 QBEND10 or IgG control 
antibody. At the relevant time point, cells were air dried onto slides, fixed, 
stained and scored for aggregation. The trypan blue assay confirmed that 
LiCI was not toxic to cells after 18 hours. No significant effect on 
aggregation induced by QBENDIO was observed (Figure 3.16). 
3.2.6.2 Lithium chloride has no effect on aggregation induced by 
anti-CD43 in KG1a cells 
To confirm that LiCI also has no effect on aggregation induced by 
anti-CD43 KG1a cells were resuspended in a15 alone or a15 containing 
LiCI. After 18 hours at 37°C, cells were aliquoted into 96-well plates with 
41.1g/mIQBEND10 or IgG control antibody. At the relevant time point, cells 
were air dried onto slides, fixed stained and scored for aggregation. No 
significant effect on aggregation induced by QBENDIO was observed 
(Figure 3.17). 
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Time (hours) 
Figure 3.16 The effect of Lithium Chloride on QBEND10-induced 
aggregation of KG1a cells. KG1a cells were resuspended at 1x106/ml in a15 
alone or a15 containing LiCI. Aliquots of 100p,1 were placed into 96-well plates in 
triplicate and incubated with 4µg/ml QBENDIO or IgG control antibody. After 1 
and 3 hours, cells were gently resuspended and air-dried onto multi-well slides. 
After fixing in ethanol for 5 minutes, cells were stained with Giemsa and scored 
for aggregation. The average percentage aggregation with IgG control antibody 
was subtracted from the average percentage value obtained for cells incubated 
with anti-CD34 to give the specific aggregation index. At least 500 cells were 
scored per well. Values are expressed as specific aggregation index (%) ± 
standard error, n=5. Results were analysed using the paired t-test, p=NS. 
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Time (hours) 
Figure 3.17 The effect of Lithium chloride treatment on aggregation 
induced by anti-CD43 in KG1a cells. KG1a cells were resuspended at 
1x106/m1 in a15 alone or a15 containing LiCI. Aliquots of 1000 were placed into 
96-well plates in triplicate and incubated with 4µg/m1 anti-CD43 or IgG control 
antibody. After 1 and 3 hours, cells were gently resuspended and air-dried onto 
multi-well slides. After fixing in ethanol for 5 minutes, cells were stained with 
Giemsa and scored for aggregation. The average percentage aggregation with 
IgG control antibody was subtracted from the percentage value obtained for 
cells incubated with anti-CD43 to give the specific aggregation index. At least 
500 cells were scored per well. Values are expressed as specific aggregation 
index (%) ± standard error, n=5. Results were analysed using the paired t-test. 
p=NS. 
3.2.6.3 Lithium chloride has no effect on QBENDIO-induced 
aggregation of primary AC133-positive cells 
To confirm that LiCI also has no effect on primary cell aggregation, 
AC133-positive cells were resuspended in a15 alone or a15 containing 
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LiCI and incubated at 37°C. After 18 hours, cells were aliquoted into 96-
well plates and incubated at 37°C with 4pg/mIQBEND10. At the relevant 
time point, cells were air dried onto slides, fixed, stained and scored for 
aggregation. No significant difference in aggregation was observed at 
any time point (Figure 3.18). 
Time (hours) 
Figure 3.18 The effect of LiCI treatment on QBEND10-induced aggregation 
of AC133-positive cells. AC133-positive cells were isolated from PBPC 
harvests using MiniMacs technology and resuspended at 1x106/m1 in a15 alone 
or a15 containing LiCI. Aliquots of 100til were placed into 96-well plates and 
incubated with 4µg/m1 QBENDIO or IgG control antibody At the relevant time 
point, cells were gently resuspended and air-dried onto multi-well slides. After 
fixing in ethanol for 5 minutes, cells were stained with Giemsa and scored for 
aggregation. The percentage aggregation with IgG control antibody was 
subtracted from the percentage value obtained for cells incubated with anti-
CD34 to give the specific aggregation index. At least 500 cells were scored per 
well. Values are expressed as specific aggregation index (%) ± standard error, 
n=5. Results were analysed using the paired t-test. p=NS. 
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3.3 Discussion 
This study has shown that the epitope specific anti-CD34 antibody, 
QBENDIO, can induce KG1a aggregation with aggregation being 
maximal at 3 hours and still present after 5 days. Madjic et al., the first 
group to report QBENDIO induced aggregation in KG1a cells, found 
maximum aggregation after only 90 minutes but this may be a reflection 
of their less quantitative aggregation scoring system or due to the slightly 
higher cell concentration used in their study.138 A similar pattern of 
aggregation was also found to be induced by anti-CD43, consistent with 
the hypothesis that, due to their structural similarities, CD34 and CD43 
have overlapping functions.139 However, it has been shown that 
engagement of CD43 on haemopoietic cells induces apoptosis, an effect 
which does not occur in cells treated with anti-CD34.140' 153 This, together 
with the general acceptance that signalling events following antibody 
ligation can mimic binding by the natural ligand, a finding which is 
commonly utilised during the investigation of T cell activation, has lead to 
the suggestion that QBENDIO-induced aggregation of KG1a cells is a 
suitable model for CD34-mediated adhesion and signalling events in 
primary CD34-positive cells. 140, 169, 180 
Primary AC133-positive cells were also demonstrated to undergo 
QBENDIO induced aggregation, with aggregation peaking at 24 hours but 
being absent by 5 days.1" Primary cells may aggregate more slowly than 
KG1a cells due to higher expression of CD34 on KG1a cells or the 
natural variation in CD34 levels both between cells in a sample and 
between patient samples whereas KG1a cells represent a more 
homogeneous population of cells. Aggregation in AC133-positive cells is 
consistent with the findings of Gordon et al. who also highlighted the 
potential of CD34-mediated aggregation in the contact-mediated inhibition 
of progenitor cell proliferation.140  
Cytokines, such as G-CSF and IL-3, activate downstream 
signalling pathways affecting cell cycle progression, cell survival and 
differentiation together with cytoskeletal reorganisation.1 Combinations of 
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these cytokines have been shown to significantly increase progenitor cell 
self-renewal and may influence cell adhesion through activation of 
members of the integrin family.57' 17.1 As QBEND10-induced aggregation 
has been found to reduce self-renewal, it was hypothesized that 
cytokines may also have an effect on CD34-positive cell aggregation.14°  
In this investigation, single cytokines were found to reduce QBEND10 
induced aggregation in KG1a cells at 1, 2 and 3 hours. In primary cells, 
G-CSF and IL-3, both alone and in combination, were found to 
significantly reduce aggregation induced by QBEND10. As cytokines 
appear to reduce aggregation, it seems unlikely that they exert their effect 
through activation of adhesion molecules. The greater effect in primary 
cells could be due to the much longer incubation period of 24 hours 
compared to 3 hours for KG1a cells. It should also be noted that 
progenitor cell mobilisation involves G-CSF, therefore primary cells have 
already been exposed to cytokines.181  In agreement with this, exposing 
KG1a cells to cytokines for 24 hours before the induction of aggregation 
gave a greater effect with the combination, an effect which is not due to a 
decrease in the cell surface expression of CD34. The results are 
consistent with the hypothesis that aggregation of CD34-positive cells 
leads to the contact-mediated inhibition of progenitor cell self-renewal. As 
cytokines reduce this aggregation, an increase in self-renewal would be 
expected as demonstrated by Lewis et al. using G-CSF and 1L-3 in 
combination.3 
Interestingly, It has been reported that culture of cord blood CD34-
positive cells with stem cell factor (SCF), thrombopoietin (TPO), Flt3-
ligand and G-CSF increases the expression of very late antigen-4 (VLA-
4), VLA-5, LFA-1 and CD44. However, in the same study, the number of 
cells expressing L-selectin actually decreased following cytokine 
culture.58 Additionally, following G-CSF mobilization, CD34-positive cells 
have been found to have decreased levels of VLA-4 and LFA-1 cell 
surface expression compared with untreated bone marrow cells." These 
results demonstrate that cytokines may mediate the activation and 
expression of cellular adhesion molecules and may lead to a decrease in 
expression. Therefore, cytokines could potentially have an effect on 
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CD34-mediated aggregation through an effect on adhesion molecules 
although the role of adhesion molecules such as LFA-1 in sialomucin-
mediated aggregation has yet to be determined. 
As the effects of G-CSF and IL-3 on self-renewal have been 
proposed to be mediated through the P13-kinase pathway, the effect of 
the PI3-kinase inhibitors, wortmannin and LY294002, on QBENDIO-
induced aggregation was investigated.3 The PI3-kinase pathway has also 
been implicated in the control of lymphocyte polarization and chemotaxis 
and the redistribution of surface molecules following TCR triggering.99' 174 
However, in this study, the PI3-kinase inhibitors were found to have no 
significant effect on QBEND10-induced aggregation although aggregation 
was reduced with LY294002 at 5 days. Significantly, polarization of 
CD34-positive cells in response to early acting cytokines was found to be 
dependent on the PI3-kinase pathway. However, the cells in this study 
were isolated using anti-CD34 antibodies, inhibition of PI3-kinase only 
occurred following this and the effect of PI3-kinase inhibition only 
measured by examining cell shape using light microscopy, making the 
two studies difficult to compare.137 It is therefore possible, that cytokines 
exert their effect on polarization and aggregation through an alternative 
mechanism. 
Studies have suggested that EDTA treatment reduces aggregation 
of KG1a cells at the maximal time point of aggregation.138, 140 Here we 
have confirmed that EDTA reduces aggregation up to, and including the 
time of maximal aggregation, in both KG1a and primary cells. Therefore, 
primary cell and KG1a aggregation is dependent on divalent cations like 
calcium. In KG1a cells, anti-CD43-induced aggregation was unaffected 
following EDTA treatment. However, CD43-induced aggregation was 
significantly reduced in primary cells indicating that KG1a cells may not 
be a suitable model for CD43-mediated aggregation. All integrin/ligand 
binding is dependent on divalent cations, indicating a potential 
explanation for the effect of EDTA on adhesion between CD34-positive 
cells.°  
Within the haemopoietic system, one signalling pathway implicated 
in the control of haemopoietic stem and progenitor cell proliferation as 
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well as cell orientation, cell polarity and adhesion is the Wnt pathway."' 
176 One component of this pathway, I3-catenin provides a link between 
cadherins and the actin cytoskeleton through a-catenin.64 N-cadherin has 
also been implicated in adhesion between KG1a cells and blocking 
antibodies lead to a dose-dependent reduction in cytokine-induced 
primary cell colony formation.67 Significantly, signalling through cadherins 
is calcium dependent indicating a possible target for the effect of 
EDTA.182 It has been suggested that the two functions of 13-catenin are 
not mutually exclusive and factors which affect Wnt signalling may also 
affect catenin/cadherin binding." Therefore, cells were treated with LiCI, 
which leads to an accumulation of 13-catenin in the cytoplasm and Wnt 
activation. Additionally, treatment of manic—depressive illnesses with 
lithium leads to leukocytosis indicating its possible effect within the 
haemopoietic system.183 However, in this study, LiCI treatment had no 
significant effect on QBENDIO-induced aggregation in either KG1a or 
primary cells. It is therefore possible that the Wnt pathway and cadherin 
mediated adhesion is not involved in QBEND10-induced polarization and 
aggregation, assuming that the Wnt and cadherin pathways are 
connected in these cells. However, visualisation of the distribution of N-
cadherin on aggregated cells would provide further evidence to support 
this statement and determine the involvement of cadherins in sialomucin-
mediated aggregation. 
In conclusion, QBEND10-induced aggregation is a property of both 
KG1a and primary CD34-positive cells. This aggregation is dependent on 
divalent cations and can be affected by factors known to influence 
progenitor cell proliferation and differentiation. 
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CHAPTER 4. THE LOCATION OF ADHESION MOLECULES DURING 
SIALOMUCIN-MEDIATED AGGREGATION 
4.1 Introduction 
Haemopoietic progenitors express more than 20 different adhesion 
receptors including integrins, cadherins, selectins, CD44 molecules, 
members of the IgG superfamily and sialomucins.46  
Homotypic aggregation between cells of the CD34-positive cell 
line, KG1a, induced by anti-CD34 or anti-CD43, has been demonstrated 
to be accompanied by the formation of a cap of CD34 or CD43 
respectively which is colocalised with F-actin.139 CD34-positive cells in 
developing myeloid colonies (CFU-GM) and haematons (multi-cellular 
aggregates) isolated from freshly aspirated bone marrow have been 
shown to be bound together with CD34 localised at the common contact 
point between the cells.1" The function of CD34 within the haemopoietic 
environment is unclear. However, roles in both cell adhesion and 
signalling pathways have been suggested. 144  As aggregation has been 
demonstrated to significantly decrease progenitor cell self-renewal, it is 
hypothesized that a specialised adhesive junction exists between CD34-
positive cells which plays a role in the control of haemopoietic stem and 
progenitor cell self-renewal.1" 
One example of an adhesive junction with a role in intercellular 
signalling is the immunological synapse which exists between a T cell 
and antigen presenting cell.96 Through this interaction, antigen receptors 
on the T cell surface recognise antigenic peptides bound to major 
histocompatibility molecules (MHC) on the antigen-presenting cell." The 
characteristic distribution of cell surface molecules at the synapse 
provides a stable contact point for the sustained signalling required for T 
cell activation.96 Circulating, unstimulated T cells are rounded with a 
uniform distribution of receptors across their cell surfaces. However, in 
response to a chemokine gradient, T cells become polarised through 
actin polymerisation, leading to the formation of a leading edge, or 
lamellapodium which is rich in cell surface receptors and adhesion 
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molecules, together with a trailing edge, or uropod, at the rear.98 Initially 
the adhesive contact is between a central cluster of adhesion molecules 
such as lymphocyte function-associated antigen-1 (LFA-1) on the T cell 
surface and ICAM-1 on the antigen-presenting ce11.198 This close 
adhesion functions to bring the T cell receptor (TCR) and MHC 
molecules, initially located in an outer ring surrounding the central zone, 
into close enough proximity to interact.107 Within minutes of MHC-peptide 
engagement, initial signalling events cause the TCR-MHC complex to 
move into the centre of the contact interface. This area is termed the 
central supramolecular activation cluster (c-SMAC) and also contains co-
stimulatory molecules such as CD28 and CD80 together with associated 
signal transduction molecules such as PKC-0.99 LFA-1, bound to its 
ligand ICAM-1, moves to a ring surrounding this central zone. This area is 
termed the adhesion ring or peripheral supramolecular activation cluster 
(p-SMAC) and contains a number of other molecules including the actin 
binding protein talin.197 Together, these separate domains form the stable 
`bulls-eye' structure of the immunological synapse.118 Due to its large size 
and negative charge, like CD44 and CD45, CD43 is actively excluded 
from the immunological synapse through its interaction with the ERM 
family of cytoskeletal linker proteins, which is proposed to aid integrin-
mediated adhesion by removing steric hindrance or through an 
intracellular mechanism.111, 154, 184 
The mechanism by which CD34-mediated aggregation affects 
progenitor cell self-renewal is unclear although alterations in cell cycle 
regulatory proteins have been observed.141 CD34 itself has two potential 
protein kinase C (PKC) phosphorylation sites plus an additional tyrosine 
kinase phosphorylation site on its intracellular tail indicating a potential 
role in signal transduction.144 Upon aggregation, KG1a cells were found 
to have increased phosphorylation of tyrosine on their intracellular CD34 
tails accompanied by the translocation of PKC from the membrane to the 
cytoplasm."°  
Blocking antibodies to LFA-1 and ICAM-1 have been shown to 
significantly inhibit QBEND10-induced aggregation. Therefore, this 
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aggregation is proposed to be caused, in part, by the simultaneous 
activation of the p2 integrin adhesion pathway, indicating the presence of 
a specialised junction between haemopoietic stem and progenitor cells 
analogous to the immunological synapse.138 We have also demonstrated 
that QBENDIO-induced aggregation is dependent on the availability of 
divalent cations, which are also necessary for integrin/ligand binding 
(Figure 3.10).53' 54 
The aim of this part of the investigation was the characterise the 
adhesive junction between homotypically aggregated CD34-positive cells 
in terms of other adhesion molecules involved in this interaction and the 
role that they may play, focusing on those adhesion molecules shown to 
be critical in immunological synapse formation and those implicated to 
have roles in the control of haemopoiesis. 
4.2 Results 
4.2.1 The distribution of the sialomucins during aggregation 
The sialomucins are a family of mucin-like transmembrane 
glycoproteins which are involved in a wide range of cell-cell and cell-
extracellular matrix interactions within the haemopoietic system.78 A 
number of sialomucin family members are expressed on primitive 
haemopoietic cells, including CD34, CD43, CD45, CD164 and P-selectin 
glycoprotein ligand-1 (PSGL-1).4  
Stimulation of KG1a cells with either anti-CD34 or anti-CD43 has 
been demonstrated to lead to cell polarization with the formation of a 'cap' 
of CD34 or CD43 respectively.139 Due to their structural similarities, CD34 
and CD43 are proposed to have partially overlapping functions in both 
cell adhesion of signalling. 145 Both CD34 and CD43 are likely candidates 
in the formation of a specialised adhesive junction between CD34-
positive cells analogous to the immunological synapse formed between a 
T cell and antigen-presenting cell. Therefore, the distribution of these 
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sialomucins was examined on KG1a and primary CD34-positive cells, 
prior to, and during aggregation. 
4.2.1.1 The distribution of CD34 on unaggregated and aggregated 
cells 
4.2.1.1.1 CD34 localises to the contact point between aggregated 
KG1a cells. 
To examine the distribution of CD34 on unaggregated and 
aggregated cells, KG1a cells were resuspended in either a15 alone, or 
a15 with 411g/m1 QBENDIO or anti-CD43. After 3 hours, cells were air 
dried onto slides, fixed and stained with mouse anti-CD34 followed by 
anti-mouse FITC. On cells incubated with a15 alone, CD34 remains 
uniformly distributed over the cell surface. However, following exposure to 
QBEND10, CD34 becomes polarised, both on single cells and to the 
contact point between aggregated cells. On cells exposed to anti-CD43, 
CD34 remains uniformly distributed (Figure 4.1). Cells incubated with IgG 
controls followed by FITC-conjugated secondary antibody or secondary 
antibody alone showed no significant staining above background levels. 
To quantify the extent of CD34-polarisation, single cells and cells 
in aggregates consisting of 2-4 cells were scored as either unpolarised 
(A), polarised (B) or totally polarised (C) as indicated in Figure 4.2 
The majority of unaggregated cells appeared unpolarised whereas, 
when cells are exposed to QBENDIO, the significantly more single cells 
and cells in small aggregates appear polarised or totally polarised. In the 
case of cells in aggregates, this polarisation is towards the point of cell-to-
cell contact. In contrast, on cells exposed to anti-CD43, CD34 remains 
unpolarised, with the number of cells exhibiting some degree of 
polarisation being significantly less than the controls (Figure 4.3). 
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Aggregation conditions 
(a) Control 	(b) anti-CD34 
	
(c) anti-CD43 
Figure 4.1 The distribution of CD34 (green) on (a) unaggregated or 
aggregated KG1a cells exposed to (b) anti-CD34 or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 4µg/ml QBEND10 or anti-CD43. After 3 hours, cells were gently 
resuspended and air-dried onto teflon-coated multi-well slides. Cells were fixed 
with 3% paraformaldehyde for 15 minutes and stained using goat anti-CD34 
followed by rabbit anti-goat FITC. Additional slides were stained with goat IgG 
followed by the FITC-conjugated secondary to control for non-specific antibody 
binding. Coverslips were mounted with 1 drop of vectashield containing DAPI 
and the slides examined under the fluorescent microscope using the x40 
objective lens. 
A 
	
B 	 C 
Figure 4.2 Scoring polarisation in unaggregated and aggregated cells. 
Cells were either scored as (A) unpolarised where the distribution of the surface 
marker remains uniform across the cell surface, (B) polarised where there is 
clear accumulation of the surface marker to one point on the cell but some 
staining on the rest of the cell surface or (C) totally polarised where all the 
surface staining is concentrated at one point and any other surface staining is 
very faint or not apparent. 
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*** 	*** 	 ** 	 ** 
Figure 4.3 Polarisation score for CD34 on unaggregated and aggregated 
KGla cells. Cells were resuspended in a15 and incubated either alone or with 
the addition of 41.1g/m1 QBENDIO or anti-CD43. After 3 hours, cells were air-
dried onto multi-well slides, fixed in 3% paraformaldehyde for 15 minutes and 
stained using goat anti-CD34 followed by rabbit anti-goat FITC. Additional slides 
were stained with goat IgG followed by the FITC-conjugated secondary to 
control for non-specific antibody binding. Cells were scored as unpolarised, 
polarised or totally polarised as in Figure 4.2. Results are expressed as the 
percentage of the total number of cells scored that are either unpolarised, 
polarised or totally polarised tstandard deviation, at least 100 cells were scored 
per sample, n=4. The percentages of polarised cells were compared using the 
ANOVA test for statistical significance. *p<0.05, **p<0.01, ***p<0.001. 
4.2.1.1.2 CD34 is polarised and becomes localised to the contact 
point between primary AC133-positive cells isolated from normal 
peripheral blood progenitor cell harvests (PBPC) and exposed to 
QBENDIO. 
To determine if CD34 becomes polarised on primary CD34-
positive cells, cells were isolated on AC133 and incubated in a15 alone or 
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with 4µg/m1 QBEND10 or anti-CD43 overnight. Following fixation, cells 
were stained with goat anti-CD34 and anti goat-FITC secondary. Without 
exposure to QBENDIO, CD34 distribution remains uniform across the cell 
surface. However, in the presence of QBENDIO, cells become polarised 
with CD34 directed towards the point of cell-to-cell contact (Figure 4.4). 
Cells incubated with IgG controls followed by FITC-conjugated secondary 
antibody or secondary antibody alone showed no significant staining 
above background levels. 
Aggregation conditions 
(a) Control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.4 The distribution of CD34 (green) on (a) unaggregated or 
aggregated AC133-positive cells exposed to (b) QBENDIO or (c) anti-CD43. 
AC133-positive cells were isolated from PBPC samples using Mini-Macs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/ml QBEND10. After 24 hours, cells were 
gently resuspended and air-dried onto teflon-coated multi-well slides. Cells were 
fixed with 3% paraformaldehyde for 15 minutes and stained using goat anti-
CD34 followed by rabbit anti-goat FITC. Additional slides were stained with goat 
IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Coverslips were mounted with 1 drop of vectashield containing 
DAPI and the slides examined under the fluorescent microscope using the x40 
objective lens. 
To quantify the extent of CD34 polarisation on AC133-positive 
cells, unaggregated and aggregated cells were scored as in Figure 4.2. 
CD34 remains uniformly distributed across the cell surface in the majority 
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of unaggregated cells whereas, when cells are exposed to QBEND10, 
significantly more single and aggregated cells are either polarised or 
totally polarised. In the case of aggregated cells, this polarisation always 
occurs towards the cell-to-cell contact point. In contrast, cells exposed to 
anti-CD43 exhibit little CD34 polarisation (Figure 4.5). 
Figure 4.5 Polarisation score for CD34 on unaggregated and aggregated 
AC133-positive cells. AC133-positive cells were isolated from PBPC harvests 
using MiniMacs technology. Cells were resuspended in a15 and incubated 
either alone or with the addition of 414/m1 QBEND10 or anti-CD43. After 24 
hours, cells were air-dried onto multi-well slides, fixed in 3% paraformaldehyde 
for 15 minutes and stained using goat anti-CD34 followed by rabbit anti-goat 
FITC. Additional slides were stained with goat IgG followed by the FITC-
conjugated secondary to control for non-specific antibody binding. Cells were 
scored as unpolarised, polarised or totally polarised as in Figure 4.2. Results are 
expressed as the percentage of the total number of cells scored that are either 
unpolarised, polarised or totally polarised ±standard deviation, at least 100 cells 
were scored per sample, n=4. The percentages of polarised cells were 
compared using the ANOVA test for statistical significance, *p<0.05, **p<0.01. 
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4.2.1.1.3 CD34 localises to the contact point between primary 
AC133-positive cells isolated from normal bone marrow (NBM). 
To confirm that the distribution of CD34 was the same on normal 
bone marrow, AC133-positive cells were isolated from normal bone 
marrow and air-dried onto Teflon-coated multi-well slides. Cells were then 
fixed and stained with goat anti-CD34 followed by rabbit anti-goat FITC. 
As with KG1a cells and primary cells from PBPC samples, CD34 is 
uniformly distributed on unaggregated cells and becomes polarised when 
cells are exposed to QBEND10 (Figure 4.6). Cells incubated with IgG 
controls followed by FITC-conjugated secondary antibody or secondary 
antibody alone showed no significant staining above background levels. 
Aggregation conditions 
(a) Control 	(b) anti-CD34 
Figure 4.6 The distribution of CD34 (green) on (a) unaggregated and (b) 
aggregated AC133-positive cells exposed to QBEND10, isolated from 
normal bone marrow. AC133-positive cells were isolated from NBM using 
MiniMacs technology. Cells were then incubated in a15 alone or with 4µg/m1 
QBEND10. After 24 hours, cells were gently resuspended and air-dried onto 
multi-well slides. The cells were then fixed in 3% paraformaldehyde for 15 
minutes and the cells stained with goat anti-CD34 followed by rabbit anti-goat 
FITC. Additional slides were stained with goat IgG followed by FITC-conjugated 
secondary to control for non-specific antibody binding. Coverslips were mounted 
with one drop of vectashield containing DAPI and examined using a fluorescent 
microscope and the x40 objective lens. 
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4.2.1.1.4 CD34 distribution resembles a ring structure on KG1a cells 
exposed to QBENDIO 
To determine if the distribution of CD34 bears any resemblance to 
the ring structure of adhesion molecules at the immunological synapse, 
CD34 on KG1a cells exposed to QBENDIO was examined using laser 
scanning confocal microscopy which allows serial sections of cells to be 
examined. Cells were scanned from the slide towards the coverslip in 15 
1i.IM sections. The final 4 sections of a typical KG 	cell are shown in 
Figure 4.7. Moving from the slide to the coverslip, CD34 is seen to be 
distributed in a ring-like structure. 
Figure 4.7 The distribution of CD34 on KGla cells exposed to QBENDIO 
and examined using confocal microscopy. KG1a cells were resuspended in 
a15, aliquoted into 96-well plates and incubated with or without 44/m1 
QBENDIO. After 3 hours, cells were gently resuspended and attached to poly-L-
lysine coated slides. Cells were then blocked and stained with goat anti-mouse 
FITC. To control for non-specific antibody binding, additional KG1a cells were 
stained with normal mouse IgG1 followed by goat anti-mouse FITC. Laser 
scanning confocal microscopy was then used to examine serial z-slices of cells 
moving upwards from the slide to the coverslip. 15 slices of around 1µm were 
captured. The figure shows the final 4 sections of a KG1a cell exposed to 
QBEND10. The arrow indicates the sequence of sections, moving from the slide 
to the coverslip. The results are typical of KG1a cells examined on 6 different 
slides. 
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4.2.1.2 The distribution of CD43 on unaggregated and aggregated 
cells 
4.2.1.2.1 CD43 is polarised on a proportion of aggregated KG1a cells 
To examine the distribution of the sialomucin CD43 on aggregated 
cells, KG1a cells were resuspended in a15 alone or in a15 containing 
4µg/m1 QBEND10 or anti-CD43. After 3 hours, cells were air-dried onto 
slides, fixed and stained with FITC-conjugated anti-CD43. The majority of 
unaggregated and aggregated KG1a cells appeared to be unpolarised 
with respect to CD43 (Figure 4.8). Cells incubated with IgG controls 
followed by FITC-conjugated secondary antibody or secondary antibody 
alone showed no significant staining above background levels. To 
quantify the extent of CD43 polarisation on KG1a cells, unaggregated 
and aggregated cells were scored as in Figure 4.2. CD43 is unpolarised 
on unaggregated cells. Following exposure to QBENDIO, CD43 is 
polarised on significantly more aggregated cells but not single cells 
exposed to QBENDIO, compared to unaggregated controls. Treatment 
with anti-CD43 leads to significant polarisation of CD43 towards the cell-
to-cell contact point on aggregated cells but less so on single cells 
(Figure 4.9) 
4.2.1.2.2 CD43 is unpolarised on unaggregated and aggregated 
AC133-positive cells 
To confirm that the distribution of CD43 on primary cells is similar 
to that on KG1a cells, cells were isolated on AC133 and incubated in a15 
alone or with 4µg/ml QBEND10 or anti-CD43 overnight. Cells were then 
air-dried onto multi-well slides, fixed and stained with FITC-conjugated 
anti-CD43. On unaggregated cells and cells exposed to QBEND10 or 
anti-CD43, some evidence of CD43 polarisation is seen although the 
majority appear unpolarised (Figure 4.10). Cells incubated with IgG 
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controls followed by FITC-conjugated secondary antibody or secondary 
antibody alone showed no significant staining above background levels. 
To quantify the extent of CD43 polarisation on AC133-positive 
cells, unaggregated and aggregated cells were scored as in Figure 4.2. 
No significant polarisation of CD43 is seen on unaggregated cells and 
cells exposed to QBENDIO or anti-CD43 (Figure 4.11). 
Aggregation conditions 
(a) Control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.8 The distribution of CD43 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 44/m1 QBENDIO. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-CD43. 
Additional slides were stained with FITC-conjugated normal mouse IgG to 
control for non-specific antibody binding. Coverslips were mounted with 1 drop 
of vectashield containing DAPI and the slides examined under the fluorescent 
microscope using the x40 objective lens. 
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Aggregation conditions 
(a) Control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.10 The distribution of CD43 (green) on (a) unaggregated and 
aggregated AC133-positive cells exposed to (b) QBENDIO or (c) anti CD43. 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/m1 QBEND10 or anti-CD43. After 24 hours, 
cells were gently resuspended and air-dried onto teflon-coated multi-well slides. 
Cells were fixed with 3% paraformaldehyde for 15 minutes and stained using 
FITC-conjugated anti-CD43. Additional slides were stained with FITC-
conjugated normal mouse IgG to control for non-specific antibody binding. 
Coverslips were mounted with 1 drop of vectashield containing DAPI and the 
slides examined under the fluorescent microscope using the x40 objective lens. 
4.2.1.3 The distribution of CD164 on unaggregated and aggregated 
cells 
CD164 is a novel member of the sialomucin family with potential 
roles in cell adhesion and signalling.162 It has also been demonstrated to 
co-localise with CD34, therefore, the distribution of CD164 on 
unaggregated and aggregated cells was examined.163 
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Figure 4.11 The distribution score for CD43 on unaggregated and 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology. Cells were then resuspended in a15 
and incubated either alone or with the addition of 414/m1 QBEND10 or anti-
CD43. After 24 hours, cells were air-dried onto multi-well slides, fixed in 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-CD43. 
Additional slides were stained with FITC-conjugated normal mouse IgG to 
control for non-specific antibody binding. Cells were scored as unpolarised, 
polarised or totally polarised as in Figure 4.2. Results are expressed as the 
percentage of the total number of cells scored that are either unpolarised, 
polarised or totally polarised ±standard deviation, at least 100 cells were scored 
per sample, n=4. The percentages of polarised cells were compared using the 
ANOVA test for statistical significance, p=NS. 
4.2.1.3.1 CD164 is polarised on unaggregated KG1a cells 
To investigate the involvement of CD164 in CD34 and CD43-
mediated aggregation, KG1a cells were resuspended in a15 alone or in 
a15 with 41.1g/mIQBEND10 or anti CD43. After 3 hours, cell were air-dried 
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onto slides, fixed and stained with FITC-conjugated anti-CD164. CD164 
was found to be polarised on a proportion of unaggregated KGla cells. 
CD164 was also polarised on aggregated cells but this polarisation was 
not towards the cell-to-cell contact point (Figure 4.12). Cells incubated 
with IgG controls followed by FITC-conjugated secondary antibody or 
secondary antibody alone showed no significant staining above 
background levels. 
To quantify the extent of CD164 polarisation, single cells and cells 
in aggregates were scored as in Figure 4.2. CD164 is polarised on 
around half of unaggregated control cells. Similar values were measured 
on cells exposed to QBEND10 and anti-CD43 (Figure 4.13). On 
aggregated cells however, polarisation was not towards the cell-to-cell 
contact point but away from it. 
4.2.1.3.2 CD164 is polarised on unaggregated cells compared to 
CD34 
To compare the distribution of CD34 and CD164 on unaggregated 
cells, KG1a cells were resuspended in a15 alone. After 3 hours, cells 
were air-dried onto slides, fixed and stained using goat anti-CD34 and 
rabbit anti-goat rhodamine followed by FITC-conjugated anti-CD164. 
CD164 is polarised, whereas CD34 remains uniformly distributed across 
the cell surface (Figure 4.14). 
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Aggregation conditions 
(a) control 	 (b) anti-CD34 	(c) anti-CD43 
Figure 4.12 The distribution of CD164 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBEND10 or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 44/m1 QBEND10. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-
CD164. Additional slides were stained with FITC-conjugated normal mouse IgG 
to control for non-specific antibody binding. Coverslips were mounted with 1 
drop of vectashield containing DAPI and the slides examined under the 
fluorescent microscope using the x40 objective lens. 
4.2.1.3.3 CD164 is polarised to the opposite pole to CD34 and is 
excluded from the contact point between aggregated KG1a cells 
To determine the distribution of CD164, relative to CD34, on 
aggregated cells, KG1a cells were resuspended in a15 containing 4µg/ml 
QBEND10. After 3 hours, cells were air-dried onto slides, fixed and 
stained first with FITC-conjugated CD164 followed by goat anti-CD34 
followed by rabbit anti-goat rhodamine. CD164 polarises to the pole 
opposite CD34 and is excluded from the contact point between 
aggregated cells (Figure 4.15). 
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Figure 4.13 The distribution score for CD164 on unaggregated and 
aggregated KG1a cells. KG1a cells were resuspended in a15 and incubated 
either alone or with the addition of 4µg/m1 QBEND10 or anti-CD43. After 3 
hours, cells were air-dried onto multi-well slides, fixed in 3% paraformaldehyde 
for 15 minutes and stained using FITC-conjugated anti-CD164. Additional slides 
were stained with FITC-conjugated normal mouse IgG to control for non-specific 
antibody binding. Cells were scored as unpolarised, polarised or totally polarised 
as in Figure 4.2. Results are expressed as the percentage of the total number of 
cells scored that are either unpolarised, polarised or totally polarised tstandard 
deviation, at least 100 cells were scored per sample, n=4. The percentages of 
polarised cells were compared using the ANOVA test for statistical significance, 
p=NS. 
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4.2.1.3.4 CD164 is polarised on unaggregated and aggregated 
AC133-positive cells 
To determine if CD164 is polarised on primary cells, cells were 
isolated on AC133 and incubated in a15 alone or with 4µg/ml QBEND10 
or anti-CD43 overnight. Cells were then air-dried onto multi-well slides, 
fixed and stained with FITC-conjugated anti-CD164. As on KG1a cells, 
CD164 is polarised on unaggregated and aggregated AC133-positive 
cells (Figure 4.16) Cells incubated with igG controls followed by FITC and 
rhodamine-conjugated secondary antibodies or secondary antibody alone 
showed no significant staining above background levels. 
Labelling 
CD164 
	
CD34 
	
Overlay 
Figure 4.14 The distribution of CD34 (red) and CD164 (green) on 
unaggregated KG1a cells. KG1a cells were resuspended in a15 for 3 hours 
and aliquots air-dried onto multi-well slides. Slides were then fixed with 3% 
paraformaldehyde for 15 minutes and dual stained using FITC-conjugated 
CD164 followed by goat anti-CD34 with rhodamine-conjugated secondary 
antibody. 
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Labelling 
CD164 
	
CD34 	 Overlay 
Figure 4.15 The distribution of CD34 (red) and CD164 (green) on 
aggregated KG1a cells. KG1a cells were resuspended in a15 and aggregated 
by incubation with QBENDIO. After 3 hours, aliquots were dried onto multi-well 
slides and fixed with 3% paraformaldehyde for 15 minutes. Cells were dual 
stained using FITC-conjugated CD164 followed by goat anti-CD34 and rabbit 
anti-goat rhodamine-conjugated secondary antibody. Results are representative 
of 3 independent experiments. 
To quantify the extent of CD164 polarisation on AC133-positive 
cells, unaggregated and aggregated AC133-positive cells were scored as 
in Figure 4.2. CD164 is polarised on the majority of unaggregated control 
cells as well as on cells exposed to QBEND10 or anti-CD43 (Figure 
4.17). As with KG1a cells, on cells in aggregates, this polarisation is not 
towards the cell-to-cell contact point. 
130 
Chapter 4. The location of adhesion molecules during sialomucin-mediated aggregation  
Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.16 The distribution of CD164 (green) on (a) unaggregated and 
aggregated AC133-positive cells exposed to (b) QBENDIO or (c) anti-CD43. 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/m1 QBENDIO or anti-CD43. After 24 hours 
FITC-conjugated anti-CD164. Additional slides were stained with FITC-
conjugated normal mouse IgG to control for non-specific antibody binding. 
Coverslips were mounted with 1 drop of vectashield containing DAPI and the 
slides examined under the fluorescent microscope using the x40 objective lens. 
4.2.1.4 The distribution of CD45 on unaggregated and aggregated 
cells 
The role of the transmembrane protein tyrosine phosphatase, 
CD45, in haemopoiesis remains unclear. However, studies have 
suggested a role in the control of cytokine signalling and, therefore, in the 
activation, differentiation and proliferation of haemopoietic progenitor 
cells.158 The varying levels of CD45 during progenitor cell development 
have been proposed to lead to alternate adhesive interactions between 
cells and the microenvironment which represents an additional 
mechanism by which CD45 may contribute to haemopoiesis.159 
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Figure 4.17 The distribution score for CD164 on unaggregated and 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology. Cells were then resuspended in a15 
and incubated either alone or with the addition of 4µg/m1 QBEND10 or anti-
CD43. After 24 hours, cells were air-dried onto multi-well slides, fixed in 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-
CD164. Additional slides were stained with FITC-conjugated normal mouse IgG 
to control for non-specific antibody binding. Cells were scored as unpolarised, 
polarised or totally polarised as in Figure 4.2. Results are expressed as the 
percentage of the total number of cells scored that are either unpolarised, 
polarised or totally polarised ±standard deviation, at least 100 cells were scored 
per sample, n=4. The percentages of polarised cells were compared using the 
ANOVA test for statistical significance, p=NS. 
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4.2.1.4.1 CD45 is not polarised on unaggregated and aggregated 
KG1a cells 
To investigate the distribution of CD45, KG1a cells were 
resuspended in a15 alone or in a15 with 41..tg/mIQBEND10 or anti-CD43. 
After 3 hours, cells were air-dried onto slides, fixed and stained with 
FITC-conjugated anti-CD45. On unaggregated and aggregated cells, 
CD45 remains unpolarised (Figure 4.18). Cells incubated with IgG 
controls followed by FITC-conjugated secondary antibody or secondary 
antibody alone showed no significant staining above background levels. 
Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.18 The distribution of CD45 (green) on (a) unaggregated and 
aggregated KGla cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 41.1g/m1 QBEND10. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-CD45. 
Additional slides were stained with FITC-conjugated normal mouse IgG to 
control for non-specific antibody binding. Coverslips were mounted with 1 drop 
of vectashield containing DAPI and the slides examined under the fluorescent 
microscope using the x40 objective lens. 
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4.2.1.5 The distribution of PSGL-1 on unaggregated and aggregated 
cells 
P-selectin glycoprotein ligand-1 (PSGL-1) on haemopoietic 
progenitor cells has been shown to be the sole ligand for P-selectin on 
marrow endothelial cells. Adhesion to P-selectin has been shown to 
inhibit cytokine-stimulated CD34-positive cell proliferation, indicating that 
PSGL-1 may function as a negative regulator of haemopoiesis.83 
Therefore, the role of PSGL-1 in sialomucin-mediated aggregation was 
investigated. 
4.2.1.5.1 PSGL-1 is not polarised on unaggregated and aggregated 
KG1a cells 
To determine if PSGL-1 plays a role in sialomucin mediated 
aggregation, KG1a cells were resuspended in a15 alone or a15 
containing µg/ml QBENDIO or anti-CD43. After 3 hours, cells were air-
dried onto slides, fixed and stained with rabbit anti-PSGL-1 followed by 
goat anti-rabbit FITC. PSGL-1 is unpolarised on unaggregated and 
aggregated KG1a cells (Figure 4.19). Cells incubated with IgG controls 
followed by FITC-conjugated secondary antibody or secondary antibody 
alone showed no significant staining above background levels. 
4.2.2 The role of the integrin family of cell adhesion molecules in 
sialomucin-mediated aggregation 
Members of the integrin family of cell adhesion molecules are 
involved in 'homing' and retention of progenitor cells within the bone 
marrow.55 Additionally, the cytoplasmic tails of these receptors interact 
with a number of cytoskeletal proteins and form focal adhesion 
complexes. Signal transduction molecules such as PI3-kinase are also 
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Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.19 The distribution of PSGL-1 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 4;1g/m1 QBEND10 or anti-CD43. After 3 hours, cells were gently 
resuspended and air-dried onto teflon-coated multi-well slides. Cells were fixed 
with 3% paraformaldehyde for 15 minutes and stained using rabbit anti-PSGL-1 
followed by goat anti-rabbit FITC. Additional slides were stained with normal 
rabbit IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Coverslips were mounted with 1 drop of vectashield containing 
DAPI and the slides examined under the fluorescent microscope using the x40 
objective lens. 
recruited to these focal adhesion complexes resulting in the activation of 
downstream signalling pathways involved in proliferation and 
differentiation.61  Members of the [31 integrin family, including VLA-4 
(a4131) and VLA-5 (a5131) have been implicated in the control of 
lymphopoiesis and myelopoiesis.57 One member of the [32 family, LFA-1, 
together with its ligand ICAM-1 are critical during early events in 
immunological synapse formation .185 Significantly, blocking antibodies to 
LFA-1 and ICAM-1 have been shown to significantly inhibit QBENDIO 
induced aggregation. Therefore, this aggregation is proposed to be 
caused, in part, by the simultaneous activation of the 132 integrin adhesion 
pathway.138 Therefore, the role of integrins in sialomucin-mediated 
aggregation was explored. 
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4.2.2.1 The distribution of LFA-1 on unaggregated and aggregated 
cells 
4.2.2.1.1 LFA-1 is unpolarised on unaggregated cells and polarised 
on KG1a cells exposed to QBENDIO. 
To determine the role of the 132 integrin, LFA-1, in CD34-mediated 
aggregation, KG1a cells were resuspended in a15 alone or a15 with 
4µg/ml QBENDIO or anti-CD43. After 3 hours, cells were air-dried onto 
slides, fixed and stained with the anti-LFA-1 antibody, anti-integrin aL, 
followed by goat anti-rabbit FITC. On cells incubated in a15 alone, LFA-1 
remains uniformly distributed over the cell surface. However, following 
exposure to QBEND10, LFA-1 becomes polarised towards to the cell-to-
cell contact point. In contrast, on aggregated cells exposed to anti-CD43, 
LFA-1 remains uniformly distributed across the cell surface (Figure 4.20). 
Cells incubated with IgG controls followed by FITC-conjugated secondary 
antibody or secondary antibody alone showed no significant staining 
above background levels. 
To quantify the extent of LFA-1 polarisation on KG1a cells, 
unaggregated and aggregated cells were scored as in Figure 4.2. On the 
majority of unaggregated cells, LFA-1 remains uniformly distributed 
across the cell surface. However, on single cells and aggregates, 
following exposure to QBENDIO, LFA-1 becomes significantly more 
polarised when compared to untreated controls. In the case of 
aggregated cells, this polarisation is towards the cell-to-cell contact point. 
On cells exposed to anti-CD43, no polarisation of LFA-1 is observed 
(Figure 4.21). 
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Aggregation conditions 
(a) Control 
	
(b) CD34 	(c) CD43 
Figure 4.20 The distribution of LFA-1 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 4[1,g/m1 QBENDIO. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using rabbit anti-integrin aL 
followed by goat anti-rabbit FITC. Additional slides were stained with normal 
rabbit IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Coverslips were mounted with 1 drop of vectashield containing 
DAPI and the slides examined under the fluorescent microscope using the x40 
objective lens. Nuclei appear blue. 
4.2.2.1.2 LFA-1 is polarised on AC133-positive cells exposed to 
QBENDIO. 
To determine if LFA-1 is also polarised on primary AC133-positive 
cells, cells were isolated on AC133 and incubated in a15 alone or with 
4µg/mIQBEND10 or anti-CD43 overnight. Cells were then air-dried onto 
multi-well slides, fixed and stained with rabbit anti-integrin aL followed by 
goat anti-rabbit FITC. On unaggregated cells and cells exposed to anti-
CD43, LFA-1 remains unpolarised whereas, on cells exposed to 
QBEND10, LFA-1 becomes polarised towards the cell-to-cell contact 
point (Figure 4.22). Cells incubated with IgG controls followed by FITC- 
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conjugated secondary antibody or secondary antibody alone showed no 
significant staining above background levels. 
Figure 4.21 The distribution score for LFA-1 on unaggregated and 
aggregated KG1a cells. KG1a cells were resuspended in a15 and incubated 
either alone or with the addition of 414/m1 QBEND10 or anti-CD43. After 3 
hours, cells were air-dried onto multi-well slides, fixed in 3% paraformaldehyde 
for 15 minutes and stained using rabbit anti-integrin aL followed by goat anti-
rabbit FITC. Additional slides were stained with normal rabbit IgG followed by 
the FITC-conjugated secondary to control for non-specific antibody binding. 
Cells were scored as unpolarised, polarised or totally polarised as in Figure 4.2. 
Results are expressed as the percentage of the total number of cells scored that 
are either unpolarised, polarised or totally polarised ±standard deviation, at least 
100 cells were scored per sample, n=4. The percentages of polarised cells were 
compared using the ANOVA test for statistical significance, *p<0.05, "p<0.01, 
***p<0.001. 
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Aggregation conditions 
Control 
	
CD34 	 CD43 
Figure 4.22 The distribution of LFA-1 (green) on (a) unaggregated and 
aggregated AC133-positive cells exposed to (b) QBENDIO or (c) anti-CD43. 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/m1 QBEND10 or anti-CD43. After 24 hours, 
cells were gently resuspended and air-dried onto teflon-coated multi-well slides. 
Cells were fixed with 3% paraformaldehyde for 15 minutes and stained using 
rabbit anti-integrin aL followed by goat anti-rabbit FITC. Additional slides were 
stained with normal rabbit IgG followed by the FITC-conjugated secondary to 
control for non-specific antibody binding. Coverslips were mounted with 1 drop 
of vectashield containing DAPI and the slides examined under the fluorescent 
microscope using the x40 objective lens. 
To quantify the extent of LFA-1 polarisation on AC133 cells 
exposed to QBENDIO unaggregated and aggregated cells were scored 
as in Figure 4.2. On the majority of unaggregated cells and cells exposed 
to anti-CD43, LFA-1 remains uniformly distributed across the cells 
surface. However, on AC133-positive cells exposed to QBEND10, there 
is significant polarisation of LFA-1 (Figure 4.23). In the case of cells in 
aggregates, this polarisation is towards the cell-to-cell contact point. 
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Figure 4.23 The distribution score for LFA-1 on unaggregated and 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology. Cells were then resuspended in al 5 
and incubated either alone or with the addition of 41,1g/m1 QBEND10 or anti-
CD43. After 24 hours, cells were air-dried onto multi-well slides, fixed in 3% 
paraformaldehyde for 15 minutes and stained using rabbit anti-integrin aL 
followed by goat anti-rabbit FITC. Additional slides were stained with normal 
rabbit IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Cells were scored as unpolarised, polarised or totally polarised 
as in Figure 4.2. Results are expressed as the percentage of the total number of 
cells scored that are either unpolarised, polarised or totally polarised ±standard 
deviation, at least 100 cells were scored per sample, n=4. The percentages of 
polarised cells were compared using the ANOVA test for statistical significance, 
*p<0.05, "p<0.01, ***p<0.001. 
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4.2.2.1.3 LFA-1 is involved in the early stages of CD34-mediated 
adhesion 
To investigate whether LFA-1 plays a role in the early stages of 
QBEND10-induced aggregation as it does in immunological synapse 
formation, LFA-1 was knocked down in KG1a cells using siRNA and the 
effect on aggregation examined." 
4.2.2.1.3.1 LFA-1 can be knocked-down in KGla cells using siRNA 
KG1a cells were treated with LFA-1 siRNA and cells harvested at 
0, 18, 24 and 48 hours for slide preparation. At each time point, 3 x104  
cells were air dried onto multi-well slides. Separate wells were prepared 
for untreated cells, LFA-1 siRNA-treated and mis-match siRNA treated 
controls. Slides were then fixed and stained with rabbit anti-integrin aL 
followed by goat anti-rabbit FITC. Slides were examined under the 
fluorescent microscope and capture settings optimised using control cells 
at the 0 time point. These capture settings were then fixed and pictures of 
LFA-1 stained control, siRNA and mis-match control cells taken (Figure 
4.24). The results indicated the optimal LFA-1 knockdown was achieved 
at 18 hours. 
To confirm and quantify the knockdown, KG1a cells were treated 
with LFA-1 siRNA for 18 hours were then lysed and western blotting 
performed on cells treated with LFA-1 siRNA and mis-match control. The 
lysates were also probed for actin in order to take into account any 
difference in lysis or loading efficiency. Compared to cells treated with the 
mis-match control, LFA-1 siRNA caused knockdown of LFA-1 in KG1a 
cells. Using densitometry software and taking into account the lower 
amount of actin in the mis-match sample, the knockdown was calculated 
to be 76.77% (Figure 4.25). 
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Figure 4.24 LFA-1 staining intensity on KG1a cells with siRNA treatment. 
KG1a cells were incubated in serum-free media alone or transfected with 
integrin aL or mismatch siRNA using oligofectamine. After a second transfection 
at 24 hours, cells were left for 4 hours before the addition of 10% FCS (time 0). 
After this point, aliquots of cells were removed at each time point and air-dried 
onto multi-well slides. The cells were then fixed in 3% paraformaldehyde for 15 
minutes and stained using rabbit anti-integrin aL followed by goat anti-rabbit 
FITC. 
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Figure 4.25 LFA-1 knockdown in KGla cells following siRNA treatment. 
KG1a cells were either treated with LFA-1 siRNA or mis-match control and 
1x106 cells lysed in 20111 lysis buffer. An equal volume of 2x sample buffer was 
added and the lysates boiled and frozen. Samples were then electrophoresed 
on polyacrylamide gels and transferred to nitrocellulose membrane. Membranes 
were then probed 11.19/mlanti-LFA-1 and anti-actin overnight at 4°C. Blots show 
the visualised LFA-1 and actin bands in both the LFA-1 siRNA (siRNA) and mis-
match control samples (MM). Bands were analysed using Image J densitometry 
software. LFA-1 is knocked down by 76.77% compared to mis-match controls. 
4.2.2.1.3.2 LFA-1 knockdown leads to a decrease in KG1a cell 
aggregation induced by QBENDIO 
To determine the role of LFA-1 in QBEND10-induced aggregation, 
KG1a cells were treated with LFA-1 siRNA or mis-match siRNA for 18 
hours and resuspended in c[15 with 411g/m1 QBEND10 or mouse IgG 
control. Cells were harvested at 0,1,2, and 3 hours and scored for 
aggregation. Aggregation was significantly reduced at 1 and 3 hours 
(Figure 4.26), with the biggest reduction being at 1 hour (Figure 4.27). 
This indicates that LFA-1 is particularly important in the early stages of 
CD34-mediated aggregation. 
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Time (hours) 
Figure 4.26 The effect of LFA-1 siRNA treatment on QBEND10-induced 
aggregation. KG1a cells were treated with LFA-1 siRNA or mis-match control 
for 18 hours before being aggregated with 4n/m1 QBENDIO or IgG control as 
normal. At the relevant time point, cells were gently resuspended and aliquots 
air-dried onto multi-well slides. The slides were then fixed in ethanol for 5 
minutes and stained with Giemsa before being scored for aggregation. At least 
500 cells per slide scored for aggregation and the percentage aggregation with 
IgG control antibody was subtracted from the percentage values obtained for 
cells incubated with anti-CD34 to give the specific aggregation index. Values are 
expressed as specific aggregation index (%) ± standard error. Results were 
analysed using GraphPad Instat software and the paired t-test for statistical 
significance n=5. * p<0.05 
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Time (hours) 
Figure 4.27 The drop in QBENDIO-induced aggregation following LFA-1 
siRNA treatment. KG1a cells were treated with LFA-1 siRNA or mis-match 
control for 18 hours before being aggregated with 4µg/m1 QBENDIO or IgG 
control as normal. At the relevant time point, cells were gently resuspended and 
aliquots air-dried onto multi-well slides. The slides were then fixed in ethanol for 
5 minutes and stained with Giemsa before being scored for aggregation. The 
reduction in aggregation following siRNA treatment was calculated and 
expressed as a percentage of the control. 
4.2.2.1.3.3 LFA-1 knockdown has no effect on aggregation induced 
by anti-CD43 
To establish if LFA-1 is also critical in the early stages of CD43-mediated 
aggregation, cells were treated with LFA-1 siRNA or mis-match siRNA as 
before and the cells aggregated with anti-CD43 or IgG control as normal. 
Cells were harvested at 0, 1, 2 and 3 hours and scored for aggregation. 
Unlike CD34-mediated aggregation, LFA-1 knockdown had no significant 
effect on CD43-mediated aggregation (Figure 4.28) 
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Figure 4.28 The effect of LFA-1 siRNA on anti-CD43-induced aggregation 
in KG1a cells. KG1a cells were treated with LFA-1 siRNA or mis-match control 
for 18 hours before being aggregated with 4µg/m1 anti-CD43 or IgG control as 
normal. At the relevant time point, cells were gently resuspended and air dried 
onto multi-well slides. The slides were then fixed in ethanol for 5 minutes and 
stained with Giemsa before being scored for aggregation. The percentage 
aggregation with IgG control antibody was subtracted from the percentage 
values obtained for cells incubated with anti-CD43 to give the specific 
aggregation index. At least 500 cells were scored for aggregation per well and 
the results expressed as the specific aggregation index± standard error. Results 
were analysed using the paired t-test for statistical significance, n=5. p=NS. 
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4.2.2.2 The distribution of ICAM-1 on unaggregated and aggregated 
cells 
4.2.2.2.1 ICAM-1 is not polarised on KG1a cells exposed to 
QBENDIO 
To determine the distribution of the LFA-1 ligand, ICAM-1, KG1a 
cells were resuspended in a15 alone or aggregated in a15 with 4µg/m1 
QBENDIO or anti-CD43. After 3 hours, cells were air-dried, fixed and 
stained with either FITC-conjugated ICAM-1 or normal mouse IgG1 FITC. 
Unaggregated cells display a uniform distribution of ICAM-1 on the cell 
surface. Following aggregation, unlike LFA-1, ICAM does not localise at 
the contact point between aggregated KG1a cells. Single cells exposed to 
QBENDIO also show no polarisation of ICAM-1 (Figure 4.29). Cells 
incubated with IgG controls followed by FITC-conjugated secondary 
antibody or secondary antibody alone showed no significant staining 
above background levels. 
4.2.2.2.2 ICAM-1 is polarised on a proportion of primary AC133 
positive cells exposed to QBENDIO. 
As LFA-1 showed strong polarisation on AC133-positive cells 
induced to aggregate with QBENDIO, the distribution of the LFA-1 ligand, 
ICAM-1, was examined on AC133-positive cells. Cells were isolated on 
AC133 and incubated in a15 alone or with 4µ,g/m1 QBENDIO or anti-
CD43 overnight. Cells were then air-dried onto multi-well slides, fixed and 
stained with FITC-conjugated anti-ICAM-1. Some unaggregated cells 
show polarisation of ICAM-1 although staining is generally faint. A 
proportion of aggregated cells also show ICAM-1 polarisation (Figure 
4.30). Cells incubated with IgG controls followed by FITC-conjugated 
secondary antibody or secondary antibody alone showed no significant 
staining above background levels. 
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Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.29 The distribution of ICAM-1 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 44/m1 QBEND10. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-ICAM-
1. Additional slides were stained with FITC-conjugated normal mouse IgG to 
control for non-specific antibody binding. Coverslips were mounted with 1 drop 
of vectashield containing DAPI and the slides examined under the fluorescent 
microscope using the x40 objective lens. 
To quantify the extent of ICAM-1 polarisation on AC133-positive 
cells, unaggregated and aggregated cells were scored as in Figure 4.2. 
Around 40% of unaggregated cells show some degree of ICAM-1 
polarisation although this value is significantly lower for cells exposed to 
QBEND10 or anti-CD43 (Figure 4.31). Some polarisation is seen on 
aggregated cells although this is only towards the cell-to-cell contact point 
in 50% of cases. 
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(a) control 
(b) anti-CD34 
(c) anti-CD43 
Figure 4.30 The distribution of ICAM-1 (green) on (a) unaggregated and 
aggregated AC133-positive cells exposed to (b) QBENDIO or (c) anti-CD43. 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/ml QBENDIO or anti-CD43. After 24 hours, 
cells were gently resuspended and air-dried onto teflon-coated multi-well slides. 
Cells were fixed with 3% paraformaldehyde for 15 minutes and stained using 
FITC-conjugated anti-ICAM-1. Additional slides were stained with FITC-
conjugated normal mouse IgG to control for non-specific antibody binding. 
Coverslips were mounted with 1 drop of vectashield containing DAPI and the 
slides examined under the fluorescent microscope using the x40 objective lens. 
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Figure 4.31 The distribution score for ICAM-1 on unaggregated and 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology. Cells were then resuspended in al5 
and incubated either alone or with the addition of 4µg/m1 QBEND10 or anti-
CD43. After 24 hours, cells were air-dried onto multi-well slides, fixed in 3% 
paraformaldehyde for 15 minutes and stained using FITC-conjugated anti-ICAM-
1. Additional slides were stained with FITC-conjugated normal mouse IgG to 
control for non-specific antibody binding. Cells were scored as unpolarised, 
polarised or totally polarised as in Figure 4.2. Results are expressed as the 
percentage of the total number of cells scored that are either unpolarised, 
polarised or totally polarised ±standard deviation, at least 100 cells were scored 
per sample, n=4. The percentages of polarised cells were compared using the 
ANOVA test for statistical significance, *p<0.05, "p<0.01. 
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4.2.2.3 The distribution of a4p1 integrin on unaggregated and 
aggregated cells 
4.2.2.3.1 a4131 integrin is not polarised on unaggregated and 
aggregated KG1a cells 
To determine if the [31 integrins play a role in sialomucin-mediated 
aggregation, KG1a cells were resuspended in a15 alone or with 4j.tg/m1 
QBEND10. After 3 hours, cells were air-dried onto slides, fixed and 
stained with rabbit anti-a4 followed by goat anti-rabbit FITC. On 
unaggregated controls and cells exposed to QBEND10 or anti-CD43, no 
polarisation of a4131 integrin is observed (Figure 4.32). Cells incubated 
with IgG controls followed by FITC-conjugated secondary antibody or 
secondary antibody alone showed no significant staining above 
background levels. 
Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.32 The distribution of a4r31 integrin (green) on (a) unaggregated 
and aggregated KGIa cells exposed to (b) QBEND10 or (c) anti-CD43. 
KG1a cells were resuspended in a15, aliquoted into 96-well plates and 
incubated with or without 4µ,g/m1 QBEND10 or anti-CD43. After 3 hours, cells 
were gently resuspended and air-dried onto teflon-coated multi-well slides. Cells 
were fixed with 3% paraformaldehyde for 15 minutes and stained using rabbit 
anti-a4 followed by goat anti-rabbit FITC. Additional slides were stained with 
normal rabbit IgG followed by the FITC-conjugated secondary to control for non-
specific antibody binding. Coverslips were mounted with 1 drop of vectashield 
containing DAPI and the slides examined under the fluorescent microscope 
using the x40 objective lens. 
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4.2.2.4 The distribution of a5131 integrin on unaggregated and 
aggregated cells 
4.2.2.4.1 a5r31 integrin is not polarised on unaggregated and 
aggregated KG1a cells 
To establish if the distribution of a5131 integrins differs to that of 
a4(31, KG1a cells were resuspended in a15 alone or a15 with 41.1g/ml 
QBEND10 or anti-CD43. After 3 hours, cells were sir-dried onto slides, 
fixed and stained with rabbit anti-a5 followed by goat anti-rabbit FITC. As 
with a4131 integrin, a5131 shows no polarisation on unaggregated or 
aggregated KG1a cells (Figure 4.33). Cells incubated with IgG controls 
followed by FITC-conjugated secondary antibody or secondary antibody 
alone showed no significant staining above background levels. 
Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.33 The distribution of a5131 integrin (green) on (a) unaggregated 
and aggregated KG1a cells exposed to (b) QBEND10 or (c) anti-CD43. 
KG1a cells were resuspended in a15, aliquoted into 96-well plates and 
incubated with or without 4µ,g/m1 QBEND10 or anti-CD43. After 3 hours, cells 
were gently resuspended and air-dried onto teflon-coated multi-well slides. Cells 
were fixed with 3% paraformaldehyde for 15 minutes and stained using rabbit 
anti-a5 followed by goat anti-rabbit FITC. Additional slides were stained with 
normal rabbit IgG followed by the FITC-conjugated secondary to control for non-
specific antibody binding. Coverslips were mounted with 1 drop of vectashield 
containing DAPI and the slides examined under the fluorescent microscope 
using the x40 objective lens. 
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4.2.3 The role of additional cell adhesion molecules in sialomucin-
mediated aggregation 
4.2.3.1 The distribution of PECAM-1 on unaggregated and 
aggregated cells 
PECAM-1 is a member of the IgG superfamily of adhesion 
molecules and is reported to be involved in homophilic CD34-positive cell 
adhesion as well as heterophilic cell adhesion to the extracellular matrix. 
Engagement of PECAM-1 on bone marrow CD34-positive cells using 
specific antibodies increases VLA-4 mediated aggregation to VCAM-1 
indicating the role of PECAM-1 in integrin activation signalling pathways 
as well as direct cell-cell adhesion.89 
4.2.3.1.1 PECAM-1 is not polarised on unaggregated and aggregated 
KG1a cells. 
To investigate the distribution of PECAM-1 during sialomucin-
mediated aggregation, KG1a cells were resuspended in a15 alone or with 
4µg/m1 QBENDIO or anti-CD43. After 3 hours, cells were air-dried onto 
multi-well slides, fixed and stained with rabbit anti-PECAM-1 followed by 
goat anti-rabbit FITC. On unaggregated and aggregated cells, PECAM-1 
appears unpolarised (Figure 4.34). Cells incubated with IgG controls 
followed by FITC-conjugated secondary antibody or secondary antibody 
alone showed no significant staining above background levels. 
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Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.34 The distribution of PECAM-1 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 414/m1 QBEND10 or anti-CD43. After 3 hours, cells were gently 
resuspended and air-dried onto teflon-coated multi-well slides. Cells were fixed 
with 3% paraformaldehyde for 15 minutes and stained using rabbit anti-PECAM-
1 followed by goat anti-rabbit FITC. Additional slides were stained with normal 
rabbit IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Coverslips were mounted with 1 drop of vectashield containing 
DAPI and the slides examined under the fluorescent microscope using the x40 
objective lens. 
4.2.3.2 The distribution of CD44 on unaggregated and aggregated 
cells 
CD44 is proposed to have roles in regulating both cell-cell and cell-
matrix adhesion. The extracellular domain of CD44 interacts with 
hyaluronic acid in the bone marrow extracellular matrix and is proposed 
to be important in SDF-1-dependent migration of stem/progenitor cells to 
the bone marrow.84'45 CD44 is also found to be localised to areas of actin 
polymerisation and is linked to the cytoskeleton through members of the 
ezrin-radixin-moesin (ERM) family of cytoskeletal-linker proteins and is 
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thought to be involved in signalling cascades though the actin 
cytoskeleton.86 CD44 can also act as a co-receptor for growth factors and 
cytokines and the ErbB family of receptor tyrosine kinases where CD44 is 
essential for kinase activity and is therefore involved in the regulation of 
cell survival, proliferation and differentiation.85  
4.2.3.2.1 CD44 is polarised on unaggregated and aggregated KG1a 
cells 
To determine the involvement of CD44 in sialomucin-mediated 
aggregation, KG1a cells were resuspended in a15 alone or a15 
containing 4µg/m1 QBEND10 or anti-CD43. After 3 hours, cells were air-
dried onto slides, fixed and stained with rabbit anti-HCAM (CD44) 
followed by goat anti-rabbit FITC. CD44 is polarised both on 
unaggregated cells and those exposed to QBENDIO or anti-CD43. On 
aggregated cells, this polarisation is towards the point of cell-to-cell 
contact (Figure 4.35). Cells incubated with IgG controls followed by FITC-
conjugated secondary antibody or secondary antibody alone showed no 
significant staining above background levels. 
To quantify the extent of CD44 polarisation, single cells and cells 
in aggregates were scored as in Figure 4.2. On the majority of 
unaggregated control cells, CD44 is polarised. On most single cells 
exposed to QBENDIO or anti-CD43, CD44 is also polarised. On the 
majority of cells in aggregates, CD44 is polarised with this polarisation 
being towards the point of cell-to-cell contact (Figure 4.36). 
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Aggregation conditions 
(a) control 
	
(b) CD34 
	
(c) CD43 
Figure 4.35 The distribution of CD44 (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBEND10 or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 414/m1 QBEND10 or anti-CD43. After 3 hours, cells were gently 
resuspended and air-dried onto teflon-coated multi-well slides. Cells were fixed 
with 3% paraformaldehyde for 15 minutes and stained using rabbit anti-HCAM 
followed by goat anti-rabbit FITC. Additional slides were stained with normal 
rabbit IgG followed by the FITC-conjugated secondary antibody to control for 
non-specific antibody binding. Coverslips were mounted with 1 drop of 
vectashield containing DAPI and the slides examined under the fluorescent 
microscope using the x40 objective lens. 
4.2.3.2.2 CD44 is polarised on unaggregated and aggregated AC133-
positive cells. 
To determine if CD44 is also polarised on unaggregated 
and aggregated AC133-positive cells, cells were isolated on AC133 and 
incubated in ot15 alone or with 4µg/ml QBEND10 or anti-CD43 overnight. 
Cells were then air-dried onto multi-well slides, fixed and stained with 
rabbit anti-HCAM followed by goat anti-rabbit FITC. As on KG1a cells, 
CD44 is polarised on unaggregated and aggregated AC133-positive cells 
(Figure 4.37). Cells incubated with IgG controls followed by FITC-
conjugated secondary antibody or secondary antibody alone showed no 
significant staining above background levels. 
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Figure 4.36 The distribution score for CD44 on unaggregated and 
aggregated KGla cells. KG1a cells were resuspended in a15 and incubated 
either alone or with the addition of 4µg/ml QBEND10 or anti-CD43. After 3 
hours, cells were air-dried onto multi-well slides, fixed in 3% paraformaldehyde 
for 15 minutes and stained using rabbit anti-CD44 followed by goat anti-rabbit 
FITC. Additional slides were stained with normal rabbit IgG followed by the 
FITC-conjugated secondary antibody to control for non-specific antibody 
binding. Cells were scored as unpolarised, polarised or totally polarised as in 
Figure 4.2. Results are expressed as the percentage of the total number of cells 
scored that are either unpolarised, polarised or totally polarised tstandard 
deviation, at least 100 cells were scored per sample, n=4. The percentages of 
polarised cells were compared using the ANOVA test for statistical significance, 
p=NS. 
To quantify the extent of CD44 polarisation on primary cells, 
unaggregated and aggregated AC133-positive cells were scored as in 
Figure 4.2. As with KG1a cells, CD44 is polarised on the majority of 
unaggregated and aggregated AC133-positive cells although significantly 
less on aggregated cells exposed to anti-CD43 (Figure 4.38). In the case 
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of cells in aggregates, this polarisation is towards the cell-to-cell contact 
point. 
Aggregation conditions 
(a) control 
	
(b) anti-CD34 	 (c) anti-CD43 
Figure 4.37 The distribution of CD44 (green) on (a) unaggregated and 
aggregated AC133-positive cells exposed to (b) QBEND10 or (c) anti-CD43. 
AC133-positive cells were isolated from PBPC samples using MiniMacs 
technology. Cells were then resuspended in a15, aliquoted into 96-well plates 
and incubated with or without 4µg/m1 QBEND10 or anti-CD43. After 24 hours, 
cells were gently resuspended and air-dried onto teflon-coated multi-well slides. 
Cells were fixed with 3% paraformaldehyde for 15 minutes and stained with 
rabbit anti-HCAM followed by goat anti-rabbit FITC. Additional slides were 
stained with normal rabbit IgG followed by the FITC-conjugated secondary 
antibody to control for non-specific antibody binding. Coverslips were mounted 
with 1 drop of vectashield containing DAPI and the slides examined under the 
fluorescent microscope using the x40 objective lens. 
4.2.3.2.3 Anti-CD44 antibodies do not cause aggregation in KG1a 
cells. 
As CD44 appears to play a key role in sialomucin-mediated 
aggregation, the effect of ligation of CD44 on KG1a cells was measured 
in comparison to QBEND10. Anti-CD44 antibodies did not cause 
aggregation of KG1a cells (Figure 4.39). 
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Figure 4.38 The distribution score for CD44 on unaggregated and 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology. Cells were then resuspended in a15 
and incubated either alone or with the addition of 4µg/m1 QBENDIO or anti-
CD43. After 24 hours, cells were air-dried onto multi-well slides, fixed in 3% 
paraformaldehyde for 15 minutes and stained using rabbit anti-HCAM followed 
by goat anti-rabbit FITC. Additional slides were stained with normal rabbit IgG 
followed by the FITC-conjugated secondary antibody to control for non-specific 
antibody binding. Cells were scored as unpolarised, polarised or totally polarised 
as in Figure 4.2. Results are expressed as the percentage of the total number of 
cells scored that are either unpolarised, polarised or totally polarised ±standard 
error, at least 100 cells were scored per sample, n=7. The percentages of 
polarised cells were compared using the ANOVA test for statistical significance, 
*p<0.05. 
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Time (hours) 
Figure 4.39 The effect of anti-CD44 on KG1a cells. KG1a cells were 
resuspended at 1x106/m1 in a15. Aliquots of 100111 were placed in 96-well plates 
in triplicate and incubated at 37°C either alone or with 41.1g/m1 QBENDIO, anti-
CD43 or IgG control antibody. At the relevant time point, cells were gently 
resuspended and air-dried onto multi-well slides. After fixing in ethanol for 5 
minutes, cells were stained with Giemsa and scored for aggregation. The 
average percentage aggregation with IgG control antibody was subtracted from 
the average percentage values obtained for cells incubated with anti-CD34 or 
anti-CD43 to give the specific aggregation index. At least 500 cells were scored 
per well. Values are expressed as specific aggregation index (%) ± standard 
deviation, n=3. 
4.2.3.2.4 CD44 co-localises with CD34 on aggregated KGla cells 
To confirm that CD44 polarisation occurs with CD34 polarisation, 
KG1a cells aggregated with QBENDIO for 3 hours were dual stained with 
goat anti-mouse rhodamine followed by rabbit anti-HCAM and goat anti 
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rabbit FITC. CD34 and CD44 co-localise (yellow) at the point of cell-to-
cell contact (Figure 4.40). Cells incubated with IgG controls followed by 
FITC and rhodamine-conjugated secondary antibodies or secondary 
antibody alone showed no significant staining above background levels. 
Labelling 
CD44 
	
CD34 
	
Overlay 
Figure 4.40 The distribution of CD44 (green) and CD34 (red) on aggregated 
KGla cells. KG1a cells were resuspended in a15 and incubated either alone or 
with the addition of 4µg/m1 QBEND10. After 3 hours, cells were air-dried onto 
multi-well slides, fixed in 3% paraformaldehyde for 15 minutes and stained using 
goat anti-mouse rhodamine and rabbit anti-CD44 followed by goat anti-rabbit 
FITC. Additional slides were stained with normal rabbit IgG followed by the 
FITC-conjugated secondary antibody to control for non-specific antibody 
binding. Results are representative of those seen on 3 independent slides. 
4.2.3.2.5 CD44 is involved in the later stages of CD34-mediated 
adhesion 
To investigate at what stage CD44 plays a role in CD34-mediated 
aggregation, CD44 was knocked down in KG1 a cells using siRNA and 
the effect on aggregation examined. 
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4.2.3.2.5.1 CD44 can be knocked-down in KG1a cells using siRNA 
KG1a cells were treated with CD44 siRNA and cells harvested at 
0, 18, 24, 36, 48 and 56 hours for slide preparation. At each time point, 3 
x104 cells were air dried onto multi-well slides. Separate wells were 
prepared for untreated cells, CD44 siRNA treated and mis-match siRNA 
treated controls. Slides were then fixed and stained with rabbit anti-
HCAM followed by goat anti-rabbit FITC. Slides were examined under the 
fluorescent microscope and capture settings optimised using control cells 
at the 0 time point. These capture settings were then fixed and pictures of 
CD44 stained control, siRNA and mis-match control cells taken (Figure 
4.41). The results indicated the optimal CD44 knock-down was achieved 
at 24 hours. 
To confirm and quantify the knock-down, KG1a cells were treated 
with CD44 siRNA for 24 hours were then lysed and western blotting 
performed on cells treated with CD44 siRNA and mis-match control. The 
lysates were also probed for actin in order to take into account any 
difference in lysis efficiency. Compared to cells treated with the mis-
match control, LFA-1 siRNA caused knock-down of LFA-1 in KG1a cells. 
Using densitometry software and taking into account the lower amount of 
actin in the mis-match sample, the knock-down was calculated to be 
52.78% compared to mis-match controls (Figure 4.42). 
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Figure 4.41 CD44 staining intensity in KG1a cells following siRNA 
treatment. KG1a cells were transfected with CD44 or mismatch siRNA using 
oligofectamine. After a second transfection at 24 hours, cells were left for 4 
hours before the addition of 10% FCS (time 0). After this point, aliquots of cells 
were removed at each time point and air-dried onto multi-well slides. The cells 
were then fixed in 3% paraformaldehyde for 15 minutes and stained using rabbit 
anti-HCAM followed by goat anti-rabbit FITC. 
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Figure 4.42 CD44 knock-down in KGla cells following siRNA treatment. 
KG1a cells were either treated with HCAM siRNA or mis-match control and 
1x106 cells lysed in 20µ1 lysis buffer. An equal volume of 2x sample buffer was 
added and the lysates boiled and frozen. Samples were then electrophoresed 
on polyacrylamide gels and transferred to nitrocellulose membrane. Membranes 
were then probed 1µg/ml anti-HCAM and anti-actin overnight at 4°C. Blots show 
the visualised HCAM and actin bands in both the HCAM siRNA (siRNA) and 
mis-match control samples (MM). Bands were analysed using Image J 
densitometry software. CD44 is knocked down by 52.78% compared to mis-
match controls when the relative amounts of actin in the samples are taken into 
account. 
4.2.3.2.5.2 CD44 knock-down decreases the duration of QBENDIO-
induced aggregation 
To measure the effect of CD44 knock-down on CD34-mediated 
aggregation, KG1a cells were treated with HCAM siRNA or mis-match 
control siRNA for 24 hours and aggregated with 414/m1 QBEND10 or IgG 
control as normal. At each time point, cells were air-dried onto multi-well 
slides, stained with Giemsa and scored for aggregation. QBEND-10 
induced aggregation is significantly reduced at 24 hours following HCAM 
siRNA treatment (Figure 4.43). 
164 
5 	10 	15 	20 	25 
-10 - 
** 
2 80 - 
w 
CO 
+1 70- 
0 
x 60 - a) -a 
.— • 50 - 
c 0 ta ea 40 - a) 
.) 
cl) 30 - 
co 
c.) 
F 20 - 
u a) 
ci) a 10 
--*— HCAM siRNA 
—0— Mis-match 
Chapter 4. The location of adhesion molecules during sialomucin-mediated aggregation  
Time (hours) 
Figure 4.43 The effect of HCAM siRNA treatment on QBENDIO-induced 
aggregation of KG1a cells. KG1a cells were treated with HCAM siRNA or mis-
match control for 24 hours before being aggregated with 4µ,g/m1 anti-CD34 or 
IgG control as normal. At the relevant time point, cells were gently resuspended 
and air-dried onto multi-well slides. The slides were then fixed in ethanol for 5 
minutes and stained with Giemsa before being scored for aggregation. The 
percentage aggregation with IgG control antibody was subtracted from the 
percentage values obtained for cells incubated with anti-CD34 to give the 
specific aggregation index. Results were analysed using GraphPad Instat 
software and the paired T-test for statistical significance. Values are expressed 
as specific aggregation index (%) ± standard error, n=5. * p<0.05, **p<0.01 
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4.2.3.2.5.3 CD44 knock-down has no effect on aggregation induced 
by anti-CD43 
To establish if CD44 knock-down also affects anti-CD43-induced 
aggregation, KG1a cells were treated with HCAM siRNA or mis-match 
control siRNA for 24 hours and aggregated with 4p,g/mIQBEND10 or IgG 
control as normal. At each time point, cells were air-dried onto multi-well 
slides, stained with Giemsa and scored for aggregation. No significant 
reduction in aggregation was observed at any time point (Figure 4.44). 
4.2.3.3 The distribution of N-cadherin on unaggregated and 
aggregated cells 
N-cadherin has been reported to be expressed both on a sub-
population of early progenitor cells as well as on marrow stromal cells. 
Blocking antibodies to N-cadherin lead to a dose-dependent reduction in 
cytokine-induced colony formation indicating an involvement in progenitor 
cell development. These antibodies also reduced homotypic aggregation 
between cells of the KG1a cell-line suggesting a role for N-cadherin in 
adhesion between progenitor cells.67 Therefore, the role of N-cadherin in 
sialomucin-mediated aggregation was investigated. 
4.2.3.3.1 N-cadherin is unpolarised on unaggregated and aggregated 
KG1a cells 
As CD34-mediated aggregation has been shown to be calcium 
dependent, we examined the distribution of N-cadherin, an adhesion 
molecule involved in calcium-dependent signalling. KG1a cells were 
resuspended in a15 alone or a15 containing 4µg/ml QBENDIO or anti-
CD43. After 3 hours, cells were air-dried onto slides, fixed and stained 
with goat anti-N-cadherin followed by rabbit anti goat FITC. No evidence 
of N-cadherin polarisation was found on unaggregated or aggregated 
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cells (Figure 4.45). Cells incubated with IgG controls followed by FITC-
conjugated secondary antibody or secondary antibody alone showed no 
significant staining above background levels. 
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Figure 4.44 The effect of HCAM siRNA treatment on aggregation induced 
with anti-CD43 in KGla cells. KG1 a cells were treated with HCAM siRNA or 
mis-match control for 24 hours before being aggregated with 4µg/m1 anti-CD43 
or IgG control as normal. At the relevant time point, cells were gently 
resuspended and air-dried onto multi-well slides. The slides were then fixed in 
ethanol for 5 minutes and stained with Giemsa before being scored for 
aggregation. The percentage aggregation with IgG control antibody was 
subtracted from the percentage values obtained for cells incubated with anti-
CD43 to give the specific aggregation index. Results were analysed using 
GraphPad Instat software and the paired T-test for statistical significance. 
Values are expressed as specific aggregation index (%) ± standard error, n=5. 
p=NS. 
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Aggregation conditions 
(a) control 
	
(b) anti-CD34 	(c) anti-CD43 
Figure 4.45 The distribution of N-cadherin (green) on (a) unaggregated and 
aggregated KG1a cells exposed to (b) QBENDIO or (c) anti-CD43. KG1a 
cells were resuspended in a15, aliquoted into 96-well plates and incubated with 
or without 4µg/m1 QBEND10. After 3 hours, cells were gently resuspended and 
air-dried onto teflon-coated multi-well slides. Cells were fixed with 3% 
paraformaldehyde for 15 minutes and stained using goat anti-N-cadherin 
followed by rabbit anti-goat FITC. Additional slides were stained with normal 
goat IgG followed by the FITC-conjugated secondary to control for non-specific 
antibody binding. Coverslips were mounted with 1 drop of vectashield containing 
DAPI and the slides examined under the fluorescent microscope using the x40 
objective lens. 
4.2.4 The role of the cytoskeleton in CD34-mediated aggregation 
One of the most prominent cytoskeletal changes during 
immunological synapse formation is an increase in filamentous actin (f-
actin) at the cell-to-cell contact point. This actin polymerisation and 
subsequent T cell/APC conjugate formation is inhibited by cytochalasin D. 
A link between the plasma membrane and actin cytoskeleton can be 
through members of the ERM family of cytoskeletal linker proteins.186 
CD43 is actively excluded from the immunological synapse through its 
interaction with the ERM family members.154 Capping of CD34 in KG1a 
cells has been shown to be accompanied by F-actin and QBEND10-
induced aggregation itself is inhibited by cytochalasin D.139' 1" Therefore 
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the relationship between CD34-mediated aggregation and the actin 
cytoskeleton was examined. 
4.2.4.1 Polarisation of the actin cytoskeleton accompanies CD34 
polarisation on KG1a cells aggregated with QBENDIO. 
To determine if CD34 polarisation is accompanied by polarisation 
of the actin cytoskeleton, KG1a cells were resuspended in a15 containing 
414/m1 QBEND10. After 3 hours cells were attached to poly-l-lysine 
coated slides. Cells were then stained with rabbit anti-mouse-FITC 
followed by TRITC-conjugated phalloidin and examined under a confocal 
microscope. CD34 appears green, while F-actin is red. When these 
images are overlaid, areas of colocalisation appear yellow (Figure 4.46). 
Cells incubated with IgG controls followed by FITC-conjugated secondary 
antibody or secondary antibody alone showed no significant staining 
above background levels. 
Labelling 
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Figure 4.46 The distribution of CD34 (green) and f-actin (red) on 
aggregated KGla cells. KG1a cells were incubated with 4µg/ml QBENDIO for 
3 hours, attached to poly-l-lysine coated slides and fixed with 3% 
paraformaldehyde for 15 minutes. CD34 was stained using rabbit anti-mouse 
FITC. Cells were then permeabilised with 0.5% Triton-X for 15 minutes and F-
actin stained with TRITC-conjugated phalloidin. Results shown are typical of 
three-independent experiments. 
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4.2.4.2 CD34 can be immunoprecipitated from KGla cells 
In order to determine if CD34 itself interacts with the actin 
cytoskeleton, CD34 first had to be immunoprecipitated from KG1a cells. 
CD34 was immunoprecipitated using the anti-CD34 antibody, MY10. 
Unaggregated KG1a cells were lysed and incubated with either MY10 or 
IgG control antibodies, followed by protein A/G or protein G beads. 
Samples were electrophoresed and probed with anti-CD34 followed by 
anti-mouse-HRP. CD34 was immunoprecipitated from KG1a cells using 
either protein A/G or protein G beads (Figure 4.47, Lanes A and B). No 
CD34 was pulled down in immunoprecipitation samples with either no 
lysate (Lane C) or when immunoprecipitation was performed with IgG 
control (Lane D), showing that the immunoprecipitation of CD34 observed 
was not due to antibody-related artefact, non-specific binding to beads or 
insufficient washing. 
ABCDE F G 
CD34 
Figure 4.47 Immunoprecipitation of CD34 in KGla cells. Lane A: CD34 
recovery using protein A/G beads, Lane B: CD34 recovery using protein G 
beads, Lane C: CD34 recovery with no lysate using protein G beads, Lane D: 
CD34 recovery with protein G beads and IgG control antibody, Lane E: blank, 
Lane F: CD34 in total lysate before addition of antibody and beads, Lane G: 
CD34 in control KG1a lysate. KG1a cells were lysed and incubated with the anti-
CD34 antibody MY10 or IgG control overnight at 4°C. Protein A/G or protein G 
beads were then added to the lysate. After 2 hours at 4°C, beads were spun 
down and washed 3 times in RIPA buffer. The immuno-complex was then 
dissociated from the beads by boiling each sample for 4 minutes in an equal 
volume of 2x sample buffer. Samples were loaded on polyacrylamide gels and 
transferred to nitrocellulose membranes. Membranes were then probed with 
anti-CD34 and mouse-HRP or mouse HRP alone. Blots are representative of 3 
independent immunoprecipitation experiments. 
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4.2.4.3 Actin co-immunoprecipitates with CD34 
To determine if CD34 itself is linked to the actin cytoskeleton in 
unaggregated cells, CD34 was immunoprecipitated from KG1a cells and 
immunoprecipitated samples probed for the presence of actin using HRP-
conjugated anti-actin. Actin was co-immunoprecipitated with CD34 
(Figure 4.48, Lanes A and B) showing that CD34 itself is linked to the 
actin cytoskeleton. No actin is seen in immunoprecipitation samples 
performed with no lysate (Lane C) or with IgG control antibody in place of 
anti-CD34 (Lane D) indicating that the actin bands seen are not due to 
antibody-related artefact, non-specific binding to beads or insufficient 
washing. 
ABCDE F G 
 
actin 
  
Figure 4.48 Recovery of actin in CD34 immunoprecipitates. Lane A: Actin 
recovery in IP using protein A/G beads, Lane B: Actin recovery in IP using 
protein G beads, Lane C: Actin recovery with no lysate using protein G beads, 
Lane D: Actin recovery with protein G beads and IgG control antibody, Lane E: 
blank, Lane F: Actin in total lysate before addition of antibody and beads, Lane 
G: Actin in control KG1a lysate. KG1a cells were lysed and incubated with the 
anti-CD34 antibody MY10 or IgG control overnight at 4°C. Protein A/G or protein 
G beads were then added to the lysate. After 2 hours at 4°C, beads were spun 
down and washed 3 times in RIPA buffer. The immuno-complex was then 
dissociated from the beads by boiling each sample for 4 minutes in an equal 
volume of 2x sample buffer. Samples were loaded on polyacrylamide gels and 
transferred to nitrocellulose membranes. Membranes were then probed with 
HRP-conjugated actin. Blots are representative of 3 independent 
immunoprecipitation experiments. 
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4.2.4.4 ERM proteins do not co-immunoprecipitate with CD34 
As other sialomucins have been demonstrated to be connected to 
the cytoskeleton through the ERM family of cytoskeletal linker proteins, 
immunoprecipitated CD34-samples were probed for the presence of 
Ezrin, moesin and radixin.154' 187 No ERM proteins could be detected in 
the immunoprecipitated sample (Figure 4.49). 
IP IgG Total 
 
CD34 
 
t 
Ezrin/Radixin 
4-- Moesin 
Figure 4.49 Co-immunoprecipitation of ERM proteins following 
immunoprecipitation of CD34 from KGla cells. KG1a cells were lysed and 
incubated with the anti-CD34 antibody MY10 or IgG control overnight at 4°C. 
Protein A/G or protein G beads were then added to the lysate. After 2 hours at 
4°C, beads were spun down and washed 3 times in RIPA buffer. The immuno-
complex was then dissociated from the beads by boiling each sample for 4 
minutes in an equal volume of 2x sample buffer. Samples were loaded on 
polyacrylamide gels and transferred to nitrocellulose membranes. Membranes 
were then probed with mouse anti-CD34 or mouse anti-ERM followed by anti-
mouse HRP. Blots are representative of 3 independent immunoprecipitation 
experiments. 
4.3 Discussion 
Despite growing research, the function of the transmembrane 
sialomucin, CD34, within the haemopoietic environment remains unclear. 
A number of groups have suggested roles for CD34 in both cell-to-cell 
adhesion and intracellular signalling pathways, including those involved in 
regulation of the cell CyCle,138-141  
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Following the observation that CD34-positive cells aggregate when 
incubated with the anti-CD34 antibody, QBEND10, we have proposed the 
term 'haematological synapse' to describe the adhesive structure formed 
between aggregated CD34-positive cells. 
In agreement with the findings of other groups, this study has 
confirmed that CD34-localises to the contact point between homotypically 
aggregated KG1a cells following exposure to the anti-CD34 antibody, 
QBEND10.139' 140  We have also demonstrated that this phenomenon is 
not restricted to cell lines but also occurs between AC133-positive cells 
isolated from PBPC samples and normal bone marrow. This is consistent 
with the findings of Gordon et al. who confirmed that CD34 localises to 
the intercellular contact point between developing myeloid colonies in 
vitro and `haematons' isolated from normal bone marrow, thereby 
suggesting that CD34-mediated aggregation is a normal physiological 
process.140 
At the immunological synapse, the surface markers and adhesion 
molecules are arranged in specific ring-like structures with LFA-1 and 
ICAM-1 in the outer ring and the TCR/MHC complex occupying the centre 
of the mature synapse.99 Confocal microscopy confirmed that the CD34-
distribution on KG1a cells exposed to QBEND10 resembles a ring-like 
structure with a clear area in the centre. It was therefore concluded that 
other adhesion molecules are likely to participate in this adhesion event 
and may occupy this inner ring. 
CD43 is a member of the sialomucin family and due to structural 
similarities in their extracellular domains, is proposed to have partially 
overlapping functions with CD34.139' 145 However, on KG1a and AC133-
positive cells exposed to QBEND10, little polarisation of CD43 is 
observed, indicating that CD43 does not participate in CD34-mediated 
aggregation. Tada et al., observed that stimulation of KG1a and CD34-
positive cells from normal bone marrow with anti-CD43 lead to capping of 
CD43 and the tyrosine phosphorylation of an identical set of proteins 
following CD43 or CD34-stimulation.139 In this study, similar levels of 
CD43 polarisation were observed following both anti-CD34 and anti-
CD43 stimulation. This was much lower than the degree of CD34 
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polarisation following exposure to QBENDIO. The apparent discrepancy 
between these results could be explained by the fact that some capping 
of CD43 can be observed on KG1a cells with anti-CD34 or 43 but it is 
only when this polarisation is quantified that the differences between the 
extent of CD34 and CD43 polarisation become clear. 
Initial adhesion events between a T cell and APC are mediated by 
LFA-1 and ICAM-1.188 Therefore the distribution of these two integrins on 
KG1a and AC133-positive cells was examined. LFA-1 shows strong 
localisation to the contact point between KG1a and AC133-positive cells 
exposed to QBENDIO but not anti-CD43. To determine if LFA-1 is again 
involved in early adhesion events, LFA-1 was knocked down in KG1a 
cells using siRNA treatment. When cells were then aggregated as normal 
with QBEND10, aggregation in those cells treated with anti-LFA-1 siRNA 
was significantly reduced compared to mis-match controls, an effect 
which was not seen in cells exposed to anti-CD43. This reduction was 
particularly prominent after 1 hour, indicating that LFA-1 is critical for 
early adhesion events. Interestingly, ICAM-1 was not found to be 
polarised on unaggregated or aggregated KG1a cells but it was on a 
proportion of AC133-positive cells, although this polarisation was only 
towards the cell-to-cell contact point in 50% of cases. However, although 
ICAM-1 is considered to be the major ligand of LFA-1, it also binds to 
both ICAMs 2 and 3.188 Therefore, other ligands may be more significant 
in adhesion events within the haemopoietic system. Majdic et al., 
reported that blocking antibodies to both LFA-1 and ICAM-1 reduced 
aggregation between KG1a cells exposed to QBEND10.138 However, 
cells were only examined following incubation at 0°C for 30 minutes and 
37°C for 90 minutes therefore it is difficult to compare the two studies. 
A variety of adhesion molecules implicated in the control of cell 
renewal and differentiation are expressed on haemopoietic cells. These 
include the 131 integrins, PECAM-1, PSGL-1, N-cadherin and CD45.4  
However, none of these were found to participate in CD34-mediated 
adhesion. Using blocking antibodies, N-cadherin has previously been 
shown to participate in homotypic aggregation between KG1a cells. 
However, these cells were not exposed to QBENDIO and aggregated 
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spontaneously, indicating that they are examining a different type of 
aggregation, not dependent on the ligation of CD34. Also, N-cadherin 
was only found to be expressed on a third of primary CD34-positive cells 
and is therefore unlikely to be involved in homotypic aggregation between 
the CD34-positive population as a whole. As N-cadherin was also found 
to be expressed on stromal cells, it was concluded that N-cadherin-
mediated interactions are involved in the retention and development of a 
subset of progenitor cells within the marrow microenvironment.67 
Aggregation has been shown to be reduced by exposure to 
extracellular matrix components such as heparan sulphate, hyaluronic 
acid and chondroitin sulphate (K. Jethwa, unpublished observations). 
CD44 has been implicated in the regulation of cell survival, proliferation 
and differentiation and, on haemopoietic stem and progenitor cells, 
functions as a ligand for hyaluronic acid.45' 85 Therefore, the distribution of 
CD44 was examined on unaggregated and aggregated KG1a and 
AC133-postive cells. CD44 was found to be polarised on unagggregated 
KG1a and primary cells showing that haemopoietic cells become 
polarised before aggregation, potentially through their interaction with 
extracellular matrix components. Giebel et al., reported polarisation of 
CD44 on CD34-positive cells following cytokine stimulation. However, 
these cells had been isolated on CD34 and already exposed to 
QBEND10.137 CD44 was also found to be localised to the contact point 
between KG1a and AC133-positive cells. In cells exposed to QBEND10, 
CD44 was found to strongly colocalise with CD34. It was hypothesized 
that, as CD44 is polarised before aggregation, that it would be involved in 
early adhesion events. However, following siRNA knock down of CD44, 
aggregation levels at 1 hour are identical to those seen with the mis-
match control. It is only after 24 hours that a difference is seen, with 
CD44 knock-down leading to a significant reduction in QBENDIO-induced 
aggregation but not aggregation induced with anti-CD43. It can therefore 
be concluded that CD44 is critical in the maintenance of CD34-mediated 
aggregation. 
The final adhesion molecule studied was CD164, which is a novel 
member of the sialomucin family. Although it's function remains unclear it 
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has been demonstrated to be involved in the adhesion of haemopoietic 
stem and progenitor cells to the stroma and has been shown to colocalise 
with CD34 on cord blood and bone marrow CD34-positive cells.162, 163 In 
this study, CD164 was found to be polarised on unaggregated KG1a and 
AC133-positive cells. Following exposure to QBENDIO or anti-CD43, 
CD164 always remains excluded from the cell-to-cell contact point and 
does not co-localise with CD34. Such a discrepancy between this and 
published observations may be due to the cell types involved or the fact 
that aggregation was not induced in those cells in the literature and cells 
were stained before fixing. Also McGuckin et al., adhered cells to gold 
positive slides before analysis, which may have an effect on the 
distribution of cell adhesion molecules.163 
Both CD44 and CD43 are linked, through their intracellular tails, to 
the cytoskeleton through the ERM family of cytoskeletal linker proteins.85' 
154 It is accepted that CD44 localises to areas of actin polymerisation and, 
having no intrinsic kinase activity itself, is involved in signalling cascades 
through the actin cytoskeleton.85' 86 Actin polymerisation itself is critical 
during the early stages of T cell polarisation and immunological synapse 
formation.186 To examine the interaction of CD34 and the cytoskeleton, 
CD34 and F-actin were stained on aggregated KG1a cells exposed to 
QBENDIO. CD34 and F-actin were found to colocalise the contact point 
between aggregated cells as indicated in unaggregated, QBEND10-
exposed cells by Tada et a/.139 Using immunoprecipitation, CD34 itself 
was found to be directly linked to actin which is consistent with the finding 
that CD34-mediated aggregation is dependent on an intact 
cytoskeleton.14° However, unlike CD44 and CD43, no evidence of any 
association between CD34 and the ERM family could be found indicating 
that the link is via an alternative mechanism. 
In conclusion, comparisons can be made between the 
immunological synapse and the adhesive junctions between CD34-
positive cells. We have demonstrated that CD34 itself as well as LFA-1, 
CD44 and the actin cytoskeleton are polarised towards the cell-to-cell 
contact point whereas CD164 is excluded. As in immunological synapse 
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formation, LFA-1 plays a key role in early adhesion events whereas CD44 
is involved in the stabilisation of firm adhesion. Haemopoietic cells have 
also been shown to be polarised before exposure to aggregation-inducing 
antibodies with respect to CD44 and CD164, which has not been 
described previously. Therefore, the contact-mediated inhibition of 
haemopoietic progenitor cell-self-renewal is mediated through a 
specialised intercellular junction composed of specific adhesion 
molecules that we have termed the 'haematological synapse'. 
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CHAPTER 5. THE ROLE OF LIPID RAFTS IN HAEMATOLOGICAL 
SYNAPSE FORMATION 
5.1 Introduction 
Lipid rafts are distinct plasma membrane domains that are rich in 
cholesterol and glycosphinogolipids and are proposed to play key roles in 
immunological synapse formation and associated signal transduction. 
189,121 By concentrating certain cell surface receptors and signalling 
molecules, lipid rafts are proposed to act as important platforms for cell 
adhesion, signal transduction and membrane trafficking.123 
Engagement of the T cell receptor has been shown to lead to the 
transport and clustering of lipid rafts at the immunological synapse.124 As 
some rafts may be less than 50nm in diameter, visualisation of these rafts 
is most commonly achieved by raft cross-linking and fusion using cholera 
toxin B which binds to the raft component, ganglioside GM1.119,128 
Importantly, treating T cells with methyl-B-cyclodextrin (MBCD), an 
agent which extracts cellular cholesterol and therefore disrupts lipid rafts, 
inactivates the TCR signalling cascade, indicating the importance of lipid 
rafts in TCR signal transduction.1" 
Rafts clustered at the immunological synapse are found to contain 
increased concentrations of hyperphosphorylated TCR together with 
associated signal transduction molecules including ZAP-70, Vav, PLC, 
PKCO and PI3-kinase which become tyrosine phosphorylated and/or 
concentrated within these rafts.121, 125, 190 Lipid rafts can be distinguished 
from other areas of the cell membrane by their insolubility in non-ionic 
detergents, such as Triton X-100 and Brij, at low temperatures.122 One 
percent Triton-X is commonly used in cell lysis before sucrose-density 
gradient preparation and analysis of raft components. However, LFA-1 
could only be found in lipid rafts in T cell lines isolated with 0.05% Triton 
X while LFA-1 in primary T cells was only found within rafts isolated using 
a different detergent, Brij 35. It has been suggested that extraction of lipid 
rafts with Triton X-100 may cause some components to be lost from rafts, 
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especially those with only a weak association. Therefore the choice of 
detergent is an important consideration for the investigation of lipid 
rafts.1" 
5.2 Results 
5.2.1 The distribution of lipid rafts 
As engagement of the T cell receptor has been shown to lead to 
the transport and clustering of lipid rafts at the immunological synapse, 
the distribution of these rafts was investigated on aggregated CD34-
positive cells.124 
5.2.1.1 Lipid rafts localise at the contact point between aggregated 
KG1a cells 
To determine the distribution of lipid rafts during aggregation, 
KG1a cells were aggregated as usual for 3 hours with QBENDIO and the 
lipid rafts stained with FITC-conjugated cholera toxin B. On unaggregated 
cells, lipid rafts are distributed randomly across the cell surface. However, 
on aggregated cells there is some raft localisation at the contact point 
between the cells (Figure 5.1). Evidence of raft localisation is observed in 
83% of cell doublets or triplets. 
5.2.1.2 Lipid rafts localise to the contact point between aggregated 
primary AC133 positive cells 
To confirm that raft accumulation also occurs at the contact point 
between primary cells, AC133-positive cells were isolated from PBPC 
samples and resuspended in a15 alone or a15 containing 4µg/ml 
QBEND10. After 24 hours, lipid rafts were stained on unaggregated and 
aggregated cells using FITC-conjugated cholera toxin B. Lipid raft 
polarisation at the cell-to-cell contact point was observed in 78% of cell 
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doublets (Figure 5.2). Control cells incubated with FITC conjugated 
secondary alone showed no significant staining above background levels. 
(a) 	 (b) 
Figure 5.1 The distribution of lipid rafts (green) on (a) unaggregated KG1a 
cells and (b) aggregated cells. Unaggregated and aggregated KG1a cells 
were attached to poly-L-lysine coated coverslips and incubated with 10pg/m1 
FITC-labelled cholera toxin B. Lipid rafts are green while nuclei are DAPI stained 
white. At least 100 cells were examined per experiment; results are 
representative of 3 independent experiments. 
(a) 
	
(b) 
Figure 5.2 The distribution of lipid rafts in (a) unaggregated and (b) 
aggregated AC133-positive cells. AC133-positive cells were isolated from 
PBPC samples using MiniMacs technology and resuspended in a15 alone or 
a15 containing 41.4m1 QBEND10. After 24 hours, cells were attached to poly-I-
lysine coated coverslips and lipid rafts stained green using FITC-conjugated 
cholera toxin B. At least 100 cells were examined per experiment and results are 
representative of 4 independent experiments. 
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5.2.2 Lipid raft disruption 
Treatment of T cells with methyl-p-cyclodextrin (MBCD), an agent 
which extracts cellular cholesterol and therefore disrupts lipid rafts, had 
been shown to disrupt immunological synapse formation and inactivate 
the TCR signalling cascade, indicating the importance of lipid rafts in TCR 
signal transduction.126 Therefore, the role of lipid rafts in CD34-mediated 
aggregation was investigated using MBCD. 
5.2.2.1 10mM MBCD does not decrease the viability of KG1a cells 
To confirm that the chosen concentration of MBCD does not affect 
the cell viability, KG1a cells were treated with various concentrations of 
MBCD for 15 minutes at 37°C. After 3 washes, the percentage of viable 
cells was determined using the trypan blue exclusion assay (Figure 5.3). 
10mM MBCD caused no loss in cell viability but at higher concentrations, 
viability begins to fall sharply. 
5.2.2.2 10mM MBCD causes no significant cell death in KG1a cells 
for up to 24 hours after treatment 
To establish if KG1a cells remain viable at longer time intervals 
after treatment with MBCD, cells were treated with 10mM MBCD or RPMI 
alone for 15 minutes, washed, resuspended in a15 and incubated at 
37°C. At each time point the trypan blue assay was performed to 
determine the percentage cell death (Figure 5.4). No significant difference 
in viability was observed between untreated and MBCD treated KG1a 
cells at any time point. 
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MBCD concentration (mM) 
Figure 5.3 The toxicity of MBCD. KG1a cells were treated with various 
concentrations of MBCD in RPMI for 15 minutes at 37°C. 104,1 aliquots of cells 
were mixed with an equal volume of trypan blue and those cells failing to 
exclude the dye counted as unviable. 
5.2.2.3 Lipid raft disruption reduces anti CD34-induced aggregation 
of KGla cells 
To determine if lipid rafts play a role in CD34-mediated 
aggregation, KG1a cells were incubated with 10mM MBCD for 15 
minutes, washed and resuspended in a15 containing 4µg/ml QBEND10 
or IgG control for the relevant amount of time (Figure 5.5). After 1, 3, 5 
and 24 hours, MBCD significantly reduces KG1a aggregation with anti-
CD34. 
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Figure 5.4 The toxicity of MBCD over time. KG1a cells were treated with 
10mM MBCD or RPMI alone for 15 minutes at 37°C. After 3 washes, cells were 
added in 100p1 volumes to a 96-well plate at a concentration of 1x106 cells/ml. At 
each time point cells were added to an equal volume of trypan blue and the 
percentage cell death scored for a total of at least 100 cells. 6 wells were 
prepared per time point and an average value calculated. Results are expressed 
as cell death (%) ±SEM, n=6. Results were analysed using the paired t-test, 
p=NS 
5.2.2.4 Lipid raft disruption reduces anti CD43-induced aggregation 
of KGla cells 
To determine if lipid rafts play a role in CD43-mediated 
aggregation, KG1a cells were incubated with 10mM MBCD for 15 
minutes, washed and resuspended in a15 containing 4iag/mlanti-CD43 or 
IgG control antibody for the relevant amount of time (Figure 5.6). After 1, 
3, 5 and 24 hours, MBCD significantly reduces KG1a aggregation with 
anti-CD43. 
183 
▪ Untreated 
■ Treated 
1 	 3 	 5 	 24 '77 Spe
ci
fic
  a
gg
re
ga
ti
on
  in
de
x  
(%
)  ±
  S
EM
 
-10 
80 
70 - 
60 - 
50 - 
40 - 
30 - 
20 -
10- 
0 	 
Chapter 5. The role of lipid rafts in haematological synapse formation 
Time (hours) 
Figure 5.5 The effect of MBCD treatment on QBENDIO-induced 
aggregation of KG1a cells. KG1a cells were treated with 10mM MBCD or 
RPMI alone for 15 minutes at 37°c. After 3 washes, cells were added in 100p1 
volumes to a 96-well plate at a concentration of 1x106 cells/ml. QBEND10 or IgG 
control antibody was added (4)1g/m1) and the plates incubated for the relevant 
amount of time at 37°C. An additional control plate was prepared to which no 
antibody was added. Microscope slides were prepared and at least 500 cells per 
slide scored for aggregation. The percentage aggregation with IgG control 
antibody was subtracted from the percentage values obtained for cells incubated 
with anti-CD34 or controls to give the specific aggregation index. Triplicate wells 
were scored at each time point and the average value calculated. Values are 
expressed as specific aggregation index (%) ±SEM, n=5. Results were analysed 
using the paired t-test. * = p<0.05, ** = p<0.01. 
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Figure 5.6 The effect of MBCD treatment on anti-CD43-induced 
aggregation of KGla cells. KG1a cells were treated with 10mM MBCD or 
RPMI alone for 15 minutes at 37°C. After 3 washes, cells were added in 100p1 
volumes to a 96-well plate at a concentration of 1x106 cells/ml. Anti-CD43 or IgG 
control antibody was added (41.1g/m1) and the plates incubated for the relevant 
amount of time at 37°C. An additional control plate was prepared to which no 
antibody was added. Microscope slides were prepared and at least 500 cells per 
slide scored for aggregation. The percentage aggregation with IgG control 
antibody was subtracted from the percentage values obtained for cells incubated 
with anti-CD43 or controls to give the specific aggregation index. Triplicate wells 
were scored at each time point and the average value calculated. Values are 
expressed as specific aggregation index (%) ±SEM, n=5. Results were analysed 
using the paired t-test. * = p<0.05, ** = p<0.01. 
5.2.2.5 Lipid raft disruption reduces anti-CD34-induced aggregation 
of primary CD34-positive cells 
To determine if lipid rafts also play a role in primary CD34-positive 
cell aggregation, cells isolated on CD133 were incubated with 10mM 
MBCD for 15 minutes or RPMI alone, washed and aggregated as usual 
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for the relevant amount of time (Figure 5.7). MBCD treatment significantly 
reduces primary cell aggregation at 3 hours. 
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0 
The 	effect of MBCD treatment on QBEND1 0-induced 
aggregation of AC133-positive cells. Primary AC133-positive cells were 
treated with 10mM MBCD or RPMI alone for 15 minutes at 37°C. After 3 
washes, cells were added in 100p1 volumes to a 96-well plate at a concentration 
of 1x106 cells/ml. Anti-CD34 or IgG control antibody was added (44/m1) and the 
plates incubated for the relevant amount of time at 37°C. An additional control 
plate was prepared to which no antibody was added. Microscope slides were 
prepared and at least 500 cells per slide scored for aggregation. The percentage 
aggregation with IgG control antibody was subtracted from the percentage 
values obtained for cells incubated with anti-CD34 or controls to give the specific 
aggregation index. Values are expressed as specific aggregation index (%) ± 
SEM, n=5. Results were analysed using the paired t-test. * = p<0.05. 
5.2.2.6 Lipid raft disruption reduces anti-CD43 induced aggregation 
of primary CD34-positive cells 
To determine if lipid rafts play a role in primary CD34-positive cell 
aggregation, cells isolated on CD133 were incubated with 10mM MBCD 
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for 15 minutes or RPMI alone, washed and aggregated as usual for the 
relevant amount of time (Figure 5.8). No significant effect on aggregation 
induced by anti-CD43 is seen. 
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Figure 5.8 The effect of MBCD treatment on anti-CD43-induced 
aggregation of AC133-positive cells. Primary AC133-positive cells were 
treated with 10mM MBCD or RPMI alone for 15 minutes at 37°C. After 3 
washes, cells were added in 100p1 volumes to a 96-well plate at a concentration 
of 1x106 cells/ml. Anti-CD43 or IgG control antibody was added (4µg/m1) and the 
plates incubated for the relevant amount of time at 37°C. An additional control 
plate was prepared to which no antibody was added. Microscope slides were 
prepared and at least 500 cells per slide scored for aggregation. The percentage 
aggregation with IgG control antibody was subtracted from the percentage 
values obtained for cells incubated with anti-CD43 or controls to give the specific 
aggregation index. Values are expressed as specific aggregation index (%) 
±SEM, n=5. Results were analysed using the paired t-test, p=NS. 
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5.2.2.7 Reconstituting cellular cholesterol restores the ability of 
KW a cells to aggregate. 
To show that the effect of MBCD treatment on aggregation was 
solely due to cholesterol depletion, cholesterol was reconstituted in 
MBCD treated KG1a cells to see if the effects were reversible. KG1a cells 
were incubated alone or with 10mM MBCD for 15 minutes. After washing, 
half of the untreated and treated cells were resuspended in HBSS 
containing 60µg/m1 water soluble cholesterol to reconstitute cellular 
cholesterol.128 Cells were then washed and resuspended in al 5 alone or 
in a15 containing 4µg/mIQBEND10 or IgG control and incubated at 37°C. 
At the relevant time point, cells were air dried onto slides, fixed, stained 
and scored for aggregation. While MBCD treatment significantly reduces 
KG1a aggregation at 3 hours, cholesterol reconstitution restores 
aggregation levels to normal (Figure 5.9). 
5.2.3 Lipid raft isolation 
In T cells, lipid rafts concentrate certain cell surface receptors and 
signalling molecules and are proposed to act as important platforms for 
cell adhesion, signal transduction and membrane trafficking.123 Rafts 
clustered at the immunological synapse are found to contain increased 
concentrations of the hyperphosphorylated T cell receptor together with 
associated signal-transduction molecules such as ZAP-70, Vav, PLC, 
PKCO and PI3-kinase.117,121 Therefore, the content of lipid rafts was 
examined in unaggregated and aggregated KG1a cells. 
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Figure 5.9 The effect of cholesterol reconstitution on sialomucin-mediated 
aggregation. KG1a cells were treated with 10mM MBCD for 15 minutes, 
washed and resuspended in a15 alone or a15 containing 60µg/ml water soluble 
cholesterol. After 30 minutes at 37°C, cells were washed and resuspended in 
a15 alone or a15 containing 4i_ig/m1QBEND10, anti-CD43 or IgG control. After 3 
hours, microscope slides were prepared and at least 500 cells per slide scored 
for aggregation. The percentage aggregation with IgG control antibody was 
subtracted from the percentage values obtained for cells incubated with 
QBEND10, anti-CD43 or controls to give the specific aggregation index. Values 
are expressed as specific aggregation index (%) ±SEM, n=5. Results were 
analysed using the paired t-test. *p<0.05, **p<0.01. 
5.2.3.1 CD34, CD43 and LFA-1 are not localised within lipid rafts in 
KG1a cells lysed using 1% Triton-X 100 
After sucrose-density gradient ultracentrifugation, lipid rafts 
localise to the interface between the 30% and 15% sucrose layers 
corresponding to fractions 3 and 4 of the harvested fractions.168 To 
confirm their presence, all 10 aggregated fractions and the pellet were run 
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on a 10% gel and probed for the presence of the lipid raft marker Lyn 
(Figure 5.10).117 This was repeated for unaggregated fractions. As 
expected, in both aggregated and unaggregated cells, Lyn is particularly 
concentrated in fraction 4. Further gels were run and probed for the 
presence of CD34, CD43 and LFA-1 (Figure 5.10). No CD34 or CD43 is 
present in fraction 4 in either aggregated or unaggregated cells 
suggesting that there is no localisation within lipid rafts. Similarly, in 
unaggregated cells, no LFA-1 is present in fraction 4. All these molecules 
appear in higher density fractions. Additionally, there appears to be no 
difference in the distribution of these molecules between unaggregated 
and aggregated cells. 
5.2.3.2 Varying the detergent concentration or using an alternative 
detergent has an effect on raft isolation. 
To determine the importance of the choice of detergent in raft 
isolation, unaggregated cells were either lysed in one of 3 concentrations 
of Triton-x or with 1c/0 Brij 35. Sucrose-density gradient ultracentrifugation 
was performed as normal. Fractions from each sample were probed for 
the presence of the lipid raft marker, Lyn. With 1% Triton X, lipid rafts are 
present in fraction 4 (Figure 5.11). However, with lower concentrations 
Lyn does not appear in fraction 4 and in the case of 0.05%, the cells 
failed to lyse properly as indicated by the faint band in the total lysate 
lane. Lysis using Brij 35 gave good raft isolation. 
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Figure 5.10 Analysis of lipid rafts after lysis with 1% Triton-X. After lysis 
with 1% Triton-X and sucrose density gradient ultracentrifugation, fractions 1-10 
from (+) aggregated and (-) unaggregated KG1a cells, plus the pellet (P), were 
suspended in 2x sample buffer and boiled. These fractions, plus a total control 
KG1a lysate, were run on polyacrylamide gels and transferred to nitrocellulose 
membrane. Membranes were then blocked and probed with 1µg/m1 of the 
relevant primary antibody overnight at 4°C. Blots show fractions 1-10, the pellet 
(P), a control KG1a lysate (K) and the total lysate before sucrose-density 
gradient ultracentrifugation (T). 
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Figure 5.11 Analysis of Lyn in lipid rafts after lysis with various detergents. 
After lysis with various detergents and sucrose density gradient 
ultracentrifugation, fractions 1-10 from unaggregated KG1a cells, plus the pellet 
(P), were suspended in 2x sample buffer and boiled. These fractions, plus a 
total control KG1a lysate, were run on polyacrylamide gels and transferred to 
nitrocellulose membrane. Membranes were then blocked and probed with 
1µg/ml anti-Lyn overnight at 4°C. Blots show fractions 1-10, the pellet (P), a 
control KG1a lysate (K) and the total lysate before sucrose-density gradient 
ultracentrifugation (T). 
5.2.3.3 A small fraction of total CD34 is present within lipid rafts 
when isolated with 1% Brij 35. 
As the sample isolated with Brij35 in figure 5.11 showed good raft 
isolation, in a preliminary study, the same fractions were re-run and 
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probed for the presence of CD34. A faint band in fraction 4 indicates that, 
a small proportion of the total cellular CD34 is present within lipid rafts 
(Figure 5.12). 
1% Brij 35 
1 2 3 	4 	5 	6 7 8 9 10 P K 
1—CD34 
Figure 5.12 Analysis of CD34 in lipid rafts after lysis with Brij35. After lysis 
with Brij35 and sucrose density gradient ultracentrifugation, fractions 1-10 from 
unaggregated KG1a cells, plus the pellet (P), were suspended in 2x sample 
buffer and boiled. These fractions, plus a total control KG1a lysate, were run on 
polyacrylamide gels and transferred to nitrocellulose membrane. Membranes 
were then blocked and probed with QBend10 overnight at 4°C . Blots show 
fractions 1-10, the pellet (P), a control KG 	lysate (K) and the total lysate 
before sucrose-density gradient ultracentrifugation (T). 
5.2.3.4 Lipid rafts isolated from KG1a cells using Brij35 contain 
some CD34, LFA-1, CD44 and CD164. 
As Brij 35 was shown to give good raft isolation, rafts were isolated 
from unaggregated and aggregated KG1a cells following lysis in 1% Brij 
35 and the analysis repeated for CD34 and other adhesion molecules. 
The resulting fractions were run and probed for the presence of Lyn, 
CD34, LFA-1, CD44 and CD164. Particularly in aggregated cells, a 
proportion of the total cellular CD34, LFA-1, CD44 and CD164 is present 
within lipid rafts (Figure 5.13). 
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Figure 5.13 Analysis of the content of lipid rafts in aggregated and 
unaggregated cells lysed with Brij35. After sucrose density gradient 
ultracentrifugation, fractions 1-10 plus the pellet were suspended in 2x sample 
buffer and boiled. These fractions from (+) aggregated and (-) unaggregated 
cells, plus a total control KG1a lysate, were run on polyacrylamide gels and 
transferred to nitrocellulose membrane. Membranes were then blocked and 
probed with the relevant primary antibody overnight at 4°C. Blots show fractions 
1-10, the pellet (P) and a control KG1a lysate (K) .Results are representative of 
3 independent experiments. 
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5.3 Discussion 
Lipid rafts have been proposed to be critical in organising the TCR, 
co-stimulators, signal transduction molecules and the actin cytoskeleton 
at the immunological synapse.121 Engagement of the TCR has been 
shown to induce lipid raft clustering and translocation to the 
immunological synapse.114, 124 In this study, lipid rafts were shown to 
localise at the contact point between aggregated KG1a cells and primary 
AC133-positive cells, indicating their involvement in haematological 
synapse formation. 
The TCR signalling cascade is has been shown to be inactivated 
following lipid raft disruption.199 Disrupting lipid rafts in both KG1a cells 
and primary CD34-positive cells reduces aggregation induced by both 
QBend10 and anti-CD43. This reduction was significant at all time points 
in KG1a cells but only at 3 hours in AC133 cells when aggregation is 
induced with QBENDIO. The effect on aggregation in KG1a cells 
indicates that lipid rafts and their components play a role in both anti-
CD34 and anti-CD43 mediated aggregation. The smaller effect in primary 
cells could be explained by the fact that aggregation in maximal after 3 
hours in the cell lines and after 18 hours in primary cells. It is possible 
that primary cells are able to reconstitute their cellular cholesterol before 
any real effect on aggregation is seen. In epithelial cell lines, cholesterol 
re-constitution has been found to be nearly complete 22 hours after 
MBCD treatment but it is possible that this value may differ between cell 
types.191 Attempts to measure reconstitution using the cholesterol stain, 
filipin, were hampered by the fact that filipin strongly photobleaches under 
UV light, making comparisons between cells at different time points 
difficult. The specificity of MBCD treatment was indicated by the finding 
that when cellular cholesterol is reconstituted, aggregation returns to 
normal. 
In T cells, a number of proteins are either found to be constitutively 
associated with lipid rafts or concentrated within rafts following TCR 
engagement.121 In this study, CD34, CD43 and LFA-1 were not found to 
be associated with lipid rafts of KG1a cells isolated with 1% Triton X. This 
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is in agreement with the findings of Filatov et al., who, using flow 
cytometry, showed that a number of membrane antigens, including CD34 
and CD43, were easily solubilized in Triton-X 100 and therefore not 
considered components of lipid rafts.123 These results suggest that lipid 
rafts are not responsible for the transport of CD34, CD43 or LFA-1 to the 
haematological synapse. 
However, recently it has been suggested that Triton-X extraction 
may lead to the loss of components from lipid rafts, particularly those that 
are only weakly raft-associated.129 It was also possible that Triton-X 
treatment may only yield a particular subset of rafts while CD34, CD43 
and LFA-1 may be found in rafts not isolated by this method. This was 
demonstrated in T cells where MBCD treatment of T cell lines and 
primary T cells was shown to significantly reduce LFA-1 mediated 
adhesion but LFA-1 itself was only present in lipid rafts isolated with 
0.05% Triton-X in T cell lines and those isolated with Brij 35 in primary T 
cells.128 Therefore, to investigate the effect of detergents on raft isolation 
in KG1a cells, 3 different concentrations of Triton-X or Brij35 were used 
during the isolation process. Isolation with Brij 35 revealed that CD34, 
CD44, LFA-1 and CD164 can be found in lipid rafts. Interestingly, 
particularly in the case of LFA-1, the concentration of these components 
within rafts is increased following aggregation. This is comparable to T-
cells, in which rafts in activated cells are found to contain increased 
concentrations of the hyperphosphorylated T cell receptor.125 Importantly, 
the role of LFA-1 in CD34-mediated aggregation has already been 
reported by Madjic et al., who demonstrated that aggregation can be 
inhibited with blocking antibodies to LFA-1 and also in this study using 
LFA-1 siRNA (Figure 4.27).138 
In primary T cells, LFA-1 co-localises with cholesterol but not the 
ganglioside GM1 whereas in T cell lines, LFA-1 is found in lipid rafts 
enriched in both. Therefore, it was concluded that lipid rafts are 
heterogeneous and specific molecules may localise within subsets of 
these rafts.128 In agreement with this theory, lipid rafts have been shown 
to localise to both the leading edge and uropod of polarized T cells.139 
This study has demonstrated that a proportion of the total cellular CD164 
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is also present within lipid rafts, despite CD164 being excluded from the 
haematological synapse. This would also indicate that, in KG1a cells, lipid 
rafts are heterogeneous. However, as only a proportion of the surface 
markers found to participate in haematological synapse formation were 
found to reside within lipid rafts, rafts may also function to transport other, 
as yet unidentified, cell adhesion and signalling molecules to the contact 
point between aggregated cells and also exclude those not required. 
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CHAPTER 6. GAP JUNCTIONS AND SIALOMUCIN-MEDIATED 
AGGREGATION 
6.1 Introduction 
Gap junctions are specialised structures that form direct channels 
connecting the cytoplasms of adjacent cells.192 These hydrophilic pores 
allow ions and molecules of around 1kDa or less, including second 
messengers such as cyclic-AMP and Ca2+, to pass through while proteins 
and nucleic acids cannot.36 Gap junctions function to couple the 
metabolic and electrical activities of adjacent cells and allow coordinated 
responses from groups of cells to environmental stimuli.193 
Each channel is formed when a connexon, a cylindrical structure 
made up of 6 oligomerised proteins called connexins, attaches head to 
head with the connexon on an adjoining cell.193  In mammals, 19 members 
of the connexin family have been identified and each connexon may be 
composed of the same type or different types of connexins.192 
Many cells have been demonstrated to communicate via gap 
junctions including cardiac and smooth muscle cells, epithelial cells and, 
more recently, progenitor cells and stromal cells of the bone marrow. 37 
Dye transfer experiments have confirmed the existence of gap 
junctions both between stromal cells themselves and, less frequently, 
between stromal and haemopoietic cells.92' 194, 195 It has been suggested 
that gap junctional communication may be important for regulating cell 
growth within the haemopoietic system.192 
Communication between stromal cells and between stromal cells 
and CD34-positive cells has been demonstrated to be mediated by 
connexin 43.92 The expression of connexin 43 has been found to be 
relatively low during steady state blood cell production but increases 
during periods of enhanced production such as during embryogenesis or 
following cytoablative treatment.91  Connexin 43 knock-out mice display 
deficiencies in lymphopoiesis and myelopoiesis and, using cell lines from 
knock-out animals, stromal cells show significantly greater cobblestone 
area-forming cell outgrowth when connexin 43 is re-introduced compared 
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to their knock-out counterparts.196'197 Increased expression of connexin 
43 in murine stromal cell lines leads to an increase in the number of 
haemopoietic precursors together with a increase in myeloid precursor 
differentiation.192 Together these data indicate the importance of gap 
junction mediated communication in haemopoiesis, particularly with 
reference to connexin 43. Although connexin 43-mediated communication 
between stromal cells has been well described, communication between 
CD34-positive cells and the expression of connexin 43 by haemopoietic 
stem and progenitor cells themselves is disputed.92, 196, 197 
Within this laboratory, gap junction-mediated communication has 
been suggested to exist between homotypic and heterotypic aggregated 
of CD34-positive cells and T-cells, aggregated using anti-CD43. The 
connection between gap junctional communication, sialomucin-mediated 
aggregation and reduced progenitor cell proliferation has led to the 
suggestion that gap junctions may serve to transmit negative regulatory 
signals between haemopoietic cells." 
6.2 Results 
6.2.1 Calcein transfer as a measurement of gap junctional 
communication 
To look for the presence of gap junctions between aggregated 
KG1a and AC133-positive cells, cells were stained with either the red 
membrane dye PKH26 or calcein, a green fluorescent dye that is cleaved 
to the membrane impermeable form by cellular esterases and can 
therefore only be passed between cells through gap junctions.195  When 
visualised under the fluorescent microscope, calcein stained cells appear 
green, PKH26 stained cells are red and cells acquiring calcein through 
gap junctions appear orange/yellow (Figure 6.1). 
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(a) 
	
(b) 
	
(c) 
Figure 6.1 Appearance of AC133-positive cells stained with (a) PKH26 and 
(b) calcein or cells containing (c) both. PKH26 cells participating in gap 
junctional communication with calcein positive cells acquire calcein and appear 
as orange/yellow. 
6.2.1.1 Calcein transfer occurs between primary AC133-positive 
cells and, to a lesser extent, between KG1a cells 
To quantify the extent of gap junctional communication between 
aggregated cells, cells were stained with PKH26 or calcein, mixed in 
equal proportions, and then aggregated as normal with either anti-CD34 
or anti-CD43. After 24 hours, aliquots of cells were carefully removed for 
aggregation scoring and the remaining cells dispersed in mounting 
medium and examined under the fluorescent microscope. The number of 
yellow cells was scored and expressed as a percentage of the possible 
recipients, i.e. PKH26 cells that had aggregated and had become yellow 
(Figure 6.2). In the control and anti-CD34 and anti-CD43 aggregated 
cells, the percentage of yellow cells in AC133 positive cells was 
significantly higher than in KG1a cells indicating that gap junctional 
communication occurs far more frequently in primary cells. Interestingly, 
communication is also observed in the control cells, a discrepancy which 
is discussed later. 
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Figure 6.2 The percentage of possible recipients acquiring calcein through 
gap junctional communication. KG1a and AC133-positive cells were stained 
with either PKH26 or calcein. Equal numbers of cells with each stain were mixed 
and aggregated with anti-CD34 or anti-CD43 as normal for 24 hours. Cells were 
then examined by fluorescence microscopy and the number of yellow cells 
scored. Results are expressed as the percentage yellow cells out of the total 
number of PKH26-positive cells that could have acquired calcein during 
aggregation ±SEM, n=6. At least 500 cells were scored per slide. Results were 
analysed using the unpaired t-test for statistical significance. *=p<0.05, 
**=p<0.01 
6.2.1.2 Inhibition of gap junctional communication between AC133-
positive cells can be achieved using carbenoxolone. 
To prove that yellow cells were a result of gap junctional 
communication and not passive uptake of any residual dye, calcein and 
PKH26 staining was repeated in AC133 positive cells but an additional 
plate was prepared to which the gap junction inhibitor, carbenoxolone 
was added at a concentration shown the reduce calcein transfer between 
haemopoietic progenitor cells and stromal cells.195 The cells were then 
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harvested and the number of yellow cells scored (Figure 6.3) In each 
case, there was a significant drop in the percentage of yellow cells, 
indicating that gap junctional communication was present between 
AC133-positive cells which can be inhibited with carbenoxolone. 
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Figure 6.3 The effect of the gap junction inhibitor, carbenoxolone, on the 
number of PHK26-positive primary cells acquiring calcein. Primary AC133-
positive cells were stained with either PKH26 or calcein. Equal numbers of each 
were mixed and aggregated as normal. An additional plate contained the same 
mixture of cells but with 15011M carbenoxolone added. Results are expressed as 
the percentage drop in the number of yellow cells in the carbenoxolone treated 
sample relative to the untreated control ±SEM, n=5. At least 500 cells were 
scored per slide. Results were analysed using the paired t-test for statistical 
significance. *=p<0.05 
6.2.1.3 Calcein transfer between KG1a cells is not significantly 
reduced with carbenoxolone 
To determine if the small amount of calcein transfer see between 
KG1a cells is due to the presence of gap junctions, calcein and PKH26 
staining was repeated in but an additional plate was prepared to which 
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the gap junction inhibitor, carbenoxolone was added. The cells were then 
harvested and the number of yellow cells scored (Figure 6.4) In this case, 
no significant drop in the number of yellow cells was observed following 
treatment with carbenoxolone, indicating that a small amount of calcein 
uptake in KG1 a cells is due to the passive transfer of dye which, from 
these results, can be estimated to occur at a frequency of between 2 and 
5%. 
Control 
	
Anti-CD34 	 Anti-CD43 
Figure 6.4 The effect of the gap junction inhibitor, carbenoxolone, on the 
number of PHK26-positive KGla cells acquiring calcein. KG1 a cells were 
stained with either PKH26 or calcein. Equal numbers of each were mixed and 
aggregated as normal. An additional plate contained the same mixture of cells 
but with carbenoxolone added. Results are expressed as the percentage of 
yellow cells out of those that could have become yellow ±SEM, n=5. At least 500 
cells were scored per slide. Results were analysed using the paired t-test for 
statistical significance. p=NS. 
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6.2.1.4 Carbenoxolone has no effect on AC133-positive cell 
aggregation 
To show that carbenoxolone does not reduce the number of yellow 
cells simply by reducing aggregation, aliquots of both treated and 
untreated cells AC133-postive cells were scored for aggregation (Figure 
6.5). No significant difference in the percentage aggregation was 
observed between the treated and untreated cells. 
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Figure 6.5 The effect of carbenoxolone treatment on aggregation in AC133-
positive cells. During dye transfer experiments, aliquots of AC133-positive cells 
were carefully removed and scored for aggregation. Results are expressed as 
the percentage of cells in aggregates ±SEM, n=5. At least 500 cells were scored 
per treatment. Results were analysed using the paired t-test for statistical 
significance. p=NS. 
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6.2.1.5 Carbenoxolone inhibits the reduction in self-renewal caused 
by aggregation 
To determine the role of gap junctions in the reduction of 
progenitor cell self-renewal during aggregation, cells were treated with 
carbenoxolone and the effect on self-renewal measured using the CFU-
GM replating assay. AC133-positive cells were either incubated in a15 
alone or in a15 containing 150µM carbenoxolone either with or without 
4µg/m1 QBENDIO. After 24 hours overnight 37°C cells were then 
disaggregated and resuspended in methylcellulose supplemented with 
cytokines. After 7 days, colonies containing 50 or more cells were 
counted and 90 of these colonies picked and dispersed into 
methylcellulose in individual wells of a 96-well plate. After a further 7 
days, the number of colonies in each well were counted and the AUC, or 
proliferation index, calculated. 
6.2.1.5.1 The number of primary colonies is unaffected by 
carbenoxolone or QBENDIO. 
After 7 days in culture, the number of primary colonies containing 
50 or more cells was counted to determine if carbenoxolone had any 
effect on the ability to culture primary cells. AC133-positive cells were 
incubated overnight in a15 alone or a15 containing 150 IAM 
carbenoxolone and with or without QBENDIO. Cells were then grown in 
methylcellulose for 7 days and the number of primary colonies counted. 
Carbenoxolone causes no decrease in the number of primary colonies 
after 7 days (Figure 6.6). 
6.2.1.5.2 Aggregation induced by QBENDIO significantly reduces 
progenitor cell proliferation while carbenoxolone inhibits this effect. 
To determine the effect of carbenoxolone on self-renewal, 90 
primary colonies of 50 or more cells were picked and individually 
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dispersed into methylcellulose in separate wells of a 96-well plate. After a 
further 7 days, the number of colonies containing 50 or more cells in each 
well was counted and the numbers entered into a program to determine 
the proliferation index or AUC. In untreated cells, aggregation induced by 
QBEND10 decreased the proliferation index (Figure 6.7). However, 
closing gap junctions with carbenoxolone completely inhibited this effect. 
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Figure 6.6 The effect of carbenoxolone treatment on primary colony 
numbers. AC133-positive cells were isolated from PBPC samples using 
MiniMacs technology and incubated overnight in a15 alone or a15 containing 
150mM carbenoxolone either with or without 414/m1 QBEND10. Cells were then 
suspended in 3m1 methylcellulose supplemented with GM-Mix and 1m1 aliquots 
placed into petri dishes. After 7 days the number of primary colonies were 
counted. Results are expressed as the total number of primary colonies, n=3. 
6.2.2 Connexin 43 is expressed on AC133-positive cells 
As connexin 43 has been proposed to be the main connexin 
expressed within the haemopoietic system, KG1a and primary CD34-
positive cells were lysed and, using western blotting, probed for the 
presence of connexin 43 (Figure 6.8).92 Connexin 43 was found to be 
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expressed by KG1a cells and primary cells. The amount of total protein in 
the cells was equivalent as indicated by the actin loading controls. 
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Figure 6.7 The effect of carbenoxolone treatment on AC133-positive cell 
self-renewal in unaggregated and aggregated cells. AC133-positive cells 
were isolated from PBPC samples using MiniMacs technology and incubated 
overnight in a15 alone or a15 containing 150mM carbenoxolone either with or 
without 4µ9/m1 QBENDIO. Cells were then suspended in 3m1 methylcellulose 
supplemented with GM-Mix and 1m1 aliquots placed into petri dishes. After 7 
days, 90 primary colonies containing 50 or more cells were individually picked 
and dispersed into methylcellulose in separate wells of a 96-well plate. After a 
further 7 days, the number of colonies of 50 or more cells in each well was 
counted and the proliferative index calculated. Results are expressed as the 
proliferative index (AUC) ± standard deviation, n=3. 
6.2.2.1 Connexin 43 does not localise to the contact point between 
aggregated KG1a or primary AC133-positive cells 
To determine if connexin 43 becomes localised to the intercellular 
contact point, connexin 43 was stained on unaggregated and aggregated 
KG1a and primary AC133-positive cells. No evidence of accumulation of 
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connexin 43 was observed between aggregated KG1a or primary cells 
(Figure 6.9). Cells incubated with IgG control followed by FITC-
conjugated secondary antibody or the FITC conjugated secondary alone 
showed no significant staining above background levels. 
1 2 3 4 
Connexin 43 -• 1-  Actin 
Figure 6.8 The expression of connexin 43 in KG1a and primary AC133-
positive cells. Lanes 1 and 2 show the expression of connexin 43 in KG1a and 
AC133-positive cells respectively while lanes 3 and 4 are the loading controls 
and show actin in the same samples. KG1a or primary cells (107 of each) were 
lysed and the total connexin 43 or actin determined by western blotting. Results 
are representative of 3 separate primary cell lysates. 
(a) 	 (b) 
KG1a 
AC133 
Figure 6.9 The distribution of connexin 43 on (a) unaggregated and (b) 
aggregated KG1a and primary AC133-positive cells. Cells were resuspended 
in a15 alone or a15 containing 414/m1 QBEND10 and after 3 hours for KG1a 
cells or 24 hours for primary cells, aliquots were air-dried on slides, fixed in 3% 
paraformaldehyde for 10 minutes and stained with rabbit anti-connexin 43 
followed by goat anti-rabbit FITC. At least 100 cells were examined per slide, 
results are representative of 4 independent experiments, 
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6.3 Discussion 
Although gap junction formation between stromal cells has been 
well characterised, the existence of connexin mediated communication 
between haemopoietic stem and progenitor cells themselves is less 
clear.92 Within this laboratory, gap junctions have been proposed to exist 
between cells induced to aggregate with anti-sialomucin antibodies.94 
We have demonstrated that calcein transfer occurs between 
AC133-positive cells and, to a lesser extent, between KG1a cells. Calcein 
is a membrane permeable dye that is cleaved to an impermeable form by 
cellular esterases and can then only be passed between cells via gap 
junctions.195 The lack of gap junctional communication between KG1a 
cells could be explained by the fact that KG1a is an acute myeloid 
leukaemic cell line. It is well documented that tumorigenic cell lines are 
either deficient in gap junctional communication or have fewer gap 
junctions than their normal counterparts.198 
Interestingly, calcein transfer occurs between AC133-positive cells 
whether they have undergone anti-sialomucin induced aggregation or not. 
The results were calculated as the percentage yellow cells out of the 
possible recipients i.e. relative to the amount of aggregation and number 
of PKH26 cells. This indicates that although the aggregation was lower in 
control cells, gap junctional communication still occurs between those 
that do aggregate. It is conceivable that cells without anti-CD34 and anti-
CD43 are continually connecting and dispersing and therefore exhibit a 
higher frequency of gap junctional communication than expected at any 
single time point. In this case, cells that have been induced to aggregate 
with antibodies have a continual 'stick' signal and cannot disperse and 
reconnect with other cells, thereby reducing the number of gap junctions 
formed. In either case, it is clear that these junctions must form as a 
consequence of aggregation and play no part in the formation of stable 
CD34-mediated adhesive junctions, as carbenoxolone had no effect on 
the level of aggregation in AC133-positive cells. However, it is clear that 
gap junctions do form between haemopoietic stem and progenitor cells 
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and at a higher frequency than between stromal cells, estimated at 10% 
in stromal cell lines.193 
To show that the presence of yellow cells is not merely due to the 
uptake of any residual calcein within the system or by passive transfer of 
dye, cells were also incubated in the presence or absence of the gap 
junction inhibitor, carbenoxolone. Carbenoxolone has been described as 
a specific gap junction closer and has been demonstrated to reduce 
calcein transfer between stromal and haemopoietic cells.195' 199 In this 
investigation, treatment with carbenoxolone was found to decrease 
calcein transfer between 50 and 90% when compared to the control 
levels. This suggests that at least 50% of the calcein transfer observed is 
due to gap junction formation between these cells. In KG1a cells, 
carbenoxolone has no significant effect on the 2-5% of calcein transfer 
observed indicating that passive transfer and uptake of residual dye is 
only responsible for up to 5% of yellow cells seen. 
It has, however, been suggested that gap junction closers may 
have more widespread effects at the membrane level.199  Therefore, we 
examined the effect of carbenoxolone treatment on the level of 
aggregation as a possible alternative explanation for the reduction in gap 
junction formation. Contrary to this theory, there was no significant 
reduction in aggregation in AC133-positive cells following carbenoxolone 
treatment, providing further evidence that carbenoxolone exerts its effects 
through the closure of gap junctions. 
Importantly, carbenoxolone treatment inhibited the ability of 
aggregation to reduce progenitor cell self-renewal indicating that at least 
part of the negative regulatory signal passed between aggregated cells is 
done so through gap junctions. The precise nature of this signal is 
unclear although possible candidates include calcium, cAMP, inositol 
triphosphates or possibly even microRNAs (miRNA) which have been 
suggested to play a role in stem cell self-renewal and differentiation and 
can be passed through gap junctions.200-202  
Although connexin 43 has been described as the predominant 
member of the connexin family expressed within the haemopoietic 
environment, it's expression on haemopoietic stem and progenitor cells 
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themselves is disputed.92 Montecino-Rodriguez et a/., reported no 
connexin 43 mRNA expression by haemopoietic stem cells using PCR 
analysis, a result also confirmed by Cancelas et al., who concluded that 
the haemopoietic defects observed in connexin 43 deficient stromal cells 
lines are due to the disruption of communication only between stromal 
cells themselves and not haemopoietic cells.196' 197 However, in contrast 
to these results, connexin 43 expression has been reported on CD34-
positive cells using FAGS analysis and connexin 43-type gap junctions 
shown to exist between stromal cells and haemopoietic stem cells.197 
Using western blotting, we demonstrated connexin 43 expression 
on CD34-positive cells. However, no evidence of connexin 43 localisation 
was observed at the contact point between aggregated KG1a or primary 
AC133-positive cells. It is reasonable to conclude that either polarisation 
of gap junctions is not necessary or haemopoietic stem and progenitor 
cells may also express other connexins and that the junctions formed 
between stem cells and stromal cells may consist of connexin 43 on the 
stromal cells but alternative connexins on the haemopoietic cells. It is 
accepted that gap junctions may consist of more than one type of 
connexin and more than 9 different connexins have been identified in 
stromal cell lines.192 195 Interestingly, it has also been suggested that 
expression of connexin 43 may vary with culture conditions which could 
explain the apparent discrepancies between our results concerning the 
expression of connexin 43 itself on CD34-positive cells and the results of 
other groups.195 
In conclusion, we have demonstrated that gap junctional 
communication does occur between haemopoietic stem and progenitor 
cells as a consequence of homotypic aggregation and may be involved in 
the transmission of negative regulatory signals between these cells. 
Connexin 43 may play some role in the formation of these junctions but it 
is also possible that these junctions are composed of connexins other 
than connexin 43. 
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CHAPTER 7. AGGREGATION AND THE PLANE OF CELL DIVISION 
7.1 Introduction 
Asymmetrical cell division is required for the maintenance and 
homeostasis of stem cell populations while symmetrical divisions allow for 
population expansion (Figure 1.2).9 In general, asymmetrical cell division 
can be conferred by two basic mechanisms, either by the localisation of 
the daughter cells within different microenvironments or by the unequal 
portioning of cell fate determinants between the daughter cells following 
division." 
The factors involved in the control of asymmetrical cell division 
within the haemopoietic system remain unclear. In the Drosophila germ 
line, asymmetrical stem cell division is tightly regulated through contact 
with a collection of somatic cells called the hub. It is this hub that provides 
the stem cell niche and, through adherens junction components, controls 
both the position of the single centrosome in a non-dividing cell as well as 
the orientation of the mitotic spindle during cell division."' 69 In a non-
dividing cell, the single centrosome is always located adjacent to the stem 
cell-hub contact point. During cell division, the replicated centrosome 
migrates to the pole opposite the hub. In this case, cell division is always 
asymmetrical, with the daughter cell closest to the hub remaining a stem 
cell whereas the cell away from the hub becomes the more differentiated 
gonioblast." Mitotic spindle orientation has been shown to be essential to 
this process, as spindle disruption leads to the production of two stem 
cells through symmetrical division.13 Polarisation of cell fate determinants 
has also been shown to be essential for asymmetrical cell division in 
Drosophila, during neurogenesis in both the central and peripheral 
nervous system. The parent cell segregates these determinants prior to 
cell division and orientation of the mitotic spindle is controlled leading to 
unequal inheritance between the two daughter cells." 
Within the mammalian system, control of the orientation of the 
mitotic spindle has also been shown to be essential in determining the 
plane of cell division. During mouse embryo neurogenesis, horizontal or 
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vertical orientation of the mitotic spindle relative to the niche is associated 
with symmetrical and asymmetrical cell division respectively although the 
precise orientation may vary within fixed limits.20 
Unequal inheritance of cell fate determinants has also been 
observed in the mammalian cerebral cortex. Notch-1 has been shown to 
asymmetrically localised within dividing neural progenitor cells and 
orientation of the plane of cell division determines the fate of the two 
daughter cells with one daughter cell exclusively inheriting Notch-1.22  
Interestingly, Notch-1 has also been implicated in the control of cell fate 
within the haemopoietic system. Differentiation along the myeloid lineage 
has been shown to be inhibited both in vivo and in vitro following Notch-1 
activation accompanied by an increase in self-renewal. This effect is 
thought to be a result of the effect of Notch-1 activation on proteins 
involved in control of the cell cycle, particularly its effect in enhancing the 
degradation of the cyclin-dependent kinase inhibitors p27kiP1  and p2101P1.23 
Significantly, aggregation has also been proposed to exert its effect on 
self-renewal through similar mechanisms.1" However, Notch-1 signalling 
has also been shown to decrease self-renewal and promote 
differentiation along the macrophage and granulocyte lineages, therefore 
the precise function of Notch signalling within the haemopoietic 
environment remains unclear.30 
7.2 Results 
7.2.1 The position of the centrosome is linked to aggregation 
7.2.1.1 Aggregation can affect the position of centrosomes in non-
dividing KGla cell doublets. 
To determine if cell-to-cell contact can influence the position of the 
single centrosome in non-dividing aggregated CD34-positive cells, KG1a 
cells were aggregated for 3 hours with QBENDIO, air-dried onto slides, 
fixed and the centrosomes stained with pericentrin. The positions of the 
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centrosomes in KG1a doublets were scored according to the scheme in 
Figure 8.1. 
Figure 7.1 The position of the single centrosome in aggregated non-
dividing KG1a doublets. Six possible centrosome arrangements were 
identified and assigned a number. KG1a cells aggregated for 3 hours were air-
dried onto multi-well slides and fixed in acetone for 1 minute. Centrosomes were 
stained using rabbit anti-pericentrin followed by goat anti-rabbit FITC. Slides 
were examined under a fluorescent microscope and the position of centrosomes 
recorded in doublets where both centrosomes were clear. Results are 
expressed as the percentage of total doublets scored with each centrosome 
position ± SD. At least 100 cells were scored per experiment, n=4. 
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The arrangement indicated by orientation 4 was found to be 
present in almost 60% of cases, where one centrosome was opposite the 
contact point and the other, to the side. Orientation 1, where both 
centrosomes were adjacent to the contact point was only seen in 0.89% 
of cases and orientations 1,2 or 3, where both centrosomes lie on the 
vertical line radiating from the contact point in 12.5% of cases, indicating 
that the position of the centrosomes in aggregated cells is not random 
and aggregation affects the position of the interphase centrosomes in 
both participating cells. 
7.2.1.2 The position of the single centrosomes does not differ after 
24 hours aggregation. 
To determine if prolonged aggregation affected centrosome 
position, KG1a cells were aggregated for 24 hours, fixed in acetone and 
centrosomes stained using pericentrin followed by goat anti-rabbit FITC. 
The centrosome position in doublets was scored as in Figure 7.1. (Figure 
7.2). As in Figure 7.1, orientation 4 predominated and there were no 
doublets with both centrosomes located adjacent to the contact point. 
This indicates that the effect seen at the maximal aggregation time (3 
hours) is maintained for at least 24 hours. Cells incubated with FITC-
conjugated secondary antibody alone showed no significant staining 
above background levels. 
7.2.1.3 Aggregation can affect the position of centrosomes in non-
dividing primary AC133-positive cell doublets. 
To determine if the effect of aggregation on the centrosome 
position in doublets was mirrored in primary cells, cells from PBPC 
samples were isolated on AC133 and aggregated for 24 hours overnight. 
As in KG1a cells, aggregation seems to prevent the positioning of 
centrosomes along the central vertical line radiating from the contact 
point, an orientation which is only seen in 12.3% of cases (positions 1, 2 
and 3, Figure 7.1). In contrast to the results in KG1a, cell, orientation 6 
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predominated in primary cells, although orientations 4 and 5 were also 
commonly seen (Figure 7.3). It appears that, as in KG1 a cells, the 
position of centrosomes in non-dividing cell doublets is not random. 
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Figure 7.2 The position of the single centrosome in non-dividing KGla 
doublets aggregated for 24 hours. Six possible centrosome arrangements 
were identified and assigned a number as in Figure 7.1. KG1 a cells were air-
dried onto multi-well slides and fixed in acetone for 1 minute. Centrosomes were 
stained using rabbit anti-pericentrin followed by goat anti-rabbit FITC. Slides 
were examined under a fluorescent microscope and the position of centrosomes 
recorded in doublets where both centrosomes were clear, n=1. 
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Figure 7.3 The position of the single centrosome in non-dividing primary 
AC133-positive cell doublets aggregated for 24 hours. Six possible 
centrosome arrangements were identified and assigned a number as in Figure 
8.1. Cells were isolated on AC133, aggregated, air-dried onto multi-well slides 
and fixed in acetone for 1 minute. Centrosomes were stained using rabbit anti-
pericentrin followed by goat anti-rabbit FITC. Slides were examined under a 
fluorescent microscope and the position of centrosomes recorded in doublets 
where both centrosomes were clear, n=4 ± standard error. 
7.2.1.4 The centrosome and CD164 are colocalised in unaggregated 
cells 
To determine the position of the centrosome in unaggregated cells, 
KG1a and primary CD34-positive cells were dual-stained for pericentrin 
and CD164. CD164 was chosen as a reference point as it is polarised on 
50% of unaggregated KG1a and 70% primary cells and is excluded from 
the contact point (see 4.2.1.3). As we have demonstrated that it is rare to 
find both centrosomes in a doublet positioned adjacent to the contact 
point, a link between CD164 and the centrosome is indicated. The 
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position of the centrosome and CD164 were scored as indicated in Figure 
7.4. Dual staining revealed that in 76.0% of KG1a and 83.1% of 
unaggregated primary cells, CD164 and the interphase centrosome are 
strongly co-localised (Figures 7.4 and 7.5). Cells incubated with IgG 
controls followed by FITC and rhodamine-conjugated secondary 
antibodies or secondary antibody alone showed no significant staining 
above background levels. 
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Figure 7.4 The position of the single centrosome (red) in unaggregated 
cells in relation to CD164 (green). Unaggregated KG1a and AC133-positive 
cells isolated from PBPC harvests and normal bone marrow (NBM) were air-
dried onto multi-well slides and fixed with acetone for 1 minute. Centrosomes 
were stained with pericentrin followed by rhodamine conjugated goat anti-rabbit. 
CD164 was stained with FITC-conjugated anti-CD164. Cells displaying polarised 
CD164 were photographed and the centrosome position scored, at least 100 
cells were scored per sample, n=1. 
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Figure 7.5 The position of the centrosome in relation to CD164 in 
unaggregated AC133-positive cells isolated from a PBPC harvest. Primary 
cells were isolated on AC133, resuspended in a15 and air-dried onto slides. 
Cells were then fixed in acetone for 1 minute and CD164 was stained with FITC-
conjugated anti-CD164 (green). Centrosomes were stained with pericentrin 
followed by rhodamine conjugated goat anti-rabbit (red). When these images are 
overlaid, areas of co-localisation appear yellow. 
7.2.2 Aggregation regulates the orientation of the mitotic spindle 
The plane of cell division cannot be precisely determined from the 
position of a single centrosome, only when the centrosome is duplicated 
during mitosis.203 To determine if aggregation had an effect on the 
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potential orientation of the mitotic spindle, centrosomes in KG1a cells 
were stained as before and examined for the presence of cells with two 
centrosomes (Figure 7.6). This was found to be a rare event, only 
occurring in 5% of cases. The position of double centrosomes was scored 
as in Figure 7.6 (a). Rather than lying perpendicular to the contact point 
as seen in Drosophila (position 1), 82% of spindles were found to be 
aligned along lines 2 or 6 which are mirror images of each other. The 
single interphase centrosome in the connected cell was found to be 
opposite the contact point in 67% of cases as indicated in Figure 7.6 (b) 
This indicates that aggregation does affect the orientation of the mitotic 
spindle although the precise orientation can vary within limits. Assuming 
that we are seeing the final position of the centrosomes before dividing to 
produce 2 daughter cells, orientation along either of these lines would 
confer asymmetrical cell division, providing a link between aggregation 
and self-renewal. Cells incubated with FITC-conjugated secondary 
antibody alone showed no significant staining above background levels. 
7.2.3 The cell fate determinant Notch-1 is polarised on primary 
CD34-positive cells 
7.2.3.1 Notch-1 is polarised on unaggregated and aggregated CD34-
positive cells 
As aggregation does appear to play a role in cell fate and 
polarisation of Notch-1 has been linked with asymmetrical cell division, 
we looked at the distribution of Notch-1 on unaggregated and aggregated 
primary CD34-positive cells.22 Notch-1 was polarised on unaggregated 
and aggregated AC133-positive cells. In aggregated cells, this 
polarisation was to the contact point between the cell doublets or triplets 
(Figure 7.7). 	Cells incubated with IgG controls followed by FITC- 
conjugated secondary antibody or secondary antibody alone showed no 
significant staining above background levels. Notch was found to be 
polarised on 70% of unaggregated cells, 57% of single cells exposed to 
QBEND10 and in 56% of doublets (Figure 7.8). 
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Figure 7.6 The orientation of the mitotic spindle in dividing AC133-positive 
cells. KG1a cells were aggregated for 3 hours and air-dried onto multi-well 
slides. Centrosomes were stained using rabbit anti-pericentrin followed by goat 
anti-rabbit FITC. (a) shows the scoring scheme for centrosome pairs while (b) 
shows a typical centrosome (green) arrangement. The results represent the 
cumulative scores from 5 separate aggregation experiments. The y axis shows 
the percentage of the total number of doublets containing one cell with 2 
centrosomes with the centrosomes scored as lying along 1 of 6 lines (x axis). 
The observed and expected results were compared using Microsoft excel and 
the chi-squared test, p<0.01. 
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(a) (b) 
Figure 7.7 Polarisation of Notch-1 (green) on (a) unaggregated and (b) 
aggregated primary AC133-positive cells. AC133-positive cells were 
incubated in a15 alone or a15 containing 4µg/m1 QBEND10. After 24 hours cell 
were air-dried onto multi-well slides, fixed in paraformaldehyde for 10 minutes 
and stained using goat anti-Notch-1 followed by rabbit anti-goat FITC. 
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Figure 7.8 Polarisation of Notch-1 on primary AC133-positive cells. Primary 
cells isolated on AC133 were resuspended in a-15 alone or a15 containing 
41.1g/m1 QBEND10. After 24 hours unaggregated and aggregated cells were air-
dried onto multi-well slides. Slides were then fixed in 3% paraformaldehyde for 
10 minutes and stained using goat-anti Notch-1 followed by rabbit anti-goat 
FITC. Unaggregated and aggregated cells were scored as unpolarised, 
polarised or totally polarised as in Figure 4.2. Results are expressed as the 
percentage of the total number of cells scored that are either unpolarised, 
polarised or totally polarised ±standard deviation, at least 100 cells were scored 
per sample, n=3. 
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7.2.3.2 Notch-1 co-localises with CD34 in aggregated cells 
To determine if Notch-1 is polarised with CD34 in aggregated 
single cells exposed to QBEND10, aggregated primary cells were dual 
stained for CD34 and Notch-1 (Figure 7.9). Co-localisation between 
CD34 (red) and Notch-1 (green) was observed in 100% of cells displaying 
polarisation of Notch-1. Cells incubated with IgG controls followed by 
FITC and rhodamine-conjugated secondary antibodies or secondary 
antibody alone showed no significant staining above background levels. 
(b) 	 (c) 
Figure 7.9 Co-localisation of Notch-1 and CD34. Primary AC133-positive cells 
were resuspended in 05 containing 41.1g/mIQBEND10, after 24 hours, were air-
dried onto multi-well slides and fixed in paraformaldehyde for 10 minutes. Slides 
were dual stained using goat anti-Notch (a) and mouse anti-CD34 (b) followed 
by FITC and rhodamine—conjugated secondary antibodies respectively. When 
these images are over-laid, areas of co-localisation appear yellow. Results are 
representative of those observed during 3 independent experiments. 
7.3 Discussion 
Asymmetrical cell division can be conferred by two basic 
mechanisms, either by positioning of the two daughter cells within 
different microenvironments or by polarisation of cell fate determinants in 
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the parent cell, leading to unequal distribution of these determinants in 
the daughter cells." 
Haemopoietic stem and progenitor cells are generally thought of 
as rounded cells, with a uniform distribution of cell surface markers. 
However, we have demonstrated that a proportion of haemopoietic cells 
are polarised with respect to the sialomucin CD164 as well as CD44 (see 
chapter 4). The adhesive interaction between CD34-positive cells, which 
occurs physiologically, but can also be induced with the anti-CD34 
antibody QBEND10, leads to further cell polarisation with respect to 
CD34 itself together with the integrin adhesion molecule LFA-1. This 
aggregation has be found to significantly decrease progenitor cell self-
renewal, thereby providing a link between cell polarisation and 
proliferation within the haemopoietic system.1" 
Studies in Drosophila have provided clues regarding the control of 
asymmetrical cell division. Polarisation itself is insufficient to confer cell 
asymmetry and the unequal distribution of cell fate determinants to the 
daughter cells depends on the plane of cell division. Within the 
Drosophila germline, the single interphase centrosome is always 
positioned adjacent to the contact point between a stem cell and its niche, 
the hub. In this case the position of the centrosome in the non-dividing 
cell indicates the orientation of the mitotic spindle. During cell division, the 
replicated centrosome migrates to the opposite pole of the cell and 
division is always asymmetrical with the daughter cell staying in contact 
with the niche remaining a stem ce11.13 Also, during immunological 
synapse formation, repositioning of the centrosome is an early marker of 
T cell polarisation.101  In this study, the position of the single interphase 
centrosome in both KG1a and primary CD34-positive cell doublets was 
found to be influenced by aggregation. This suggests that aggregation 
affects centrosome position in each cell, relative to the other as it was 
rare to find both centrosomes along the central line radiating vertically 
from the contact point. 
It would be expected that, in a system as dynamic and responsive 
as haemopoiesis, the fixed arrangement of the interphase centrosome 
seen in Drosophila would be unlikely as it does not allow any alterations 
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in the frequency of asymmetrical and symmetrical division. Therefore, 
although aggregation does affect this position of centrosomes within a 
doublet, it does not predispose aggregated cells towards symmetrical or 
asymmetrical cell division. However, in dividing cells, the mitotic spindle 
was found to be orientated with regard to the cell-to-cell contact point. 
This was not found to be directly perpendicular to the contact point as in 
Drosophila but slightly skewed either clockwise or anti-clockwise. This fits 
with studies on mouse embryo neurogenesis which found that the precise 
orientation can vary within limits.20 In this study, the observed orientation 
would result in asymmetrical cell division with the daughter cells inheriting 
unequal amounts of the polarised surface markers such as CD34. This 
could result in the daughter cells responding differently to their 
microenvironments and could also explain the existence of CD34-
negative stem cells as a result of asymmetrical cell division.204 
There does, however, seem to be some control over centrosome 
position in unaggregated single cells as the centrosome was found to 
colocalise with CD164 in 80% of cells where CD164 is polarised. It is 
therefore reasonable to propose that orientation of the mitotic spindle is 
also controlled in unaggregated cells. How CD164 may control the 
centrosome position is unclear as the function of CD164 is unknown. 
However, CD164 is a member of the same family as CD34 and, due to 
structural similarities, the two are proposed to have overlapping 
functions.163 CD164 was found to be polarised in unaggregated and 
aggregated cells and may also itself be linked to the cellular cytoskeleton, 
as has been found with CD34. As well as functioning as a cell adhesion 
molecule, CD164 ligation has also been shown to reduce the recruitment 
of quiescent CD34-positive cells into the cell cycle and increase cell 
death, thereby indicating an additional role for CD164 in CD34-mediated 
aggregation.162  
To confirm the link between aggregation and cell fate, the 
distribution of the cell fate determinant, Notch-1 was examined in primary 
CD34-positive cells. Notch-1 is known to affect the determination of cell 
fate although the effect differs with the context studied and has been 
shown to alter with ligand concentration.3° Like CD164, Notch-1 was also 
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polarised in a proportion of unaggregated cells as well as localising to the 
contact point between aggregated cells. This would indicate that, prior to 
aggregation, cells become polarised in order to be able to aggregate. 
This is seen during immunological synapse formation, where T cells 
become polarised with respect to LFA-1 in response to a chemokine 
gradient. This polarisation allows the T cell and antigen-presenting cell to 
come into close enough contact for further ligand-receptor interactions to 
occur necessary for T cell activation." Therefore, following aggregation, 
asymmetrical cell division is conferred by further polarisation and control 
of mitotic spindle orientation. 
Notch-1 is thought to exert its effects through proteins involved in 
control of the cell cycle, particularly through degradation of the cyclin-
dependent kinase inhibitors, p27"1 and p21ciP1.27 Significantly, CD34-
mediated aggregation has also been shown to effect expression of cell 
cycle proteins including upregulation of the cyclin-dependent kinase 
inhibitors p16Ink4a and p27Kip1 (Bullock et al., submitted 2006), as well as 
significantly reducing progenitor cell self-renewal.140, 141 
Therefore, CD34-mediated aggregation appears to control the 
number of cells undergoing asymmetrical cell division. This may be a 
crowding effect to reduce self-renewal when significant numbers of CD34 
-positive cells are in close proximity to each other. This effect may involve 
Notch-1 activation and signalling via the cell cycle machinery. 
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8.1 Discussion 
The function of the haemopoietic stem and progenitor cell marker, 
CD34, is unknown although roles in both cell adhesion and signalling 
pathways have been suggested. Majdic et al., were the first group to 
describe homotypic adhesion between cells of the CD34-positive cell line, 
KG1a, induced by the class II anti-CD34 antibody, QBEND10.138 This 
aggregation is accompanied by polarisation of CD34 to the cell-to-cell 
contact point, which is also seen between developing myeloid colonies in 
vitro and haematons isolated from normal bone marrow, indicating that 
CD34-mediated aggregation is a normal physiological process and CD34 
is pro-adhesive in this context.1" The signalling potential of this 
aggregation is indicated by the finding that capping of CD34 is 
accompanied by the tyrosine phosphorylation of a novel set of proteins at 
the capping site.139 More recently, CD34-mediated aggregation has been 
demonstrated to lead to the tyrosine phosphorylation of CD34 itself on its 
intracellular tail and translocation of protein kinase C from the membrane 
to the cytoplasm. Significantly, aggregation between primary CD34-
positive cells has been shown to significantly decrease progenitor cell 
self-renewal and CD34-positive cells from chronic myeloid leukaemia 
patients are deficient in their ability to aggregate (unpublished 
observations), indicating that communication between CD34-positive cells 
may function in the contact-mediated inhibition of progenitor cell self-
renewal.1" 
The maintenance and expansion of haemopoiesis has been 
suggested to involve the balance between asymmetrical and symmetrical 
cell division (Figure 1.2), the control of which is not fully understood.6 A 
number of studies in Drosophila have provided clues to the mechanisms 
controlling asymmetrical cell division and have been found to include 
interaction between cells, polarisation of cell fate determinants and mitotic 
spindle orientation.16 
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Since cell-to-cell communication and cell polarisation are also 
features of CD34-mediated aggregation, we hypothesized that formation 
of a specialised adhesive junction between CD34-positive cells may 
function to control asymmetrical cell division, thereby limiting progenitor 
cell proliferation. 
We have observed that KG1a and primary CD34-positive cell 
aggregation can be influenced by factors, such as cytokines, known to 
affect progenitor cell proliferation and differentiation. We have 
demonstrated that CD34, but not CD43, becomes localised to the 
intercellular contact point between aggregated KGIa and primary AC133-
positive cells. Due to their structural similarities, CD34 and CD43 are 
proposed to have partially overlapping functions although in this situation, 
this appears not to be the case.145 However, despite displaying a 
significant reduction in progenitor cell colony forming ability, CD34 knock 
out mice develop normally, therefore it was concluded that an alternative 
adhesion molecule, such as CD43, may be able to compensate for its 
loss.78 205 Aggregation has also been demonstrated to be induced by 
anti-CD43 antibodies but important differences between both types of 
aggregation have been demonstrated throughout this investigation, 
particularly with reference to the adhesion molecules involved. 
Significantly, engagement of CD43 on haemopoietic cells, but not more 
differentiated cells has been shown to induce apoptosis although no cell 
loss was observed with anti-CD43 throughout this investigation or with 
QBEND10 as demonstrated by Gordon et al., providing further evidence 
for the use of QBENDIO induced aggregation as a model for CD34-
mediated cell communication in ViV0.145' 153 
CD34 was shown to adopt a ring-like structure on aggregated 
cells, similar to the arrangement of cell adhesion and signalling molecules 
at the immunological synapse. Importantly, the [32 integrin , LFA-1 and its 
ligand ICAM-1 are known to play key roles in the early stages of 
immunological synapse formation.185 Using siRNA, we confirmed that 
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here too, LFA-1 is critical during the early stages of CD34-mediated 
aggregation although ICAM-1 does not appear to be its major ligand in 
this situation. The finding that LFA-1 is involved in CD34-mediated 
aggregation is consistent with the findings of Majdic et al., who 
demonstrated that blocking antibodies to LFA-1 inhibited QBENDIO-
induced aggregation. However, blocking antibodies to ICAM-1 were also 
shown to inhibit aggregation.138 This discrepancy could be explained by 
the fact that blocking studies were only done for 90 minutes whereas we 
were looking at longer time point. Therefore ICAM-1 may be involved 
initially but an alternative ligand required for stable synapse formation. 
EDTA treatment was found to significantly reduce QBENDIO-induced 
aggregation of KG1a and primary AC133-positive cells, an effect which 
may be explained by the requirement for divalent cations for 
integrin/ligand binding.53 
CD44 has previously been demonstrated to be polarised on 
primary CD34-positive cells exposed to early acting cytokines.137 
However, these cells had been isolated on CD34 and, therefore, already 
been exposed to QBENDIO. We have found CD44 polarisation on 
unaggregated cells suggesting that polarisation of haemopoietic cells 
may be both induced and constitutive as seen in mammalian 
neuroepithelial cells.21  Even though CD44 is constitutively polarised, 
siRNA knockout showed that it is critical, not to the process of 
aggregation itself, but to the maintenance of stable aggregation. This 
agrees with the suggestion that, as well as being involved in adhesion to 
the extracellular matrix, CD44 is involved in cell-to-cell interactions.85 The 
ligand for CD44 on haemopoietic stem and progenitor cells is unknown 
although a number of studies have suggested that hyaluronic acid may 
form a bridge between two CD44-expressing cells." 
We have also demonstrated that, the sialomucin, CD164 is 
polarised in unaggregated and aggregated cells but is actively excluded 
from the cell-to-cell contact point. Like CD44, CD164 has also been 
suggested to be involved in adhesion of progenitor cells to the niche 
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indicating that polarisation of these surface markers may be involved in 
their interaction with the niche.162 Similar exclusion of surface markers is 
observed during immunological synapse formation, removing steric 
hindrance and aiding T cell receptor engagement.111  
One of the earliest markers of T cell polarisation is F-actin 
accumulation at the leading edge, an event which has been shown to be 
essential for T cell receptor signalling.186 Similarly, we have observed F-
actin localisation at the contact point between aggregated CD34-positive 
cells and demonstrated a functional link between CD34 and the 
cytoskeleton itself. These findings are consistent with studies 
demonstrating that CD34-mediated aggregation requires an intact 
cytoskeleton.138' 140 It was anticipated that, like CD43 and CD44, a link 
between actin and CD34 may be achieved through the ERM family of 
cytoskeletal linker proteins.86' 164 However, ERM family members failed to 
immunoprecipitate with CD34 demonstrating that the link must be via an 
alternative mechanism. 
In T cells, polarisation of surface markers to the immunological 
synapse is achieved through lipid-raft mediated transport. Similar 
mechanisms controlling the reorganisation of cell adhesion molecules is 
likely to be as critical during CD34-mediated aggregation. As in polarised 
T cells, lipid raft accumulation can be observed and the intercellular 
contact point between aggregated CD34-positive cells.127 Significantly, 
LFA-1 itself has been shown to be involved in the recruitment of lipid rafts 
to the immunological synapse.206 As we have shown LFA-1 to be critical 
during early stages of haematological synapse formation, it may serve a 
similar function on CD34-positive cells. 
Further evidence for the role of lipid rafts in the transport of cell 
surface molecules is indicated by a decrease in aggregation following 
treatment with methyl-f3-cyclodextrin.128 Analysis of rafts in unaggregated 
and aggregated KG1a cells showed that a proportion of the total cellular 
CD34, CD44 and LFA-1 are all present in lipid rafts, particularly following 
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aggregation. Interestingly, CD164 was also found within the lipid raft 
fraction despite being actively excluded from the cell-to-cell contact point. 
This is consistent with the theory that lipid rafts are heterogeneous and 
different subsets of rafts may be responsible for the transport of various 
molecules to particular areas of the cell surface.128 As only a proportion of 
the total cellular content of the adhesion molecules involved in CD34-
mediated aggregation can be found within lipid rafts, it is also possible 
that these rafts are responsible for the transport of an as yet unidentified 
signalling or adhesion molecule to the intercellular contact point. 
Interestingly, members of the connexin family have been shown to 
localise within lipid rafts indicating a link between lipid raft polarisation 
and gap junction formation.36 
Previous studies within the laboratory have indicated that gap 
junctions are associated with the close cell-to-cell contact observed 
during CD34-mediated aggregation." Here we have confirmed that gap 
junctions exist between primary CD34-positive cells but to a lesser extent 
between KG1a cells. This may be due to the fact that KG1a cells are a 
leukaemic cell line and it is known that malignant cells are deficient in gap 
junctional communication compared to their normal counterparts.198 Gap 
junctions have previously been demonstrated to exist between 
haemopoietic cells and stromal cells as well as between stromal cells 
themselves.192' 193 Significantly, gap junctional communication has been 
demonstrated to be critical for polarization in epithelial cells and connexin 
43 itself found to reside within lipid rafts."' Additionally, in Drosophila, 
germ line stem cell differentiation has been shown to be dependent on 
communication via gap junctions.208 We have demonstrated the 
importance of gap junctions in haemopoietic progenitor cell self-renewal 
using the specific gap junction closer, carbenoxolone. Following 
carbenoxolone treatment, the reduction in self-renewal induced by CD34-
mediated aggregation is inhibited indicating that messengers passed 
through gap junctions are critical in the control of haemopoietic cell self-
renewal. It appears unlikely that, in this case, gap junctions are involved 
in haemopoietic cell polarization as carbenoxolone had no effect on the 
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level of aggregation. Gap junctions allow ions and molecules of less than 
1kDa to pass through including metabolites and second messengers, 
while proteins and nucleic acids cannot.36' 192 Potential second 
messengers include calcium, cAMP and inositol triphosphates, all of 
which are capable of activating various downstream signalling pathways 
including the activation of PKC, already implicated T cell activation and 
signalling following sialomucin-mediated aggregation.140' 200, 209 Cyclic 
AMP is also implicated control of the cell cycle and regulation of cyclin-
dependent kinase inhibitors although its precise effects are cell-type 
specific.21° Recently, a role for miRNAs in the control of stem cell 
proliferation and differentiation has been suggested.201  Interestingly, 
these miRNAs have also been shown to be passed between cells via gap 
junctions indicating a potential mechanism by which intercellular 
communication may result in the regulation of self-renewal.202  
We have demonstrated polarisation of the cell fate determinant 
Notch-1 on unaggregated primary AC133-positive cells and localisation of 
Notch-1 to the intercellular contact point. Notch-1 is known to exert its 
effects of haemopoietic progenitor cell self-renewal and differentiation 
through modulation of the cyclin-dependent kinase inhibitors and 
therefore, regulation of cell cycle kinetics.27 CD34-mediated aggregation 
has also been shown to lead to alterations in the same set of cyclin-
dependent kinase inhibitors, upregulation of which has been linked with a 
decrease in progenitor cell self-renewal, providing a link between cell 
polarisation, Notch-1 and regulation of the cell cycle.28' 141 Also, King et 
al., demonstrated a link between connexin expression and alterations in 
the levels of the cyclin-dependent kinase inhibitors therefore, also 
connecting gap junctions to this pathway.211 
Polarization of cell fate determinants and surface markers has 
been linked to the induction of asymmetrical cell division.16 In a cell, 
centrosomes act to organise the mitotic spindle during cell division, the 
orientation of which determines the plane of cell division.203 It is accepted 
that cell-to cell contacts can determine the balance between symmetrical 
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and asymmetrical cell division.212 We have observed that during 
interphase, the single centrosome in aggregated cells does not appear to 
be randomly distributed and is influenced by the position of the 
sialomucin, CD164. Once the centrosome duplicates during mitosis, 
again the orientation does not appear to be random, the alignment of 
which indicates the outcome of division would be asymmetrical with one 
of the daughter cells inheriting more of the markers polarised to the 
intercellular contact point. However, orientations indicating strictly 
horizontal or vertical divisions were not seen indicating that the position of 
both centrosomes may vary within limits allowing both asymmetrical and 
symmetrical divisions, as seen in the developing telencephalon, which 
may be expected in a system as dynamic as haemopoiesis." Niche-
independent self-renewal has been described within the haemopoietic 
system and it is possible that CD34-mediated interactions may provide a 
mechanism by which division is controlled without contact with the niche, 
with each cell providing divisional cues to the other. 213 
In conclusion, we have used the term 'haematological synapse' to 
describe a specialised adhesive junction between CD34-positive cells, 
analogous to the immunological synapse between a T cell and antigen-
presenting cell. This interaction functions in the contact-mediated 
inhibition of haemopoietic progenitor cell self-renewal through modulation 
of the cell cycle and the plane of cell division. 
Initial adhesion appears to be mediated by the integrin family of 
adhesion molecules, specifically LFA-1, potentially activated in response 
to environmental signals or by clustering of the receptor itself. This 
functions to bring the cells into close enough contact for engagement of 
CD34. It appears that polarisation of CD164 away from the contact point 
may aid in this adhesion and control the position of the centrosome. Links 
with the cytoskeleton then allow polarisation of the cytoskeleton itself, 
CD34, LFA-1 and recruitment of lipid rafts. Although CD44 is polarised on 
unaggregated cells, it functions to stabilise aggregation allowing gap 
junctional communication and cell cycle related signalling events to occur, 
potentially thorough Notch-1. During cell division, the duplicated 
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centrosome migrates to the opposite pole of the cell, thereby determining 
the plane of cell division. 
8.2 Future work 
8.2.1 The distribution of adhesion molecules at the haematological 
synapse 
As we have described the distribution of CD34 as a ring-like 
structure at the intercellular contact point it would be interesting to 
visualise the distribution of other surface markers known to be involved in 
haematological synapse formation. It appears that CD34 may occupy an 
outer adhesion ring, therefore we would anticipate that another adhesion 
molecule such as LFA-1 may occupy the inner zone. Using live cell 
confocal imaging it would also be possible to determine which of these 
markers is polarised first and which are involved in the later stages of 
synapse formation. 
8.2.2 Confirmation of results in specific haemopoietic stem and 
progenitor cell populations 
Studying AC133-positive cells provides an idea of the situation in 
both haemopoietic stem and progenitor cells. Often, this has been 
following progenitor cell mobilisation. Results could be confirmed in both 
haematons isolated from normal bone marrow and developing myeloid 
colonies where CD34-mediated aggregation has been observed 
previously.140 Also, further isolation could be used to identify the small 
population of haemopoietic stem cells to determine the role of sialomucin-
mediated aggregation in control of the size of the stem cell pool. 
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8.2.3 The role of PDZ domain containing proteins in CD34-positive 
cell aggregation 
PDZ domain containing proteins have been proposed to form a 
network, linked to the cytoskeleton, capable of controlling the localisation 
of specific proteins during cell polarization and asymmetrical cell 
division.104 Recently members of this family have been identified in T cells 
and implicated in T cell polarization during immunological synapse 
formation.705 Interestingly, analysis of CD34 itself reveals a potential 
PDZ-binding domain on its intracellular tail indicating the potential for a 
protein network linking polarization and the cytoskeleton.146 The 
expression of PDZ domain proteins such as Scribble, shown to be critical 
for T cell polarization, could be studied, their localisation investigated 
using immunofluorescence and any effect on sialomucin-mediated 
aggregation determined using siRNA techniques."5 
8.2.4 The role of miRNAs in the inhibition of progenitor cell self-
renewal 
One candidate for the role of gap junctions in the inhibition of 
progenitor cell self-renewal is the transfer of MicroRNAs (miRNAs). 
MiRNAs are endogenously expressed short, non-coding, RNAs of around 
22 nucleotides in length. They are capable of regulating gene expression 
at the post-transcriptional level through specific sequence-guided 
interactions with coding mRNA.2'4  
First discovered in C.elegans, miRNAs are thought to play 
important roles in both animal and plant development. Significantly, in the 
worm, they have been shown to play a role in the control of asymmetrical 
expression of chemosensory receptors in neurons.214 
Although no specific functions for miRNAs have been identified in 
mammals, a role in the control of haemopoiesis is indicated through 
studies in mice where a number of miRNAs are differentially expressed in 
haemopoietic organs both during embryogenesis and lineage 
differentiation.214 The ectopic expression of miRNAs has been shown to 
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affect lineage differentiation for example, on specific miRNA known as 
Mik-181 is expressed in B lymphoid cells and ectopic expression 
increases B cell number in the bone marrow and circulation, an effect 
which is thought to be mediated through the repression of Notch signals. 
MiRNAs are also implicated in leukaemogenesis, with the genes for 3 
miRNAs being located at the sites of break points of translocations and 
deletions linked to human leukaemias.215 
MiRNAs bear close resemblance to siRNAs, the transfer of which 
has been demonstrated to occur through gap junctions connecting 
connexin-specific cell lines, this movement being specifically through 
junctions composed of connexin-43 (Cx43). With a molecular weight of 
between 2 and 4 kDa, siRNAs exceed previously known molecular weight 
limits of gap junction transfer although diffusion is slow with the diameter 
of siRNA being 1nm moving through a pore of between 1 and 1.5nm 
wide.216 
It was hypothesized that miRNAs may also be transferred through 
gap junctions and may be capable of regulating gene expression in a 
neighbouring cell. This was demonstrated by Wolvetang et a/. who 
observed transfer of green fluorescent protein (GFP) miRNA through 
Cx43 type gap junctions in two embryonic stem cell lines.202 Therefore 
miRNA transfer between aggregated CD34-positive cells could be 
observed by fluorescence microscopy. 
8.2.5 The role of Notch-1 on aggregated CD34-positive cells 
As Notch-1 is known to play a role in stem cell proliferation and 
differentiation and we have demonstrated Notch-1 polarisation both on 
unaggregated and aggregated CD34-positive cells, it would be useful to 
confirm what role Notch-1 is playing in this situation, whether it functions 
to increase or decrease self-renewal.217 This could be achieved through 
siRNA knock-out and the CFU-GM assay to measure progenitor cell 
proliferation. 
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8.2.6 The role of defective aggregation in CML 
CD34-positive cells from chronic myeloid leukaemia (CML) 
patients are defective in their ability to undergo CD34-mediated 
aggregation. The reason for this is unclear but the abnormal circulation 
and proliferation of progenitor cells has been linked to defects in integrin-
mediated adhesion.62 Therefore CML progenitors could be analysed for 
their ability to undergo polarisation with the respect to those surface 
markers known to be involved in haematological synapse formation and 
those known to be constitutively polarised on haemopoietic progenitors. 
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